mitomycin has been researched along with Intraocular Pressure in 892 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This unicentric randomized clinical trial was designed to compare the surgical outcomes of mitomycin C-enhanced trabeculectomy (MMC-TRAB) with and without subtenon triamcinolone acetonide (TAAC) injection in patients with non-inflammatory glaucomas." | 9.51 | Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial. ( Almeida, I; Dias, DT; Gracitelli, CPB; Kanadani, FN; Lopes, FS; Prata, TS; Ushida, M, 2022) |
| "Comparison of the effect of mitomycin C (MMC) versus bevacizumab-methylcellulose mixture (BMM) on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure in patients with open-angle glaucoma was made." | 9.30 | Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study). ( Ghojazadeh, M; Latifi, A; Moghaddam, N; Mostafaei, A; Taheri, N, 2019) |
| "To determine whether adjunctive mitomycin C (MMC) or amniotic membrane transplantation (AMT) improve the outcomes of Ahmed glaucoma valve (AGV) implantation." | 9.22 | Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. ( Doozandeh, A; Ghahari, E; Mahboobipour, H; Pakravan, M; Yazdani, S, 2016) |
| "To compare the results of subscleral trabeculectomy (SST) augmented with mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control and incidence of complications." | 9.17 | Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. ( Ellakwa, AF; Mandour, SS; Marey, HM, 2013) |
| "To evaluate the potential usefulness of a freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C (MMC) in the maintenance of functioning glaucoma surgery in cases of pediatric glaucoma." | 9.14 | A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma. ( Almasalamy, SM; Almasary, AM; Anany, HA; Mahdy, RA; Nada, WM, 2010) |
| "To evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in eyes undergoing Ahmed Glaucoma Valve implantation." | 9.11 | Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. ( Arcieri, ES; Azuara-Blanco, A; Costa, VP; Lesk, MR; Netland, PA, 2004) |
| "In one-year-follow up patients after trabeculectomies with or without topical use of mitomycin C were controlled for early and late complications, and levels of intraocular pressure." | 9.11 | [Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications]. ( Szaflik, J; Zaleska-Zmijewska, A, 2004) |
| "To evaluate subconjunctival mitomycin C (MMC) injection efficacy and safety in patients with failing glaucoma non-penetrating filtering blebs." | 9.10 | Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. ( Iester, M; Mermoud, A; Ravinet, E, 2002) |
| "To compare the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C." | 9.10 | A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2003) |
| "To investigate the long-term therapeutic effect of Hunan aqueous drainage (HAD) implantation with and without adjunctive intraoperative mitomycin C (MMC) for refractory glaucoma." | 9.10 | [Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma]. ( Duan, X; Jiang, Y; Qing, G, 2003) |
| "To verify if partial intraoperative Tenon's capsule resection (PTCR) with adjunctive mitomycin C is effective in developing thin, avascular blebs in eyes undergoing Ahmed glaucoma valve insertion, and to assess the efficacy and safety of this procedure." | 9.10 | Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. ( Susanna, R, 2003) |
| "The use of adjunctive intraoperative mitomycin C has considerably improved the success rate of glaucoma filtering surgery." | 9.08 | The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. ( Mégevand, GS; Murray, AD; Salmon, JF; Scholtz, RP, 1995) |
| "Twenty-eight eyes of 28 patients with advanced primary open-angle glaucoma undergoing primary trabeculectomy were randomized to either mitomycin C (0." | 9.08 | Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. ( Comegno, PE; Costa, VP; José, NK; Malta, RF; Vasconcelos, JP, 1996) |
| "To evaluate the adjunctive use of mitomycin-C (MMC) during trabeculotomy and trabeculectomy for eyes with high-risk congenital glaucoma." | 9.08 | Mitomycin-C in congenital glaucoma. ( Agarwal, HC; Honavar, SG; Sanga, L; Sihota, R; Sood, NN, 1997) |
| "Although there is a currently a revolution in angle-based procedures, subconjunctival filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for glaucoma surgeons." | 9.05 | Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. ( Fellman, RL; Grover, DS; Kornmann, HL, 2020) |
| " We concluded mitomycin C might be more effective in reducing intraocular pressure and increasing qualified success compared to 5-fluorouracil." | 8.98 | Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma? ( Pimentel, E; Schmidt, J, 2018) |
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 8.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| "To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC)." | 8.31 | The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits. ( Demirci Küçük, K; Furat Rençber, S; Öztürk, A; Yazır, Y; Yüksel, N; Yüksel, R, 2023) |
| "To evaluate the effect of intraoperative mitomycin C (MMC) on the surgical outcomes of ciliary sulcus (CS) Ahmed glaucoma valve (AGV) tube placement." | 8.31 | Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement. ( Bae, HW; Choi, W; Kim, CY; Kim, NE; Kim, SS; Lee, JS; Lee, K; Lee, SY, 2023) |
| "To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)." | 8.31 | Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023) |
| "To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)." | 8.31 | A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023) |
| "The purpose of this study was to report a case of infective necrotizing scleritis following XEN Gel Stent with mitomycin-C." | 8.12 | Infective Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C. ( Kingston, EJ; Lusthaus, JA; McCluskey, PJ; Raman, P; Symes, RJ; Zagora, SL, 2022) |
| "This study aimed to compare the effectiveness of combination therapy consisting of low-dose mitomycin C (MMC) and valproic acid (VPA) against high-dose MMC for improving the scar phenotype in minimally invasive glaucoma surgery (MIGS)." | 8.12 | Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery. ( Chu, SWL; Ibrahim, FI; Seet, LF; Teng, X; Toh, LZ; Wong, TT; Yap, ZL, 2022) |
| "To determine surgical outcomes and risk factors for failure of trabeculectomy with mitomycin C (TMMC) in pediatric traumatic glaucoma." | 8.12 | Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study. ( Jain, E; Mohan, A; Peeush, P; Prasad, K; Sen, A; Sen, P; Shah, C; Tripathi, S, 2022) |
| "We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series." | 8.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 8.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "2 mg/mL mitomycin C, either alone or in combination with cataract surgery." | 8.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "To compare the short-term outcomes of combined phaco-emulsification with posterior chamber intra-ocular lens and mitomycin augmented trabeculectomy in patients with pseudo-exfoliation glaucoma (PXFG) versus primary open-angle glaucoma (POAG)." | 8.12 | Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma. ( Krishna, SM; Kumar, MR; Odayappan, A; Puthuran, GV; Senthilkumar, VA; Uduman, MS; Wijesinghe, HK, 2022) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 8.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| "To analyse the morphological evolution of filtering blebs with anterior-segment OCT (AS-OCT) and its correlation with intraocular pressure after ab externo SIBS microshunt implantation with mitomycin C (MMC) during a 3-month follow-up period." | 8.12 | Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction. ( Gómez de Liaño, R; Ibarz Barberá, M; Morales Fernández, L; Tañá Rivero, P; Teus, MA, 2022) |
| ": To evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgeries." | 8.12 | Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention. ( Battula, M; Dangeti, D; Garudadri, C; Rao, HL; Senthil, S, 2022) |
| "To compare the intraocular pressure-lowering effect and success rate of trabeculectomy with OloGen to that of trabeculectomy with mitomycin C (MMC) in cases of silicone oil-induced glaucoma." | 8.12 | Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma. ( Hashem, NH; Shalaby, HS, 2022) |
| "The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy." | 8.02 | [Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021) |
| "This paper reports a retrospective consecutive case series investigating the efficacy of Mitomycin C-augmented trabeculectomy in the treatment of primary and secondary pediatric glaucoma in a mixed etiology, multiethnic cohort of patients." | 8.02 | Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort. ( Ahmad, M; Gurney, SP; Makanjuola, T; Parulekar, MV; Ramm, L, 2021) |
| "To investigate the effects of halofuginone and pirfenidone on wound healing in experimental glaucoma filtration surgery (GFS)." | 8.02 | The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery. ( Akin, MM; Demir, T; Gungor Kobat, S; Kasar, K, 2021) |
| "To compare the outcomes of Aurolab aqueous drainage implant (AADI; Aurolab) placement and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to aniridia." | 8.02 | Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia. ( Durai, I; Gedde, SJ; Krishnadas, SR; Pallamparthy, S; Palmberg, P; Puthuran, GV; Robin, AL; Uduman, MS; Wijesinghe, HK, 2021) |
| "The purpose of this study was to determine the long-term outcomes of Ahmed glaucoma valve (AGV) implantation with intraoperative application of mitomycin-C (MMC) for the treatment of childhood glaucoma." | 8.02 | Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. ( Lyons, CJ; Promelle, V, 2021) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 8.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "The aim was to evaluate the effectiveness of bacterial cellulose membrane (BCM) in preventing fibrosis in trabeculectomy and the biocompatibility of BCM with conjunctiva and sclera." | 8.02 | Novel Bacterial Cellulose Membrane to Reduce Fibrosis Following Trabeculectomy. ( Akpolat, N; Koc, O; Tekin, IO; Yazgan, S, 2021) |
| "To report the first case of bilateral ocular decompression retinopathy after uneventful non-perforating deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome." | 7.96 | Bilateral decompression retinopathy after deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome. ( Díez-Álvarez, L; Garcia, CF; Muñoz-Negrete, FJ; Rebolleda, G, 2020) |
| "To examine the efficacy and safety of current trabeculectomy with mitomycin C in Japan for glaucomatous eyes with low intraocular pressure (IOP)." | 7.96 | Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. ( Higashide, T; Hirooka, K; Kiuchi, Y; Ohkubo, S; Sugimoto, Y; Sugiyama, K; Yuasa, Y, 2020) |
| "The aim of this study is to describe the effectiveness of trabeculectomy with mitomycin C and releasable suture in Posner-Schlossman syndrome (PSS) with secondary glaucoma." | 7.91 | The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series. ( Artini, W; Bani, AP, 2019) |
| "Complete atrophy of the filtration bleb is a very rare complication after trabeculectomy with mitomycin C and collagen matrix implant (Ologen®, Aeon Astron Corporation, Taipei, Taiwan)." | 7.88 | [Early atrophy of the conjunctiva after trabeculectomy with mitomycin C and collagen matrix implant]. ( Dietlein, T; Siggel, R, 2018) |
| "To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma." | 7.88 | Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations. ( Bayoumi, NH, 2018) |
| " The triamcinolone + mitomycin C acetate group presented better indices as for the maximum bleb height and vascularization of the bleb central area (p=0." | 7.88 | Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study. ( Araújo, ID; Cronemberger, S; Rangel, HMDA; Rolim, HT; Vidigal, P, 2018) |
| "To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 7.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
| "To examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation." | 7.85 | Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. ( Cui, QN; Han, Y; Hsia, YC; Lin, SC; Mehta, N; Naseri, A; Porco, TC; Rose-Nussbaumer, J; Stamper, RL, 2017) |
| "To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma." | 7.85 | Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma. ( Crouch, ER; Nash, DL, 2017) |
| "To evaluate the intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma." | 7.85 | Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To report the outcomes of primary trabeculectomy with mitomycin-C (MMC) in eyes with glaucoma secondary to iridocorneal endothelial (ICE) syndrome." | 7.83 | Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome. ( Chandran, P; Choudhari, NS; Garudadri, CS; Mandal, AK; Rao, HL; Senthil, S, 2016) |
| "To evaluate the short-term outcomes of lensectomy, combined with vitrectomy, scleral-fixated intraocular lens (SFIOL), and trabeculectomy with adjunctive mitomycin C (MMC) in patients with subluxated/dislocated crystalline lenses with associated elevated intraocular pressure (IOP)." | 7.83 | Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens. ( Balekudaru, S; David, RL; George, RJ; Lingam, V; Sen, P, 2016) |
| "To evaluate the outcomes of trabeculectomy with mitomycin-C (MMC) in uveitis associated with Vogt-Koyanagi-Harada disease (VKH)." | 7.83 | Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2016) |
| " We aim to assess the changes in corneal scar density with serial Scheimpflug images following primary pterygium excision with topical application of mitomycin-C." | 7.81 | Monitoring corneal densities following primary pterygium excision with adjuvant topical mitomycin-C application--an observational study of corneal scar changes. ( Belin, MW; Kam, KW; Young, AL, 2015) |
| "To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion." | 7.80 | Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. ( Chandra, A; Gupta, V; Kumar, S; Sihota, R; Singh, D, 2014) |
| "To compare outcomes between patients undergoing trabeculectomy with an Ex-PRESS mini glaucoma device using mitomycin-C (MMC) to those undergoing the same procedure using a subconjunctival collagen matrix implant (Ologen)." | 7.80 | Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. ( Johnson, MS; Sarkisian, SR, 2014) |
| "To evaluate the surgical outcome of Ahmed glaucoma valve (AGV) implantation with a new technique of mitomycin C (MMC) application." | 7.80 | Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. ( Huang, W; Wang, W; Zhang, X; Zhou, M, 2014) |
| "To compare the effects of silver nanoparticles (AgNPs) and mitomycin C (MMC) on intraocular pressure (IOP) and external, histologic, and immunohistochemical bleb characteristics in a rabbit model of filtration surgery." | 7.79 | Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery. ( Butler, MR; Chevez-Barrios, P; Frankfort, BJ; Orengo-Nania, S; Prospero Ponce, CM; Weinstock, YE, 2013) |
| "To evaluate the prognostic factors for surgical outcomes of subsequent trabeculectomy with mitomycin C (MMC) after prior incisional glaucoma surgery." | 7.79 | Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2013) |
| "To report outcomes of deep sclerectomy (DS) with intraoperative mitomycin C (MMC) application in eyes with previous failed glaucoma surgery (GS) and/or cataract extraction (CE)." | 7.78 | Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia. ( Anand, N; Wechsler, D, 2012) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 7.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "To determine the medium-term intraocular pressure (IOP) control and visual outcomes for patients with advanced glaucoma undergoing trabeculectomy with mitomycin C." | 7.77 | Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. ( King, AJ; Stead, RE, 2011) |
| "To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery." | 7.77 | Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011) |
| "To investigate the relationship between intrascleral bleb height and intraocular pressure (IOP) following deep sclerectomy with collagen implant (DSCI) and mitomycin C (MMC) in eyes with clinically flat blebs." | 7.76 | Postoperative IOP is related to intrascleral bleb height in eyes with clinically flat blebs following deep sclerectomy with collagen implant and mitomycin. ( Mavrakanas, N; Mendrinos, E; Shaarawy, T, 2010) |
| "To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)." | 7.75 | Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009) |
| "To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma." | 7.74 | Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008) |
| "The primary objective of this study was to determine if intraoperative application of mitomycin C (MMC) is safe as an adjunct for pterygium surgery." | 7.74 | Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery. ( Díaz, L; Emanuelli, A; Izquierdo, NJ; Villegas, VM, 2008) |
| "To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 7.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
| "The purpose of this study was to compare the outcomes of mitomycin C (MMC)-augmented trabeculectomy in glaucoma patients with uveitis to those without uveitis but with other high-risk characteristics." | 7.74 | Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. ( Birt, C; Derzko-Dzulynsky, L; Noble, J; Rabinovitch, T, 2007) |
| " Here, we report a case of iris prolapse caused by blunt ocular trauma after NPT with sinusotomy and mitomycin C treatment." | 7.74 | Iris prolapse after non-penetrating trabeculectomy with sinusotomy and mitomycin C. ( Ataka, S; Kohno, T; Nomura, Y; Shiraki, K; Takahashi, Y; Wada, S, 2007) |
| "To evaluate the effects of mitomycin C (MMC) on intraocular pressure (IOP) and ciliary body via transmission electron microscopy when applied under conjunctiva or different depths of sclera, without performing any filtering surgery." | 7.73 | Effect of mitomycin C on ciliary body and intraocular pressure with various application depths: an experimental study. ( Hasanreisoglu, B; Onol, M; Ozdek, S; Ozogul, C; Sari, A, 2005) |
| "To assess intraocular pressure (IOP) changes of the contralateral eyes of eyes undergoing trabeculectomy with mitomycin C (MMC)." | 7.73 | Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. ( Flammer, J; Haefliger, IO; Shaarawy, T; Vysniauskiene, I, 2005) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 7.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery." | 7.73 | Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006) |
| "Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy." | 7.73 | Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C. ( Flesner, P; Jensen, PK; Kessing, SV, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 7.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma." | 7.72 | Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003) |
| "To evaluate the results of trabeculectomy with and without the use of mitomycin C in children with primary congenital glaucoma." | 7.72 | Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. ( de Arruda Melo, PA; Júnior, AP; Montezano, FT; Prata, J; Rodrigues, AM, 2004) |
| "To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure." | 7.72 | Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004) |
| "To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 7.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
| "To describe the surgical technique and clinical outcomes of a procedure for refractory glaucoma, concurrent Baerveldt glaucoma implant (BGI) and trabeculectomy with mitomycin C." | 7.71 | Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002) |
| "In medically uncontrolled post-traumatic angle recession glaucoma trabeculectomy with mitomycin C is an effective surgical procedure with an acceptable complication rate." | 7.71 | Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. ( Barron, A; Manners, T; Murray, AD; Salmon, JF; Willies, C, 2001) |
| "To evaluate the short-term effect of trabeculectomy with adjunctive mitomycin-C (MMC) on corneal astigmatism and axial length." | 7.71 | Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism. ( Kim, HB; Kook, MS; Lee, SU, 2001) |
| "To investigate the changes of tear film functions due to the use of postoperative 5-fluourouracil (5-Fu) and intraoperative mitomycin C (MMC) in glaucoma filtration surgery." | 7.71 | [Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery]. ( Li, J; Pang, L, 2001) |
| "The authors determine if the intraoperative placement of paclitaxel powder in the subconjunctival space improves the outcome of glaucoma filtration surgery in rabbits." | 7.70 | The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. ( Jampel, HD; Moon, JI, 1998) |
| "This study aimed to compare the surgical outcomes of mitomycin C trabeculectomy glaucoma drainage device (GDD) surgery and laser neodymium:YAG (Nd:YAG) cyclophotocoagulation (CPC) in the management of intractable glaucoma after penetrating keratoplasty (PKP) in a retrospective study." | 7.70 | Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. ( Ayyala, RS; Cooper, ML; Dreyer, EB; Frangie, JP; Goldstein, MH; Mattox, C; Netland, PA; Pieroth, L; Schuman, JS; Vinals, AF; Wu, HK; Zurakowski, D, 1998) |
| "The purpose of this study was to determine the intraocular pressure (IOP), aqueous humor flow, flare and ocular side effects in eyes with a history of hypotony after trabeculectomy with adjunctive mitomycin C (MMC)." | 7.70 | Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy. ( Diestelhorst, M; Ustundag, C, 1998) |
| "Retrospective review of consecutive cases of pediatric glaucoma that underwent mitomycin C augmented trabeculectomy between January 1991 and December 1995." | 7.70 | Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. ( Beck, AD; Lynch, MG; Lynn, MJ; Noe, R; Wilson, WR, 1998) |
| "To evaluate the surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma." | 7.70 | Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999) |
| "To evaluate the effectiveness and safety of trabeculectomy with mitomycin-C (MMC) in the management of childhood glaucomas." | 7.70 | Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. ( Belmonte, SJ; Liebmann, JM; Ritch, R; Sidoti, PA, 2000) |
| "To investigate the effect of trabeculectomy with and without mitomycin C in post-keratoplasty glaucoma." | 7.70 | Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. ( Fujishima, H; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yamagami, J, 2000) |
| "To describe a case of ocular decompression syndrome in a patient after trabeculectomy with mitomycin C for neovascular glaucoma." | 7.70 | Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma. ( Danias, J; Podos, SM; Rosenbaum, J, 2000) |
| "The effects of mitomycin-C on intraocular pressure (IOP), facility of outflow (C), and Tenon's capsule fibrosis were studied over 60 days in 10 clinically normal dogs." | 7.69 | Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. ( Davidson, MG; Glover, TL; Nasisse, MP, 1995) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 7.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| "Twenty-one eyes of 21 patients with refractory glaucoma underwent glaucoma surgery involving placement of a modified Molteno implant and intraoperative application of mitomycin C." | 7.69 | Mitomycin C as adjunctive therapy with glaucoma implant surgery. ( Nicolela, MT; Susanna, R; Takahashi, WY, 1994) |
| "Mitomycin C (MMC) was used as a perioperative adjunct during trabeculectomy for 51 consecutive cases of complicated glaucoma." | 7.69 | Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months. ( Krieglstein, GK; Mietz, H, 1994) |
| "Intraoperative mitomycin-C application has been well accepted recently as a useful adjunctive procedure to enhance the filtering effect in glaucoma surgery." | 7.69 | Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery. ( Hsieh, JW; Hung, PT; Lin, LL; Wang, TH, 1995) |
| "To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin." | 7.69 | Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996) |
| "The purpose of this study was to assess the effects of intraoperative mitomycin-C (MMC) on the function of Baerveldt glaucoma implants in rabbits." | 7.69 | Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. ( Baerveldt, G; Mermoud, A; Minckler, DS; Prata, JA, 1996) |
| "An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC)." | 7.69 | Experimentally designed glaucoma implant surgery with mitomycin C in rabbit. ( Kee, C; Youn, DH, 1995) |
| "To evaluate acute retinal vein occlusion as a potential complication of trabeculectomy with mitomycin C in cases of advanced glaucoma." | 7.69 | Retinal vein occlusion after trabeculectomy with mitomycin C. ( Dev, S; Herndon, L; Shields, MB, 1996) |
| "Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure." | 7.69 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996) |
| "To inhibit the wound healing process and to achieve a better intraocular pressure lowering effect, we applied mitomycin-C (MMC) topically in trabeculectomy at different time sequences." | 7.69 | Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. ( Bair, JS; Chen, CW, 1997) |
| "Animal studies suggest that the decrease of intraocular pressure after application of mitomycin C is particularly mediated by toxic effects on the substance of ciliary body." | 7.69 | [Effect of local administration of mitomycin C on intraocular pressure]. ( Anders, N; Walkow, T; Wollensak, J, 1996) |
| "The authors studied the efficacy and complications of intraoperative mitomycin-C in glaucoma associated with ocular inflammation." | 7.69 | Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. ( McGehee, RF; Pederson, JE; Wright, MM, 1997) |
| "The purpose of the study is to determine the safety and efficacy of mitomycin C-augmented trabeculectomy in children with developmental glaucoma treated previously by conventional procedures." | 7.69 | Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. ( Jayagandan, A; John, T; Mandal, AK; Walton, DS, 1997) |
| "To evaluate the safety and efficacy of trabeculectomy with mitomycin-C in the management of postkeratoplasty glaucoma." | 7.69 | Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study. ( Gupta, A; Kumar, S; Ram, J; Sharma, A, 1997) |
| "We studied the efficacy and safety of using topical mitomycin C (MMC) as an adjunct to glaucoma filtration surgery." | 7.68 | Effects of topical mitomycin C on glaucoma filtration surgery. ( Hong, C; Hyung, SM; Kim, DM; Song, KY; Youn, DH, 1993) |
| "In this study, an experimental model of glaucoma filtration surgery was used to evaluate the clinical and histologic effects of a single intraoperative topical application of mitomycin C." | 7.68 | Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. ( Dorman-Pease, ME; Jampel, HD; Pasquale, LR; Quigley, HA; Thibault, D, 1992) |
| " 1989 trabeculectomy with per-operative topical application of mitomycin C was performed on eyes with refractory glaucoma." | 7.68 | Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. ( Bair, JS; Chen, CW; Huang, HT; Lee, CC, 1990) |
| "Mitomycin C (MMC) is an alkylating agent with extraordinary ability to crosslink DNA, preventing DNA synthesis." | 6.72 | History, presence, and future of mitomycin C in glaucoma filtration surgery. ( Al Majidi, R; Beckers, HJM; Gorgels, TGMF; Pinchuk, L; van Mechelen, RJS; Webers, CAB; Wolters, JEJ, 2021) |
| "To study the clinical effect of trabeculectomy combined with Mitomycin C and removed suture." | 6.71 | [Trabeculectomy combined with mitomycin C and removed suture in glaucoma]. ( Feng, Y, 2003) |
| "The mean intraocular pressures were significantly (P < ." | 6.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "Late postoperative complications are similar with the exception of an increased incidence of Tenon cyst formation in the MMC-treated eyes." | 6.68 | Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. ( Bergstrom, TJ; Higginbotham, EJ; Johnson, AT; Katz, GJ; Lichter, PR; Musch, DC; Skuta, GL, 1995) |
| "Raised intraocular pressure is a risk factor for glaucoma." | 6.52 | Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. ( Cabourne, E; Clarke, JC; Evans, JR; Schlottmann, PG, 2015) |
| "Mitomycin C seems to be a better treatment than 5 fluorouracil." | 6.38 | [Mitomycin C in glaucoma surgery]. ( Collignon-Brach, J, 1993) |
| " Outcome measures included IOP reduction from baseline, mean IOP change from baseline at month 6, medication use at 6 months, complications, adverse events, and need for further procedures." | 5.91 | Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. ( Burgos-Blasco, B; Fernandez-Vigo, JI; García-Feijóo, J; Gines-Gallego, C; Martinez de la Casa, JM; Mendez-Hernandez, CD; Morales-Fernandez, L; Perucho-Gonzalez, L; Saenz-Frances, F, 2023) |
| "To evaluate the efficacy and safety of using Mitomycin-C (MMC) or Ologen implant as an adjunct to combined trabeculotomy-trabeculectomy (CTT) surgery relative to non-augmented CTT surgery in achieving higher success rates in patients with primary congenital glaucoma (PCG)." | 5.69 | Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial. ( Al-Nashar, HY; Fawzi, KM; Kenawy, S; Khairy, MA, 2023) |
| "This unicentric randomized clinical trial was designed to compare the surgical outcomes of mitomycin C-enhanced trabeculectomy (MMC-TRAB) with and without subtenon triamcinolone acetonide (TAAC) injection in patients with non-inflammatory glaucomas." | 5.51 | Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial. ( Almeida, I; Dias, DT; Gracitelli, CPB; Kanadani, FN; Lopes, FS; Prata, TS; Ushida, M, 2022) |
| "Both cataract and glaucoma are significant public health problems." | 5.40 | Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy. ( Kunhammad, S; Singh, P, 2014) |
| "Mitomycin C could cause the degeneration of lens epithelial cells." | 5.31 | [The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract]. ( Huang, J; Liu, Y; Zheng, D; Zheng, H, 2001) |
| " The dosage of mitomycin-C was 0." | 5.31 | Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000) |
| "To compare the efficacy and safety of trabeculectomy with Ologen versus Mitomycin C in primary glaucoma." | 5.30 | Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh. ( Abdullahi, SM; Alam, S; Badmus, S; Hassan, Z; Kabir, J; Mahatma, M; Malek, MI; Rahman, M; Sarker, BK, 2019) |
| "Comparison of the effect of mitomycin C (MMC) versus bevacizumab-methylcellulose mixture (BMM) on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure in patients with open-angle glaucoma was made." | 5.30 | Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study). ( Ghojazadeh, M; Latifi, A; Moghaddam, N; Mostafaei, A; Taheri, N, 2019) |
| "To evaluate the intraocular pressure-lowering effect of sutureless scleral tunnel trabeculectomy with Mitomycin-C (MMC) compared to the standard trabeculectomy with MMC in patients with primary open angle glaucoma (POAG)." | 5.27 | Sutureless Scleral Tunnel Trabeculectomy: Evaluation of Feasibility and Effectiveness versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma. ( Elsawy, MF; Khairy, HA; Said-Ahmed, K, 2018) |
| "We assessed bleb morphology and the intraocular pressure (IOP)-lowering effect of trabeculectomy with ologen compared to mitomycin C (MMC) in juvenile open-angle glaucoma (JOAG)." | 5.24 | Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study. ( Abdelhakim, MASE; El-Saied, HMA; El-Sayyad, F, 2017) |
| "This was a prospective, controlled, cohort study that included 64 eyes of 46 children younger than 12 years with uncontrolled glaucoma, who underwent trabeculectomy with mitomycin C in an institutional setting." | 5.22 | Excision of Tenon Capsule in Pediatric Trabeculectomy: A Controlled Study. ( Awadein, A; El Sayed, YM, 2016) |
| "To determine whether adjunctive mitomycin C (MMC) or amniotic membrane transplantation (AMT) improve the outcomes of Ahmed glaucoma valve (AGV) implantation." | 5.22 | Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. ( Doozandeh, A; Ghahari, E; Mahboobipour, H; Pakravan, M; Yazdani, S, 2016) |
| " The purpose of this study was to compare intraocular pressure (IOP)-lowering efficacy and safety of trabeculectomy or combined phacoemulsification and trabeculectomy with mitomycin-C (MMC) vs." | 5.22 | Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial. ( de Moraes, CG; Godfrey, DG; Rademaker, AW; Ritch, R; Sarkisian, SR; Tanna, AP; Vold, SD, 2016) |
| "To evaluate the intraocular pressure (IOP)-lowering effect of trabeculectomy with the use of amniotic membrane transplant (AMT) compared with the standard trabeculectomy with Mitomycin-C (MMC) in patients with primary open-angle glaucoma." | 5.20 | Trabeculectomy With Mitomycin-C Versus Trabeculectomy With Amniotic Membrane Transplant: A Medium-term Randomized, Controlled Trial. ( Elsawy, MF; Khairy, HA, 2015) |
| "The rate of reoperation for glaucoma was higher following trabeculectomy with mitomycin C than tube shunt surgery in the TVT Study." | 5.19 | Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study. ( Feuer, WJ; Gedde, SJ; Saheb, H; Schiffman, JC, 2014) |
| "In this preliminary study, diclofenac sodium is at least as good as topical dexamethasone phosphate for glaucoma patients undergoing two-site combined phacotrabeculectomy with mitomycin C." | 5.17 | Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C. ( Goldenfeld, M; Kalev-Landoi, M; Katz, G; Levkovitch-Verbin, H, 2013) |
| "To compare phacoemulsification versus trabeculectomy with adjunctive mitomycin C in medically uncontrolled chronic angle-closure glaucoma (CACG) without cataract." | 5.17 | Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. ( Baig, N; Kwong, YY; Lam, DS; Leung, DY; Li, FC; Tham, CC, 2013) |
| "To compare the results of subscleral trabeculectomy (SST) augmented with mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control and incidence of complications." | 5.17 | Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. ( Ellakwa, AF; Mandour, SS; Marey, HM, 2013) |
| "Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC 0." | 5.16 | Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2012) |
| "Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C ([MMC]; 0." | 5.16 | Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2012) |
| "Combined phacotrabeculectomy with adjunctive mitomycin C is more effective than phacoemulsification alone in controlling IOP in medically uncontrolled CACG eyes with coexisting cataract." | 5.14 | Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. ( Chan, JC; Chiu, TY; Kwong, YY; Lai, JS; Lam, DS; Lam, SW; Leung, DY; Li, FC; Tham, CC, 2009) |
| "A 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC 0." | 5.14 | Three-year follow-up of the tube versus trabeculectomy study. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2009) |
| "Between July 2005 and October 2007, 61 consecutive medically uncontrolled glaucoma patients scheduled for first-time trabeculectomy were randomized to 1 of 3 study topical medication groups: nonsteroidal anti-inflammatory drugs (ketorolac), steroids (fluorometholone), or placebo (artificial tears)." | 5.14 | Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. ( Breusegem, C; Fieuws, S; Renier, C; Spielberg, L; Stalmans, I; Van de Veire, S; Van Ginderdeuren, R; Vandewalle, E; Zeyen, T, 2010) |
| "To evaluate the potential usefulness of a freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C (MMC) in the maintenance of functioning glaucoma surgery in cases of pediatric glaucoma." | 5.14 | A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma. ( Almasalamy, SM; Almasary, AM; Anany, HA; Mahdy, RA; Nada, WM, 2010) |
| "Combined phacotrabeculectomy with adjunctive mitomycin C may be marginally more effective than phacoemulsification alone in controlling IOP in medically controlled CACG eyes with coexisting cataract." | 5.13 | Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. ( Chan, CH; Chan, JC; Chi, CC; Chiu, TY; Kwong, YY; Lai, JS; Lam, DS; Lam, SW; Leung, DY; Li, FC; Poon, AS; Tham, CC; Yick, DW, 2008) |
| "The purpose of our study was to assess intraocular pressure control (IOP) and postoperative complications in nonpenetrating very deep sclerectomy (NPVDS) with reticulated hyaluronic acid implant (SKGEL) and Mitomycin C (MMC)." | 5.13 | Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment. ( Forminśka-Kapuścik, M; Gierek-Ciaciura, S; Leszczyński, R; Mrukwa-Kominek, E; Rokita-Wala, I, 2008) |
| "To compare the long-term effects of low-dosage mitomycin C (MMC) in both deep sclerectomy (DSMMC) and trabeculectomy (TPMMC) on intraocular pressure (IOP)." | 5.13 | Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. ( Casuccio, A; Cillino, G; Cillino, S; Di Pace, F; Lodato, G, 2008) |
| "350 mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC)." | 5.12 | Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2007) |
| "To compare the intraocular pressure (IOP)-lowering effect of combined viscocanalostomy and phacoemulsification and combined trabeculectomy and phacoemulsification with mitomycin C in eyes with primary open-angle glaucoma." | 5.12 | Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy. ( Kobayashi, H; Kobayashi, K, 2007) |
| "To evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in eyes undergoing Ahmed Glaucoma Valve implantation." | 5.11 | Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. ( Arcieri, ES; Azuara-Blanco, A; Costa, VP; Lesk, MR; Netland, PA, 2004) |
| "In one-year-follow up patients after trabeculectomies with or without topical use of mitomycin C were controlled for early and late complications, and levels of intraocular pressure." | 5.11 | [Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications]. ( Szaflik, J; Zaleska-Zmijewska, A, 2004) |
| "Study patients were randomized to undergo placement of a 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (0." | 5.11 | The tube versus trabeculectomy study: design and baseline characteristics of study patients. ( Brandt, JD; Feuer, WJ; Gedde, SJ; Heuer, DK; Parrish, RK; Schiffman, JC, 2005) |
| "To evaluate subconjunctival mitomycin C (MMC) injection efficacy and safety in patients with failing glaucoma non-penetrating filtering blebs." | 5.10 | Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. ( Iester, M; Mermoud, A; Ravinet, E, 2002) |
| "To compare the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C." | 5.10 | A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2003) |
| "To investigate the long-term therapeutic effect of Hunan aqueous drainage (HAD) implantation with and without adjunctive intraoperative mitomycin C (MMC) for refractory glaucoma." | 5.10 | [Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma]. ( Duan, X; Jiang, Y; Qing, G, 2003) |
| "To verify if partial intraoperative Tenon's capsule resection (PTCR) with adjunctive mitomycin C is effective in developing thin, avascular blebs in eyes undergoing Ahmed glaucoma valve insertion, and to assess the efficacy and safety of this procedure." | 5.10 | Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. ( Susanna, R, 2003) |
| "Trabeculectomy augmented with mitomycin C application at both sites could produce a greater lowering of intraocular pressure with low incidence of postoperative complications, and could provide an increased chance of long-term success." | 5.10 | Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. ( Fang, CT; Gu, YS; Ma, XQ; You, YA, 2002) |
| "To compare the efficacy and safety of subconjunctival and intrascleral applications of mitomycin C (MMC) in trabeculectomy for high-risk glaucomas." | 5.09 | Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies. ( Agarwal, HC; Saigal, D; Sihota, R, 2001) |
| "The perioperative use of oral prednisone did not alter the surgical outcome of filtering procedures associated with antifibrosis agents in this population of glaucoma patients." | 5.09 | Oral prednisone in guarded filtration procedures supplemented with antimetabolites. ( Augsburger, JJ; Azuara-Blanco, A; Spaeth, GL, 1999) |
| "To evaluate the efficacy and safety of application of mitomycin-C (MMC) in combined and separate trabeculectomy and penetrating keratoplasty for the treatment of coexisting corneal disease and glaucoma." | 5.09 | Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty. ( Chowers, I; Ticho, U, 1999) |
| "To evaluate the effect of ab-interno goniotrabeculotomy (AIGT) on the intraocular pressure (IOP) in adult patients with primary open-angle glaucoma (POAG), compared with the effects of mitomycin C trabeculectomy (MT)." | 5.09 | Ab-interno goniotrabeculotomy versus mitomycin C trabeculectomy for adult open-angle glaucoma: a 2-year randomized clinical trial. ( Hitchings, RA; Quaranta, CA; Quaranta, L, 1999) |
| "The intraoperative application of the antimetabolite mitomycin C has been recommended extensively in the literature for trabeculectomy in eyes with poor prognosis glaucoma." | 5.08 | [Effect of mitomycin C on aqueous humor flow after trabeculectomy]. ( Diestelhorst, M; Krieglstein, GK, 1995) |
| "The use of adjunctive intraoperative mitomycin C has considerably improved the success rate of glaucoma filtering surgery." | 5.08 | The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. ( Mégevand, GS; Murray, AD; Salmon, JF; Scholtz, RP, 1995) |
| "The authors assessed the efficacy of adjunctive intraoperative mitomycin C to produce lower intraocular pressures (IOPs) in patients with complicated glaucoma who underwent double-plate Molteno implantation." | 5.08 | Adjunctive mitomycin C in Molteno implant surgery. ( Cardakli, UF; Eisele, JR; Heatley, GA; Kaufman, PL; Perkins, TW, 1995) |
| "Twenty-eight eyes of 28 patients with advanced primary open-angle glaucoma undergoing primary trabeculectomy were randomized to either mitomycin C (0." | 5.08 | Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. ( Comegno, PE; Costa, VP; José, NK; Malta, RF; Vasconcelos, JP, 1996) |
| "Seventy-eight eyes of 78 patients with primary open-angle glaucoma with visually symptomatic cataracts and no previous incisional surgery were randomized to receive either no mitomycin C or a subconjunctival application of 1-, 3-, or 5-minute mitomycin C (0." | 5.08 | Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. ( Hughes, BA; Juzych, MS; Kim, C; Reed, SY; Shin, DH; Simone, PA; Song, MS, 1995) |
| "The purpose of the study is to determine whether the intraoperative application of subconjunctival mitomycin C (MMC), during combined phacoemulsification and trabeculectomy, is an effective means of improving filtration, defined as overall lower intraocular pressure (IOP) and less antiglaucoma medication use." | 5.08 | A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. ( Alward, WL; Barad, JP; Carlson, DW; Carney, BL; Zimmerman, MB, 1997) |
| "To establish the long-term, dose-response relationship between the concentration of and duration of exposure to mitomycin to a decrease in intraocular pressure (IOP) and fewer complications." | 5.08 | A long-term dose-response study of mitomycin in glaucoma filtration surgery. ( Bhatnagar, R; Katz, JD; Krishnadas, R; Ramakrishnan, R; Robin, AL; Selvaraj, S; Skuta, GL; Smith, SD, 1997) |
| "To evaluate the adjunctive use of mitomycin-C (MMC) during trabeculotomy and trabeculectomy for eyes with high-risk congenital glaucoma." | 5.08 | Mitomycin-C in congenital glaucoma. ( Agarwal, HC; Honavar, SG; Sanga, L; Sihota, R; Sood, NN, 1997) |
| "In the diclofenac group (n = 14), the preoperative intraocular pressure of 30." | 5.08 | The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. ( Cate, EA; Dubiner, HB; Kent, AR; Mundorf, TK; Stewart, JA; Stewart, WC; Whitaker, R, 1998) |
| "The authors assess whether adjunctive mitomycin C improves Molteno tube shunt surgery in terms of intraocular pressure (IOP), visual acuity, and complication rates." | 5.08 | The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. ( Bhavnani, V; Brizendine, E; Burgoyne, J; Cantor, L; Hoop, J; Sanders, S, 1998) |
| "To compare the intraocular pressure and hypotony outcomes of primary phakic trabeculectomies with no mitomycin C (MMC), shorter MMC, and longer MMC exposure." | 5.08 | Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. ( Ginde, SA; Kim, C; Kim, YY; Kupin, TH; Lee, D; Ren, J; Sexton, RM; Shin, DH, 1998) |
| "Although there is a currently a revolution in angle-based procedures, subconjunctival filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for glaucoma surgeons." | 5.05 | Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. ( Fellman, RL; Grover, DS; Kornmann, HL, 2020) |
| " We concluded mitomycin C might be more effective in reducing intraocular pressure and increasing qualified success compared to 5-fluorouracil." | 4.98 | Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma? ( Pimentel, E; Schmidt, J, 2018) |
| "The Tube Versus Trabeculectomy (TVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube-shunt surgery to trabeculectomy with mitomycin C (MMC) in eyes with previous cataract and/or failed glaucoma surgery." | 4.88 | The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. ( Feuer, WJ; Gedde, SJ; Schiffman, JC; Singh, K, 2012) |
| "The Tube Versus Trabeculectomy (TVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube-shunt surgery to trabeculectomy with mitomycin (MMC) in eyes with previous cataract and/or unsuccessful glaucoma surgery." | 4.86 | Review of results from the Tube Versus Trabeculectomy Study. ( Gedde, SJ; Heuer, DK; Parrish, RK, 2010) |
| "The preponderance of evidence from the literature suggests a small (2-4 mmHg) benefit from the use of mitomycin-C (MMC), but not 5-fluorouracil (5-FU), in combined cataract and glaucoma surgery (evidence grade B)." | 4.81 | Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. ( Bass, EB; Congdon, N; Friedman, DS; Jampel, HD; Kempen, JH; Levkovitch-Verbin, H; Lubomski, LH; Quigley, H; Robinson, KA, 2002) |
| "To examine why most ophthalmologists routinely use mitomycin C or 5-fluorouracil (antimetabolites) in association with filtering surgery for glaucoma." | 4.81 | The use of antimetabolites with trabeculectomy: a critical appraisal. ( Mutlukan, E; Spaeth, GL, 2001) |
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 4.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| "To compare the surgical outcomes of the Aurolab aqueous drainage implant (AADI) and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome." | 4.31 | Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome. ( Gedde, SJ; Krishnadas, SR; Mani, I; Nagdev, N; Puthuran, GV; Ramesh, S; Senthilkumar, VA; Tara, TD, 2023) |
| "This was a single-center, nonrandomized retrospective cohort study of 998 eyes from 854 patients with glaucoma who underwent trabeculectomy with mitomycin C." | 4.31 | Trabeculectomy Tenon Advancement Technique May Reduce Bleb-Related Infections. ( Higashide, T; Mambo, Y; Ohkubo, S; Okayama, M; Sugiyama, K; Tsuchiya, S; Udagawa, S; Wajima, R; Yamashita, Y, 2023) |
| "We retrospectively reviewed primary glaucoma patients who underwent mitomycin C-augmented trabeculectomy and completed 2 years of follow-up." | 4.31 | Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma. ( Chansangpetch, S; Itthipanichpong, R; Manassakorn, A; Ratanawongphaibul, K; Rojanapongpun, P; Tantisevi, V; Winuntamalakul, Y, 2023) |
| " To assess the influence of cataract surgery following TE, eyes which underwent cataract surgery at least 6 months after TE were matched 1:3 by sex and age to eyes who did not undergo cataract surgery during the follow-up period." | 4.31 | Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. ( Hoffmann, EM; Kianusch, K; Pfeiffer, N; Schuster, AK; Stingl, J; Wagner, FM, 2023) |
| "To evaluate the efficacy and safety of the Preserflo MicroShunt with mitomycin C in patients with complicated glaucoma." | 4.31 | One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma. ( Erokhina, M; Haus, A; Seuthe, AM; Szurman, P, 2023) |
| "To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC)." | 4.31 | The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits. ( Demirci Küçük, K; Furat Rençber, S; Öztürk, A; Yazır, Y; Yüksel, N; Yüksel, R, 2023) |
| "In this 4-year retrospective cohort study, medical records of glaucoma patients older than 18 who underwent primary trabeculectomy with Mitomycin-C between 2012 and 2020 were reviewed." | 4.31 | Impact of postoperative choroidal detachment on trabeculectomy outcomes: a four-year comparative study. ( Ghanbarnia, MJ; Yadgari, M, 2023) |
| "To evaluate the effect of intraoperative mitomycin C (MMC) on the surgical outcomes of ciliary sulcus (CS) Ahmed glaucoma valve (AGV) tube placement." | 4.31 | Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement. ( Bae, HW; Choi, W; Kim, CY; Kim, NE; Kim, SS; Lee, JS; Lee, K; Lee, SY, 2023) |
| "The purpose of this study was to evaluate the effectiveness and safety of an open bleb revision with mitomycin- C (MMC) for bleb fibrosis after PreserFlo MicroShunt implantation." | 4.31 | Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma. ( Hoffmann, EM; Pfeiffer, N; Schuster, AK; Strzalkowska, A; Strzalkowski, P, 2023) |
| "Trabeculectomy with mitomycin C was the most common primary surgery performed in Thai patients with JOAG, and successfully reduced intraocular pressure without significant complications." | 4.31 | Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand. ( Annopawong, K; Friedman, DS; Seresirikachorn, K; Thiamthat, W; Vu, DM; Wanichwecharungruang, B, 2023) |
| "To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)." | 4.31 | Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023) |
| "To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)." | 4.31 | A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023) |
| "Although mitomycin C is commonly used in glaucoma filtering surgeries, reports of postoperative posterior segment toxicity are rare." | 4.31 | RETINAL TOXICITY FOLLOWING PRESUMED INADVERTENT INTRAOCULAR INJECTION OF MITOMYCIN C DURING TRABECULECTOMY. ( Desai, R; Jampol, LM, 2023) |
| "The purpose of this study was to report a case of infective necrotizing scleritis following XEN Gel Stent with mitomycin-C." | 4.12 | Infective Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C. ( Kingston, EJ; Lusthaus, JA; McCluskey, PJ; Raman, P; Symes, RJ; Zagora, SL, 2022) |
| "This study aimed to compare the effectiveness of combination therapy consisting of low-dose mitomycin C (MMC) and valproic acid (VPA) against high-dose MMC for improving the scar phenotype in minimally invasive glaucoma surgery (MIGS)." | 4.12 | Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery. ( Chu, SWL; Ibrahim, FI; Seet, LF; Teng, X; Toh, LZ; Wong, TT; Yap, ZL, 2022) |
| "To determine surgical outcomes and risk factors for failure of trabeculectomy with mitomycin C (TMMC) in pediatric traumatic glaucoma." | 4.12 | Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study. ( Jain, E; Mohan, A; Peeush, P; Prasad, K; Sen, A; Sen, P; Shah, C; Tripathi, S, 2022) |
| " Trabeculectomy with or without augmentation with Mitomycin C(MMC) was the first-choice glaucoma incisional surgery for 96." | 4.12 | Surgical trends in glaucoma management: The current Indian scenario. ( Bhartiya, S; Ichhpujani, P; Kalra, G; Kumar, S; Singla, E, 2022) |
| "To report outcomes and assess the risk factors for failure of trabeculectomy (trab), trabeculectomy with mitomycin-C (trabMMC), and combined trabeculectomy with cataract extraction (CT) in vernal keratoconjunctivitis (VKC) eyes with steroid-induced glaucoma (SIG)." | 4.12 | Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma. ( Ali, MH; Choudhari, N; Dikshit, S; Garudadri, C; Krishnamurthy, R; Rao, HL; Sastry, R; Senthil, S, 2022) |
| "We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series." | 4.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 4.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "2 mg/mL mitomycin C, either alone or in combination with cataract surgery." | 4.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "To compare the short-term outcomes of combined phaco-emulsification with posterior chamber intra-ocular lens and mitomycin augmented trabeculectomy in patients with pseudo-exfoliation glaucoma (PXFG) versus primary open-angle glaucoma (POAG)." | 4.12 | Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma. ( Krishna, SM; Kumar, MR; Odayappan, A; Puthuran, GV; Senthilkumar, VA; Uduman, MS; Wijesinghe, HK, 2022) |
| " We included 27 eyes of 27 patients with glaucoma who underwent needling procedure using mitomycin C and were subsequently treated with ripasudil-a rho-associated protein kinase inhibitor (ripasudil group)-or without ripasudil (control group)." | 4.12 | Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study. ( Hirooka, K; Kiuchi, Y; Mizuno, Y; Okada, N; Okumichi, H; Onoe, H; Tokumo, K, 2022) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 4.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| "We aim to compare the outcomes of trabeculectomy with mitomycin-C by a fellowship-trained glaucoma surgeon in the first hundred compared to second hundred surgeries." | 4.12 | Augmented trabeculectomy-outcomes of first hundred versus second hundred surgeries of a fellowship-trained glaucoma surgeon. ( Ali, ZC; Khoo, DI; Rattanasirivilai, P; Shankar, V, 2022) |
| "To analyse the morphological evolution of filtering blebs with anterior-segment OCT (AS-OCT) and its correlation with intraocular pressure after ab externo SIBS microshunt implantation with mitomycin C (MMC) during a 3-month follow-up period." | 4.12 | Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction. ( Gómez de Liaño, R; Ibarz Barberá, M; Morales Fernández, L; Tañá Rivero, P; Teus, MA, 2022) |
| ": To evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgeries." | 4.12 | Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention. ( Battula, M; Dangeti, D; Garudadri, C; Rao, HL; Senthil, S, 2022) |
| "To compare the intraocular pressure-lowering effect and success rate of trabeculectomy with OloGen to that of trabeculectomy with mitomycin C (MMC) in cases of silicone oil-induced glaucoma." | 4.12 | Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma. ( Hashem, NH; Shalaby, HS, 2022) |
| "Phacotrabeculectomy using Mitomycin C and Ologen implant resulted in similar morphologic and functioning blebs at one year with comparable efficacy in controlling intraocular pressure." | 4.02 | Comparison of bleb morphology by anterior segment optical coherence tomography and clinical outcome after phacotrabeculectomy with mitomycin C or Ologen implant. ( Agrawal, D; Chelerkar, VJ; Deshpande, M; S Kalyani, VK, 2021) |
| "Sixty eyes of 60 patients complaining of primary open angle glaucoma and cataract, undergoing phaco-trabeculectomy, were distributed into three groups: group I: surgery was augmented with mitomycin C, group II with porcine extracellular matrix, and group III with porcine extracellular matrix combined with low dose mitomycin C." | 4.02 | The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy. ( Hamdi, IM; Hamdi, MM, 2021) |
| "The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy." | 4.02 | [Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021) |
| "This paper reports a retrospective consecutive case series investigating the efficacy of Mitomycin C-augmented trabeculectomy in the treatment of primary and secondary pediatric glaucoma in a mixed etiology, multiethnic cohort of patients." | 4.02 | Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort. ( Ahmad, M; Gurney, SP; Makanjuola, T; Parulekar, MV; Ramm, L, 2021) |
| "To determine the incidence of postoperative complications following combined trabeculotomy trabeculectomy with mitomycin C (CTTM) for congenital glaucoma (CG), in addition to documentation of some unusual complications and possible ways to manage these complications safely with minimal morbidity." | 4.02 | Common and rare complications following filtering surgery for children with congenital glaucoma; a5 years study. ( Sayed, KM, 2021) |
| "To investigate the effects of halofuginone and pirfenidone on wound healing in experimental glaucoma filtration surgery (GFS)." | 4.02 | The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery. ( Akin, MM; Demir, T; Gungor Kobat, S; Kasar, K, 2021) |
| "To compare the outcomes of Aurolab aqueous drainage implant (AADI; Aurolab) placement and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to aniridia." | 4.02 | Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia. ( Durai, I; Gedde, SJ; Krishnadas, SR; Pallamparthy, S; Palmberg, P; Puthuran, GV; Robin, AL; Uduman, MS; Wijesinghe, HK, 2021) |
| "The purpose of this study was to determine the long-term outcomes of Ahmed glaucoma valve (AGV) implantation with intraoperative application of mitomycin-C (MMC) for the treatment of childhood glaucoma." | 4.02 | Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. ( Lyons, CJ; Promelle, V, 2021) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 4.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "The aim was to evaluate the effectiveness of bacterial cellulose membrane (BCM) in preventing fibrosis in trabeculectomy and the biocompatibility of BCM with conjunctiva and sclera." | 4.02 | Novel Bacterial Cellulose Membrane to Reduce Fibrosis Following Trabeculectomy. ( Akpolat, N; Koc, O; Tekin, IO; Yazgan, S, 2021) |
| "Aniridic glaucoma can be managed efficiently by medications in early glaucomatous neuropathy, and with trabeculectomy augmented with mitomycin-C and releasable sutures for more advanced glaucomas, offering favourable long-term IOP control, visual stability and safety." | 4.02 | Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma. ( Azmira, K; Dada, T; Gupta, A; Selvan, H; Sharma, A; Sihota, R; Upadhyay, A, 2021) |
| "A prospective, noncomparative case series of 30 eyes of 30 Chinese patients with mixed types of glaucoma who underwent fornix-based trabeculectomy combined with intraoperative mitomycin C application." | 3.96 | The Tenons' Layer Reposition Approach of Trabeculectomy: A Longitudinal Case Series of a Mixed Group of Glaucoma Patients. ( Baig, N; Chan, PP; Chan, TCY; Lai, G; Wong, LYN, 2020) |
| "8% of eyes (n=10) required at least 1 mitomycin C (MMC)-enhanced needling revision to maintain their target intraocular pressure." | 3.96 | Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results. ( Bravetti, GE; Gillmann, K; Mansouri, K; Mermoud, A; Rao, HL, 2020) |
| "Adult patients who have undergone glaucoma surgery including a tube shunt, trabeculectomy with mitomycin C, trabectome, or transcleral cyclophotocoagulation from June 1, 2015 to August 30, 2017 at a single institution." | 3.96 | Reoperations for Complications Within 90 Days After Glaucoma Surgery. ( Al-Aswad, LA; Blumberg, DM; Chu, CK; Cioffi, GA; Liebmann, JM, 2020) |
| "PRéCIS:: Glaucoma drainage devices (GDD) by Australian and New Zealand glaucomatologists are implanted superotemporally under a peribulbar anesthesia without the use of mitomycin C." | 3.96 | Glaucoma Drainage Device Technique in a Cohort of Experienced Glaucoma Surgeons in Australia and New Zealand. ( Craig, JE; Danesh-Meyer, HV; Lee, GA; Liu, L, 2020) |
| "An intra-Tenon injection of mitomycin C resulted in decreased intraocular pressure measurements and bleb vascularity compared to the controls but increased levels compared to the sponge-applied group." | 3.96 | Injected Versus Sponge-Applied Mitomycin C (MMC) During Modified Trabeculectomy in New Zealand White Rabbit Model. ( Conner, IP; Happ-Smith, C; Kemmerer, M; Rosano, M; Schuman, JS; Swogger, J; Wells, A; Yates, CC, 2020) |
| " The greatest absolute success rate (= IOD ≤ 15 mmHg without antiglaucoma medication) was in the group with exclusive goniotrepanation + mitomycin C (MMC; 72." | 3.96 | [Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety]. ( Heinz, C; Koch, JM; Lommatzsch, C; Rothaus, K, 2020) |
| "To report the first case of bilateral ocular decompression retinopathy after uneventful non-perforating deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome." | 3.96 | Bilateral decompression retinopathy after deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome. ( Díez-Álvarez, L; Garcia, CF; Muñoz-Negrete, FJ; Rebolleda, G, 2020) |
| "To examine the efficacy and safety of current trabeculectomy with mitomycin C in Japan for glaucomatous eyes with low intraocular pressure (IOP)." | 3.96 | Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. ( Higashide, T; Hirooka, K; Kiuchi, Y; Ohkubo, S; Sugimoto, Y; Sugiyama, K; Yuasa, Y, 2020) |
| "A total of 1,098 eyes of patients with glaucoma who underwent trabeculectomy with mitomycin C at 34 clinical centers included in CBIITS were analyzed." | 3.91 | Trabeculectomy followed by phacoemulsification versus trabeculectomy alone: The Collaborative Bleb-Related Infection Incidence and Treatment Study. ( Arimura, S; Gozawa, M; Inatani, M; Iwasaki, K; Takamura, Y, 2019) |
| "In a retrospective clinical study, 806 patients with advanced glaucoma were treated with trabeculectomy combined with mitomycin C0." | 3.91 | [Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant]. ( Fili, S; Kohlhaas, M; Seddig, S, 2019) |
| "The cases reported concern 5 eyes in four DEX-I IVI high-responder patients whose intraocular pressure (IOP) returned to normal after administration of a XEN gel stent with mitomycin subconjunctival injection, thus allowing the continued use of DEX-I which was the only therapeutic option for these patients." | 3.91 | XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases. ( Denis, P; Kodjikian, L; Mathis, T; Rezkallah, A, 2019) |
| "To report a new approach for the treatment of severe ocular hypotony secondary to glaucoma filtering surgery with mitomycin C by injecting autologous eye platelet-rich plasma (E-PRP) in the anterior chamber to block excessive diffuse filtration through an abnormally thinned sclera." | 3.91 | Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report. ( Abdalrahman, O; Alio Del Barrio, JL; Alio, JL; Rodriguez, AE, 2019) |
| "To report on the frequency, efficacy, and safety of laser goniopuncture (LGP) in lowering intraocular pressure (IOP) following mitomycin-C-augmented nonpenetrating deep sclerectomy (NPDS) in a large cohort of eyes." | 3.91 | Outcomes of Laser Goniopuncture Following Nonpenetrating Deep Sclerectomy With Mitomycin C: A Large Retrospective Cohort Study. ( Akesbi, J; Blumen-Ohana, E; Laplace, O; Leleu, I; Nordmann, JP; Penaud, B, 2019) |
| "To estimate the incidence and predisposing factors for cataract extraction (CE) after Deep Sclerectomy (DS) with Mitomycin-C (MMC) and its effect on intraocular pressure (IOP) control." | 3.91 | Cataract extraction after deep sclerectomy and its effect on intraocular pressure control. ( Anand, N; Darcy, K; Mercieca, K; Perumal, D, 2019) |
| "The aim of this study is to describe the effectiveness of trabeculectomy with mitomycin C and releasable suture in Posner-Schlossman syndrome (PSS) with secondary glaucoma." | 3.91 | The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series. ( Artini, W; Bani, AP, 2019) |
| "Rabbit model studies suggested better morphology blebs with equal intraocular pressure (IOP) efficacy as a standard mitomycin C (MMC) trabeculectomy using a novel slow-release drug delivery antifibrotic system delivering small quantities of MMC and 5-fluorouracil (5-FU)." | 3.91 | Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model. ( Ayyala, RS; Blake, D; Fullerton, M; Greenberg, E; John, V; Le, C; Mancera, N; Margo, C; Muddasani, N; Satija, C; Singh, S; Swann, FB; Wall, J; Zhang, Z; Zurakowski, D, 2019) |
| "Phacotrabeculectomy with adjunctive mitomycin C is a good option for the management of coexisting cataract and glaucoma." | 3.91 | Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study. ( Balekudaru, S; Biswas, J; Ganesh, SK; George, AE; George, R; Lingam, V; Wadke, V, 2019) |
| "PRéCIS:: The present study suggests that immediate trabeculectomy with mitomycin C (MMC) may be performed as a safe and effective intervention in the management of refractory ocular hypertension (OHT)/glaucoma in patients with bilateral acute iris transillumination (BAIT)." | 3.91 | Long-term Results of Trabeculectomy With Mitomycin-C in Patients With Bilateral Acute Iris Transillumination. ( Altan, C; Basarir, B; Bayraktar, S; Izgi, B; Oray, M; Tugal-Tutkun, I, 2019) |
| "Primary Trabeculectomy with Mitomycin C is a safe and effective means of controlling Intraocular Pressure in both groups with good success and low rates of sight-threatening complications." | 3.91 | Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma. ( Kadar, MA; Kanduri, S; Maheshwari, D; Pillai, MR; Ramakrishnan, R, 2019) |
| "Complete atrophy of the filtration bleb is a very rare complication after trabeculectomy with mitomycin C and collagen matrix implant (Ologen®, Aeon Astron Corporation, Taipei, Taiwan)." | 3.88 | [Early atrophy of the conjunctiva after trabeculectomy with mitomycin C and collagen matrix implant]. ( Dietlein, T; Siggel, R, 2018) |
| "The purpose of this article is to analyze the results achieved in lowering intraocular pressure (IOP) after trabeculectomy or combined surgery (phacotrabeculectomy) with low-dose mitomycin C (MMC) using the Ologen Collagen Matrix (Ologen CM) implant." | 3.88 | Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. ( Bolivar, G; Castaño, B; Castejón, MA; Paz-Moreno-Arrones, J; Teus, MA, 2018) |
| "To evaluate outcomes of trabeculectomy with adjunctive mitomycin C in patients with uncontrolled intraocular pressure (IOP) after glaucoma drainage device implantation." | 3.88 | Trabeculectomy Outcomes After Glaucoma Drainage Device Surgery. ( Akil, H; Alizadeh, R; Caprioli, J; Law, SK; Tan, J, 2018) |
| "To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma." | 3.88 | Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations. ( Bayoumi, NH, 2018) |
| "We report a case of a rare complication after trabeculotomy combined with a small trabeculectomy with mitomycin C in a young patient with juvenile glaucoma." | 3.88 | Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery. ( Gericke, A; Hoffmann, EM; Klezlova, A; Liebezeit, S; Pfeiffer, N; Prokosch-Willing, V, 2018) |
| "The objective of this study is to investigate the results of an adaptive approach of bleb revision surgery for late onset hypotony after trabeculectomy with mitomycin C because of bleb leakage and/or scleral melting." | 3.88 | Results of an Adaptive Surgical Approach for Managing Late Onset Hypotony After Trabeculectomy With Mitomycin C. ( Hoffmann, EM; Lamparter, J; Pfeiffer, N; Prokosch-Willing, V; Toshev, AP; Ul Hassan, SN, 2018) |
| " The triamcinolone + mitomycin C acetate group presented better indices as for the maximum bleb height and vascularization of the bleb central area (p=0." | 3.88 | Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study. ( Araújo, ID; Cronemberger, S; Rangel, HMDA; Rolim, HT; Vidigal, P, 2018) |
| "To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 3.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
| "After a failed filtration surgery, a low-diffuse bleb was reestablished by pretreating with subconjunctival mitomycin C followed by ab interno bleb revision with the Grover-Fellman biplanar sclerostomy spatula, decreasing further more invasive glaucoma procedures." | 3.85 | Outcomes for Ab Interno Bleb Revision With a Novel Translimbal Sclerostomy Spatula. ( Fellman, RL; Grover, DS, 2017) |
| "To compare two surgical approaches for treating encapsulated blebs after trabeculectomy with mitomycin C, in terms of the development of intraocular pressure and progression of glaucoma in a long-term follow up: 1." | 3.85 | Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures. ( Culmann, PD; Grus, FH; Hoffmann, EM; Laspas, P; Pfeiffer, N; Poplawksi, A; Prokosch-Willing, V, 2017) |
| "A prospective study was conducted on 39 eyes (26 right eyes) of 39 children (20 boys; 19 girls) who had primary congenital glaucoma treated with combined trabeculotomy-trabeculectomy with mitomycin C and scleral flap closure with regular or releasable sutures." | 3.85 | Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma. ( Bayoumi, NH, 2017) |
| "To examine outcomes of trabeculectomy with mitomycin C for uncontrolled glaucoma when performed by glaucoma trainee surgeons." | 3.85 | Primary Trabeculectomy Outcomes by Glaucoma Fellows in a Tertiary Hospital in Brazil. ( Abe, RY; Costa, VP; Shigueoka, LS; Vasconcellos, JPC, 2017) |
| "To examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation." | 3.85 | Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. ( Cui, QN; Han, Y; Hsia, YC; Lin, SC; Mehta, N; Naseri, A; Porco, TC; Rose-Nussbaumer, J; Stamper, RL, 2017) |
| "To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma." | 3.85 | Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma. ( Crouch, ER; Nash, DL, 2017) |
| " Before the surgery, his intraocular pressure (IOP) was 20 to 22 mm Hg with bimatoprost 0." | 3.85 | Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature. ( Kiuchi, Y; Nakakura, S; Noguchi, A; Tabuchi, H, 2017) |
| "To evaluate the influence of phacoemulsification on intraocular pressure (IOP) control and survival of mitomycin C (MMC)-enhanced trabeculectomy in uveitic glaucoma (UG)." | 3.85 | The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To evaluate the intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma." | 3.85 | Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To report the outcomes of primary trabeculectomy with mitomycin-C (MMC) in eyes with glaucoma secondary to iridocorneal endothelial (ICE) syndrome." | 3.83 | Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome. ( Chandran, P; Choudhari, NS; Garudadri, CS; Mandal, AK; Rao, HL; Senthil, S, 2016) |
| "To evaluate the short-term outcomes of lensectomy, combined with vitrectomy, scleral-fixated intraocular lens (SFIOL), and trabeculectomy with adjunctive mitomycin C (MMC) in patients with subluxated/dislocated crystalline lenses with associated elevated intraocular pressure (IOP)." | 3.83 | Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens. ( Balekudaru, S; David, RL; George, RJ; Lingam, V; Sen, P, 2016) |
| "To evaluate the outcomes of trabeculectomy with mitomycin-C (MMC) in uveitis associated with Vogt-Koyanagi-Harada disease (VKH)." | 3.83 | Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2016) |
| " In total, 120 eyes included in this study had a glaucoma diagnosis and undergone to Trab with mitomycin." | 3.83 | Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study. ( Bigheti Pereira, C; Cena de Oliveira, T; Issa de Fendi, L; Pereira Bigheti, C; Viani, GA, 2016) |
| "To compare the complication rate and effectiveness of mitomycin C (MMC), Ologen alone, and Ologen with 5-fluorouracil (5-FU) as adjunctives with Ex-PRESS mini shunt for medically uncontrolled glaucoma." | 3.81 | Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. ( Han, Y; Lowry, EA; Menda, SA; Porco, TC; Rubin, MR; Stamper, RL, 2015) |
| "Consecutive prospective case series study to examine the 6-month outcome of 106 eyes [primary open-angle glaucoma (OAG), exfoliation glaucoma (XFG), and inflammatory glaucoma (ING)] that underwent TLE with mitomycin C performed by a single surgeon from September 2009 to September 2010 at Tokyo University Hospital." | 3.81 | Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon. ( Aihara, M; Aoyama, Y; Murata, H, 2015) |
| " We aim to assess the changes in corneal scar density with serial Scheimpflug images following primary pterygium excision with topical application of mitomycin-C." | 3.81 | Monitoring corneal densities following primary pterygium excision with adjuvant topical mitomycin-C application--an observational study of corneal scar changes. ( Belin, MW; Kam, KW; Young, AL, 2015) |
| "A retrospective comparative case series review was performed on 31 eye surgeries in 20 patients with primary congenital glaucoma who underwent trabeculectomy or Ahmed glaucoma valve implantation after a previous failed trabeculectomy with mitomycin C." | 3.81 | Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients. ( Bae, HW; Hong, S; Hong, YJ; Kim, CY; Lee, N; Ma, KT; Seong, GJ, 2015) |
| "To determine the optimum administration route of bevacizumab after glaucoma filtering surgery (GFS) and to investigate whether a reduced dose of mitomycin-C (MMC) in combination with bevacizumab could improve surgical outcome with a reduced incidence of side-effects." | 3.81 | Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery. ( Moons, L; Stalmans, I; Van Bergen, T; Vandewalle, E, 2015) |
| "To evaluate the long-term effectiveness and safety of mitomycin C (MMC)-augmented trabeculectomy undertaken within the first 2 years of life for the surgical management of glaucoma." | 3.81 | Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life. ( Bunce, C; Chiang, M; Jayaram, H; Khaw, PT; Papadopoulos, M; Pooley, F; Scawn, R; Strouthidis, NG, 2015) |
| " Data included patient demographics, pre- and postoperative intraocular pressure (IOP), use of mitomycin C (MMC), spacer device implantation, and follow-up details including surgical success rates." | 3.81 | Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. ( Anand, N; Mercieca, K; Shevade, B, 2015) |
| "To compare intraocular pressure (IOP) at one year with the InnFocus MicroShunt(®) with or without cataract surgery with according to placement and concentration of mitomycin C (MMC) DESIGN: A retrospective two-center, two-surgeon study (France and Dominican Republic)." | 3.81 | [One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C]. ( Batlle, J; Kato, YP; Parel, JM; Pinchuk, L; Riss, I; Weber, BA, 2015) |
| "The goal of this study was to identify the early postoperative intraocular pressure (IOP) that predicts low pressure control after a trabeculectomy with mitomycin C." | 3.80 | Using the early postoperative intraocular pressure to predict pressure control after a trabeculectomy. ( Akita, T; Kiuchi, Y; Okimoto, S; Tanaka, J, 2014) |
| "To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion." | 3.80 | Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. ( Chandra, A; Gupta, V; Kumar, S; Sihota, R; Singh, D, 2014) |
| "To compare outcomes between patients undergoing trabeculectomy with an Ex-PRESS mini glaucoma device using mitomycin-C (MMC) to those undergoing the same procedure using a subconjunctival collagen matrix implant (Ologen)." | 3.80 | Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. ( Johnson, MS; Sarkisian, SR, 2014) |
| "NPDS without implant placement and with intraoperative mitomycin C application seems to be an effective and well-tolerated method to reduce IOP with long-term effectiveness, casting doubt on the mandatory use of intrascleral implants in nonpenetrating glaucoma surgery." | 3.80 | Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use. ( González-Mesa, A; Gutiérrez-Ortíz, C; Moreno-Salgueiro, A; Pérez-Rico, C; Teus, MA, 2014) |
| "To investigate the safety and efficacy of Nd:YAG laser goniopuncture (LGP) in lowering intraocular pressure (IOP) in eyes having late bleb failure following trabeculectomy with mitomycin C administration." | 3.80 | Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C. ( Alencar, LM; De Moraes, CG; Ritch, R; Susanna, R, 2014) |
| "To evaluate the surgical outcome of Ahmed glaucoma valve (AGV) implantation with a new technique of mitomycin C (MMC) application." | 3.80 | Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. ( Huang, W; Wang, W; Zhang, X; Zhou, M, 2014) |
| "This retrospective case series noncomparative study included 9 eyes of 6 consecutive patients with coexistence of corneal edema resulting from Fuchs dystrophy or pseudoexfoliation keratopathy and medically uncompensated glaucoma; these patients underwent combined DSAEK and DS with mitomycin C and an absorbable collagen implant." | 3.80 | Combined deep sclerectomy and descemet stripping automated endothelial keratoplasty. ( Caramello, G; Giudiceandrea, A; Riso, M; Salgarello, T; Sammarco, MG; Vaiano, AS, 2014) |
| "To compare the effects of silver nanoparticles (AgNPs) and mitomycin C (MMC) on intraocular pressure (IOP) and external, histologic, and immunohistochemical bleb characteristics in a rabbit model of filtration surgery." | 3.79 | Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery. ( Butler, MR; Chevez-Barrios, P; Frankfort, BJ; Orengo-Nania, S; Prospero Ponce, CM; Weinstock, YE, 2013) |
| "To evaluate the prognostic factors for surgical outcomes of subsequent trabeculectomy with mitomycin C (MMC) after prior incisional glaucoma surgery." | 3.79 | Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2013) |
| " Glaucoma filtering surgery combined with intraoperative administration of mitomycin is efficacious for intraocular pressure control." | 3.79 | Iridocorneal endothelial syndrome in a Chinese child. ( Sun, S; Tang, W; Wang, Q; Wu, Z; Zhang, Q; Zhang, Y, 2013) |
| "To compare intraocular pressure (IOP) reduction after trabeculectomy with mitomycin C (MMC) in eyes that had prior clear-corneal phacoemulsification to those in a control group of phakic eyes." | 3.79 | Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes. ( Caprioli, J; Law, SK; Nouri-Mahdavi, K; Supawavej, C, 2013) |
| "To report outcomes of deep sclerectomy (DS) with intraoperative mitomycin C (MMC) application in eyes with previous failed glaucoma surgery (GS) and/or cataract extraction (CE)." | 3.78 | Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia. ( Anand, N; Wechsler, D, 2012) |
| "The medical records of patients with primary open-angle glaucoma or exfoliation glaucoma who had trabeculectomy with mitomycin-C were reviewed." | 3.78 | Impact of phacoemulsification on failure of trabeculectomy with mitomycin-C. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Kawaguchi, A; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2012) |
| "Patients within an institutional setting who underwent trabeculectomy with mitomycin C (MMC) for uncontrolled elevated intraocular pressure (IOP) after corneal graft surgery were included." | 3.78 | Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty. ( Boey, PY; Ho, CL; Mehta, JS; Tan, DT; Wong, TT, 2012) |
| "To evaluate corneal biomechanical properties and intraocular pressure (IOP) after photorefractive keratectomy (PRK) with or without mitomycin-C (MMC) 0." | 3.78 | Effect of photorefractive keratectomy with mitomycin-C on corneal biomechanical features. ( Azimzadeh, A; Esfandiari, H; Feizi, S; Zare, M, 2012) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 3.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "To analyse blebs of phacotrabeculectomies performed with Ologen collagen implants (ProTop & MediKing, Taipei, Taiwan) and to compare these with blebs of mitomycin C (MMC)–augmented phacotrabeculectomies." | 3.77 | Imaging of blebs after phacotrabeculectomy with Ologen collagen matrix implants. ( Aung, T; Boey, PY; Htoon, HM; Narayanaswamy, A; Perera, SA; Seah, SK; Tun, TA; Wong, TT; Zheng, C, 2011) |
| "A total of 908 eyes of 908 glaucoma patients who had undergone mitomycin C-augmented trabeculectomy or trabeculectomy combined with phacoemulsification and intraocular lens implantation performed at 34 clinical centers." | 3.77 | Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study. ( Kuwayama, Y; Yamamoto, T, 2011) |
| "To determine the medium-term intraocular pressure (IOP) control and visual outcomes for patients with advanced glaucoma undergoing trabeculectomy with mitomycin C." | 3.77 | Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. ( King, AJ; Stead, RE, 2011) |
| "To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery." | 3.77 | Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011) |
| "Pre- and postsurgical IOPs at 6 months were compared in one eye of each of 789 subjects with primary open-angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension who underwent trabeculectomy with adjunctive mitomycin C alone (Lectomy-MMC) (n = 145), phaco-viscocanalostomy (Phaco-VCS) (n = 320), phaco-trabeculotomy ab externo (Phaco-lotomy) (n = 116), or phacoemulsification aspiration and intraocular lens implantation alone (PEA+IOL) (n = 208)." | 3.77 | Different modes of intraocular pressure reduction after three different nonfiltering surgeries and trabeculectomy. ( Chihara, E; Hayashi, K, 2011) |
| "Patients with open-angle glaucoma who underwent either canaloplasty or trabeculectomy with mitomycin C to control the intraocular pressure (IOP) between January 2007 and December 2008 were included." | 3.77 | Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months' follow-up. ( Ayyala, RS; Chaudhry, AL; Okogbaa, CB; Zurakowski, D, 2011) |
| "We report on a patient with an overhanging bleb several years following trabeculectomy surgery with mitomycin C." | 3.77 | Dramatic dysesthetic overhanging bleb. ( Kapoor, KG; Syed, MF, 2011) |
| " Patients who could not achieve an intraocular pressure ≤21 mm Hg despite medications underwent trabeculectomy with mitomycin C." | 3.76 | Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma. ( Eslami, Y; Fakhraie, G; Katz, LJ; Moghimi, S; Prasad, A; Sabour, S; Zarei, R, 2010) |
| "To evaluate the efficacy of cyclodialysis-enhanced Mitomycin c (MMC) trabeculectomy in post-keratoplasty glaucoma." | 3.76 | Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma. ( Gupta, V; Sihota, R; Srinivasan, G, 2010) |
| "Two eyes of 2 patients status postfornix-based trabeculectomy with mitomycin C were found to have symptomatic circumferential blebs." | 3.76 | Application of handheld cautery for reduction of symptomatic circumferential trabeculectomy blebs. ( Albano, M; Schwartz, AL, 2010) |
| " After trabeculectomy with mitomycin C, mean intraocular pressure was reduced from 42." | 3.76 | Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. ( Alkawas, AA; Hussein, AM; Shahien, EA, 2010) |
| "To investigate the relationship between intrascleral bleb height and intraocular pressure (IOP) following deep sclerectomy with collagen implant (DSCI) and mitomycin C (MMC) in eyes with clinically flat blebs." | 3.76 | Postoperative IOP is related to intrascleral bleb height in eyes with clinically flat blebs following deep sclerectomy with collagen implant and mitomycin. ( Mavrakanas, N; Mendrinos, E; Shaarawy, T, 2010) |
| "To examine the rates of intermediate-term intraocular pressure (IOP) control after trabeculectomy with adjunctive mitomycin C (MMC) and assess for associated complications." | 3.76 | Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years. ( Booth, F; Karim, R; Kubay, O; Lusthaus, JA; Wechsler, D, 2010) |
| "To evaluate the safety and efficacy of deep sclerectomy with implant and mitomycin C in uveitic glaucoma." | 3.75 | Efficacy and safety of deep sclerectomy in uveitic glaucoma. ( Abu El-Asrar, AM; Al Obeidan, SA; Al-Muammar, AM; Osman, EA, 2009) |
| "Retinal hemorrhages secondary to decompression retinopathy occurred following combined trabeculotomy-trabeculectomy with mitomycine-C (MMC) in one eye of a case of congenital glaucoma and pars plana vitrectomy-lensectomy in a case of vitreous condensation secondary to pars planitis." | 3.75 | Decompression retinopathy and possible risk factors. ( Guven, D; Hasiripi, H; Kalayci, D; Karakurt, A; Saricaoglu, MS, 2009) |
| "To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)." | 3.75 | Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009) |
| "To evaluate the effect of intraoperative mitomycin-C (MMC) on polypropylene Ahmed glaucoma valve (AGV) survival 2 years after implantation during the first 2 years of life." | 3.75 | Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. ( Al-Mobarak, F; Khan, AO, 2009) |
| "To evaluate long-term outcomes after Ahmed valve implantation in patients with glaucoma when using adjunctive intraoperative mitomycin C (MMC) and postoperative 5-fluorouracil (5-FU)." | 3.74 | Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. ( Alvarado, JA; Hollander, DA; Juster, RP; Lee, LC, 2008) |
| "To compare the effects of variable mitomycin-C (MMC) applications during trabeculectomy on target intraocular pressure (IOP), number of antiglaucomatous therapy, bleb morphology and surgical complications." | 3.74 | Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application. ( Aktaş, Z; Hasanreisoğlu, B; Onol, M, 2008) |
| "To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma." | 3.74 | Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008) |
| "The primary objective of this study was to determine if intraoperative application of mitomycin C (MMC) is safe as an adjunct for pterygium surgery." | 3.74 | Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery. ( Díaz, L; Emanuelli, A; Izquierdo, NJ; Villegas, VM, 2008) |
| "The mid-term appearance of the filtering bleb and surgical outcome following tunnel-trabeculectomy, in which protective measures were carried out to avoid contact between the mitomycin C (MMC) and the conjunctival flap, are presented." | 3.74 | Protection of the conjunctival flap from contact with mitomycin C during tunnel-trabeculectomy. ( Karatas, M; Ophir, A, 2007) |
| "To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 3.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
| "The purpose of this study was to compare the outcomes of mitomycin C (MMC)-augmented trabeculectomy in glaucoma patients with uveitis to those without uveitis but with other high-risk characteristics." | 3.74 | Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. ( Birt, C; Derzko-Dzulynsky, L; Noble, J; Rabinovitch, T, 2007) |
| "The objective of this study was to look at the long-term safety, and the effectiveness on intraocular pressure, of trabeculectomy and mitomycin C (MMC) applied under the scleral flap." | 3.74 | Long-term results of trabeculectomy with mitomycin C applied under the scleral flap. ( Kumar, V; Kyprianou, I; Nessim, M; O'Neill, E, 2007) |
| "The aim of the study was to assess the outcomes of surgical revision with reopening of the scleral flap in eyes with failed glaucoma surgery and adjunctive mitomycin C (MMC)." | 3.74 | Surgical revision of failed filtration surgery with mitomycin C augmentation. ( Anand, N; Arora, S, 2007) |
| " Here, we report a case of iris prolapse caused by blunt ocular trauma after NPT with sinusotomy and mitomycin C treatment." | 3.74 | Iris prolapse after non-penetrating trabeculectomy with sinusotomy and mitomycin C. ( Ataka, S; Kohno, T; Nomura, Y; Shiraki, K; Takahashi, Y; Wada, S, 2007) |
| "To evaluate whether patients who have undergone trabeculectomy with mitomycin C have a different intraocular pressure (IOP) response profile after the water drinking test (WDT) from that of patients who are medically managed with a similar baseline IOP and level of visual field (VF) damage." | 3.74 | Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test. ( Danesh-Meyer, HV; Gamble, GD; Papchenko, T; Tan, YW, 2008) |
| "To report the experience with trabeculectomy augmented with mitomycin C and 5-fluorouracil for the treatment of paediatric glaucoma." | 3.73 | Augmented trabeculectomy in paediatric glaucoma. ( Ehrlich, R; Friling, R; Gaton, DD; Lusky, M; Snir, M; Weinberger, D, 2005) |
| "To investigate the comparative efficacy and safety of deep sclerectomy with and without intraoperative mitomycin C (MMC) application for lowering the intraocular pressure (IOP)." | 3.73 | Deep sclerectomy augmented with mitomycin C. ( Anand, N; Atherley, C, 2005) |
| " Eyes classified with moderate glaucoma had a 13%, 40%, and 80% success rate respectively for goniotomy, trabeculotomy, and combined trabeculotomy-trabeculectomy with mitomycin C." | 3.73 | Correlation between surgical success rate and severity of congenital glaucoma. ( Al-Hazmi, A; Al-Jadaan, I; Al-Mesfer, SA; Al-Mohammed, A; Awad, A; Zwaan, J, 2005) |
| "Combined trabeculotomy and trabeculectomy with mitomycin C was performed in the left eye for primary congenital glaucoma." | 3.73 | Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C. ( Gupta, V; Sihota, R; Sony, P, 2005) |
| "We studied 119 eyes of 149 patients who had undergone fornix-based trabeculectomy with mitomycin C as their primary surgery between 2000 and 2002 and in whom we could evaluate the characteristics of filtering blebs after a follow-up period of 6 months or more, and whose intraocular pressure at the evaluation time was 18 mmHg or less." | 3.73 | [Characteristics of filtering blebs after fornix-based trabeculectomy with a scleral tunnel]. ( Kano, K; Kuwayama, Y, 2005) |
| "To assess intraocular pressure (IOP) changes of the contralateral eyes of eyes undergoing trabeculectomy with mitomycin C (MMC)." | 3.73 | Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. ( Flammer, J; Haefliger, IO; Shaarawy, T; Vysniauskiene, I, 2005) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 3.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "In comparison with mitomycin C, neither intraoperative nor postoperative treatment with cyclosporin was associated with a decrease in intraocular pressure or prolonged bleb survival." | 3.73 | Cyclosporin as an adjunct to glaucoma filtration surgery. ( Allen, RC; Crouch, ER; Lattanzio, FA; Mitrev, PV; Williams, PB, 2005) |
| "To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery." | 3.73 | Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006) |
| "To determine the efficacy and safety of trabeculectomy with mitomycin-C (trabMMC) compared with that of single-site phacotrabeculectomy with mitomycin-C (phacotrabMMC) in glaucoma patients at increased risk for filtering surgery failure." | 3.73 | Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. ( Damji, KF; Hodge, WG; Murthy, SK; Pan, Y, 2006) |
| "Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy." | 3.73 | Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C. ( Flesner, P; Jensen, PK; Kessing, SV, 2006) |
| " The purpose of our study is to assess the efficacy of combining pars plana vitrectomy and PRP with trabeculectomy assisted by mitomycin C (MMC) on NVG eyes secondary to diabetic retinopathy." | 3.73 | Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. ( Ito, N; Ito, S; Kiuchi, Y; Nakae, K; Saito, Y, 2006) |
| "To evaluate long-term tonometric outcomes of trabeculectomy with adjunctive mitomycin C (MMC) and its efficacy in achieving a range of intraocular pressures (IOP) in phakic patients with open-angle glaucoma." | 3.73 | Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. ( Caprioli, J; Fontana, H; Lumba, J; Nouri-Mahdavi, K; Ralli, M, 2006) |
| "To determine the long-term intraocular pressure (IOP) control and postoperative complications after initial trabeculectomy with use of mitomycin C (MMC) in patients with primary open-angle glaucoma (POAG)." | 3.73 | Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. ( Araie, M; Chen, YN; Shigeeda, T; Shirato, S; Tomidokoro, A, 2006) |
| "To determine the outcomes of trabeculectomy with mitomycin C (MMC) combined with direct cauterization of peripheral iris before iridectomy in the management of neovascular glaucoma (NVG), and to demonstrate the effect of this surgical technique on decreasing the incidence of intraoperative bleeding and early postoperative hyphema." | 3.73 | Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. ( Batman, A; Berker, N; Cankaya, B; Elgin, U; Simsek, T, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 3.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To evaluate the efficacy of "straight scleral tunnel incision" -trabeculectomy with a releasable suture supplemented with mitomycin C (MMC) on reducing intraocular pressure (IOP), complications, and corneal astigmatism in patients with primary angle-closure glaucoma (PACG)." | 3.73 | Mitomycin C "straight scleral tunnel incision"--trabeculectomy with a releasable suture. ( Chen, LX; Fang, F; Tang, H; Wang, LN; Xiao, L; Zhang, Y; Zhao, TH, 2006) |
| "To assess the efficacy and to determine the risk factors of trabeculectomy with mitomycin C (MMC) in eyes with neovascular glaucoma (NVG) secondary to diabetic retinopathy." | 3.73 | Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. ( Ito, S; Kiuchi, Y; Nakae, K; Saito, Y; Sugimoto, R, 2006) |
| "The present findings indicate that the additional use of mitomycin C may be justified in trabeculectomies in patients with severe glaucoma." | 3.72 | Five-year results of trabeculectomy with mitomycin C. ( Beckers, HJ; Kinders, KC; Webers, CA, 2003) |
| "In this prospective interventional case series of 45 consecutive uncomplicated glaucoma patients, 45 eyes with thick Tenon's capsule underwent primary trabeculectomy with intraoperative mitomycin-C (0." | 3.72 | Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C. ( Akarsu, C; Hasanreisoglu, B; Onol, M, 2003) |
| "Mitomycin C (MMC) used as an additive agent in glaucoma surgery has been shown to improve the postoperative results of intraocular pressure (IOP), but may also lead to higher incidences of postoperative wound healing disorders and of hypotonia with choroidal detachment." | 3.72 | [Clinical experiences and results of application of mitomycin C in trabeculectomy]. ( Hudde, T; Laube, T; Ritters, B; Selbach, M, 2003) |
| "Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma." | 3.72 | Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003) |
| "To evaluate the effect of temporal corneal phacoemulsification on intraocular pressure (IOP) in eyes after primary trabeculectomy with intraoperative fluorouracil (5-FU) or mitomycin C (MMC)." | 3.72 | Effect of temporal corneal phacoemulsification on intraocular pressure in eyes with prior trabeculectomy with an antimetabolite. ( Cantor, LB; Capistrano, AP; Swamynathan, K; WuDunn, D, 2004) |
| "To evaluate the results of trabeculectomy with and without the use of mitomycin C in children with primary congenital glaucoma." | 3.72 | Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. ( de Arruda Melo, PA; Júnior, AP; Montezano, FT; Prata, J; Rodrigues, AM, 2004) |
| "To compare the efficacy and safety of fornix-based and limbus-based conjunctival flaps of phacotrabeculectomy with mitomycin C in patients with primary open angle glaucoma and cataract." | 3.72 | Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study. ( Bencić, G; Bojić, L; Mandić, Z; Zorić Geber, M, 2004) |
| "To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure." | 3.72 | Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004) |
| "To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 3.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
| "A retrospective chart review of 44 eyes of 44 patients with uveitic glaucoma who underwent trabeculectomy with mitomycin C or 5-fluorouracil." | 3.71 | Trabeculectomy with antiproliferative agents in uveitic glaucoma. ( Beck, AD; Ceballos, EM; Lynn, MJ, 2002) |
| "The authors performed a nonrandomized retrospective review of patients who received the Molteno implant (n = 27), Krupin Eye Valve with Disc (n = 13), or Ahmed Glaucoma Valve (n = 13), with adjunctive mitomycin C." | 3.71 | Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant. ( Gangnon, R; Heatley, GA; Kaufman, PL; Perkins, TW; Taglia, DP, 2002) |
| "To describe the surgical technique and clinical outcomes of a procedure for refractory glaucoma, concurrent Baerveldt glaucoma implant (BGI) and trabeculectomy with mitomycin C." | 3.71 | Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002) |
| "In medically uncontrolled post-traumatic angle recession glaucoma trabeculectomy with mitomycin C is an effective surgical procedure with an acceptable complication rate." | 3.71 | Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. ( Barron, A; Manners, T; Murray, AD; Salmon, JF; Willies, C, 2001) |
| "To evaluate the short-term effect of trabeculectomy with adjunctive mitomycin-C (MMC) on corneal astigmatism and axial length." | 3.71 | Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism. ( Kim, HB; Kook, MS; Lee, SU, 2001) |
| "02% mitomycin C (MMC) in glaucoma patients at risk for failure of filtration surgery." | 3.71 | Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. ( Casson, R; Rahman, R; Salmon, JF, 2001) |
| "After trabeculectomy with mitomycin C, extremely low intraocular pressure (IOP) with excess filtration may cause hypotonous maculopathy in the early postoperative period." | 3.71 | Autologous blood injection for marked overfiltration early after trabeculectomy with mitomycin C. ( Jian, K; Masumoto, M; Mishima, HK; Mochizuki, H; Okada, K; Okada, M; Tsukamoto, H, 2001) |
| "To investigate the changes of tear film functions due to the use of postoperative 5-fluourouracil (5-Fu) and intraoperative mitomycin C (MMC) in glaucoma filtration surgery." | 3.71 | [Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery]. ( Li, J; Pang, L, 2001) |
| " Trabeculectomy with mitomycin C controlled IOP on last visit in 8 of 13 eyes with aphakic glaucoma." | 3.70 | Surgical results of secondary glaucomas in childhood. ( Ellis, FD; Helveston, EM; Plager, DA; Raiesdana, A; Snyder, SK; Wallace, DK, 1998) |
| "Primary trabeculectomy with the use of intraoperative mitomycin lowered the IOP by 30% or more in 78% (at 2 years) to 86% (at 1 year) of the cases and is associated with a marked reduction in the percentage of patients who require glaucoma medication." | 3.70 | Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. ( Greenfield, DS; Nicolela, MT; Palmberg, PF; Rueda, JC; Schiffman, J; Scott, IU; Tsai, JC, 1998) |
| "The authors examine the intermediate-term effects of adjunctive intraoperative mitomycin C (MMC) in a cohort of patients who received double-plate Molteno implants for complicated glaucomas." | 3.70 | Molteno implant with mitomycin C: intermediate-term results. ( Gangnon, R; Kaufman, PL; Ladd, W; Libby, CM; Perkins, TW, 1998) |
| "The authors determine if the intraoperative placement of paclitaxel powder in the subconjunctival space improves the outcome of glaucoma filtration surgery in rabbits." | 3.70 | The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. ( Jampel, HD; Moon, JI, 1998) |
| "The authors investigated the safety and intraocular pressure (IOP) lowering effectiveness of trabeculectomy augmented with mitomycin C application beneath the scleral flap, and assessed the influence of preoperative risk factors on the surgical outcome." | 3.70 | Trabeculectomy augmented with mitomycin C application under the scleral flap. ( Beatty, S; Kheterpal, S; O'Neill, EC; Potamitis, T, 1998) |
| "This study aimed to compare the surgical outcomes of mitomycin C trabeculectomy glaucoma drainage device (GDD) surgery and laser neodymium:YAG (Nd:YAG) cyclophotocoagulation (CPC) in the management of intractable glaucoma after penetrating keratoplasty (PKP) in a retrospective study." | 3.70 | Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. ( Ayyala, RS; Cooper, ML; Dreyer, EB; Frangie, JP; Goldstein, MH; Mattox, C; Netland, PA; Pieroth, L; Schuman, JS; Vinals, AF; Wu, HK; Zurakowski, D, 1998) |
| "To determine whether intrascleral exposure to mitomycin-C (MMC) improves the control of intraocular pressure (IOP), increases the incidence of complications, or both." | 3.70 | Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy. ( Menapace, R; Rainer, G; Strenn, K; Vass, C, 1998) |
| "The purpose of this study was to determine the efficacy of initial mitomycin C (MMC)-augmented trabeculectomy for uncomplicated glaucoma in young patients." | 3.70 | Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients. ( Dietlein, TS; Jacobi, PC; Krieglstein, GK, 1998) |
| "The results of primary trabeculectomy with and without mitomycin C (MMC) were evaluated in young glaucoma patients." | 3.70 | The results of trabeculectomy with and without mitomycin C in young patients. ( Duman, S; Kahraman, C; Kasim, R; Nurözler, A; Yalvac, IS, 1998) |
| "Retrospective review of consecutive cases of pediatric glaucoma that underwent mitomycin C augmented trabeculectomy between January 1991 and December 1995." | 3.70 | Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. ( Beck, AD; Lynch, MG; Lynn, MJ; Noe, R; Wilson, WR, 1998) |
| "Mitomycin C trabeculectomy after dissection of conjunctival scar tissue may be useful for treating refractory glaucoma." | 3.70 | Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva. ( Honda, Y; Honjo, M; Inatani, M; Tanihara, H, 1998) |
| " Procedures for the control of glaucoma were silicone oil removal (SOR), trabeculectomy with mitomycin C, cyclocryotherapy, semiconductor diode laser contact transscleral cyclophotocoagulation (TSCPC) and anterior chamber tube shunt to encircling band (ACTSEB)." | 3.70 | Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments. ( Dandona, L; Goyal, M; Honavar, SG; Majji, AB; Naduvilath, T; Sen, PK, 1999) |
| "To evaluate corneal graft survival and intraocular pressure control in eyes that have undergone combined penetrating keratoplasty and trabeculectomy with mitomycin C (MMC)." | 3.70 | Combined penetrating keratoplasty and trabeculectomy with mitomycin C. ( Alfonso, E; Palmberg, PF; WuDunn, D, 1999) |
| "Trabeculectomy with mitomycin C might be effective in Cogan-Reese cases with glaucoma resistant to medical treatment." | 3.70 | Clinical and histopathologic findings of iris nevus (Cogan-Reese) syndrome. ( Coşar, CB; Kural, G; Onder, F; Ozdemir, Y; Usubütün, A, 1999) |
| "To evaluate the surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma." | 3.70 | Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999) |
| "To evaluate the effectiveness and safety of trabeculectomy with mitomycin-C (MMC) in the management of childhood glaucomas." | 3.70 | Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. ( Belmonte, SJ; Liebmann, JM; Ritch, R; Sidoti, PA, 2000) |
| "Retrospective analysis of all eyes that underwent phacoemulsification surgery for symptomatic cataracts and had a preoperative diagnosis of chronic hypotony (intraocular pressure [IOP] mitomycin C." | 3.70 | Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery. ( Doyle, JW; Smith, MF, 2000) |
| "To investigate the effect of trabeculectomy with and without mitomycin C in post-keratoplasty glaucoma." | 3.70 | Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. ( Fujishima, H; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yamagami, J, 2000) |
| " Visually significant cataract developed in 5/15 re-examined eyes that underwent trabeculectomy alone (33%), possibly associated with pre-existing cataract and diagnosis of angle closure glaucoma, but not with mitomycin C use." | 3.70 | Long term results of glaucoma surgery among participants in an east African population survey. ( Buhrmann, RR; Isseme, I; Oliva, MS; Quigley, HA; Scudder, M; West, SK, 2000) |
| "To describe a case of ocular decompression syndrome in a patient after trabeculectomy with mitomycin C for neovascular glaucoma." | 3.70 | Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma. ( Danias, J; Podos, SM; Rosenbaum, J, 2000) |
| "A concurrent series (from January 1, 1987, to October 1, 1997) of one surgeon's consecutive 585 (456 patients) combined cataract extraction, intraocular lens implantation, and trabeculectomy surgeries, some with intraoperative mitomycin C and/or postoperative subconjunctival 5-fluorouracil." | 3.70 | Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries. ( Hahn, J; Larive, B; Rockwood, EJ, 2000) |
| "The effects of mitomycin-C on intraocular pressure (IOP), facility of outflow (C), and Tenon's capsule fibrosis were studied over 60 days in 10 clinically normal dogs." | 3.69 | Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. ( Davidson, MG; Glover, TL; Nasisse, MP, 1995) |
| " In patients with lower risk for failure a reduction of concentration and application time of Mitomycin C should minimise side effects while maintaining the beneficial effect of lower intraocular pressure." | 3.69 | [Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 minute). Independent evaluation of a retrospective nonrandomized study]. ( Annen, DJ; Stürmer, J, 1995) |
| "We evaluated the effectiveness of combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C in patients with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C. ( Alward, WL; Munden, PM, 1995) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 3.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| "Twenty-one eyes of 21 patients with refractory glaucoma underwent glaucoma surgery involving placement of a modified Molteno implant and intraoperative application of mitomycin C." | 3.69 | Mitomycin C as adjunctive therapy with glaucoma implant surgery. ( Nicolela, MT; Susanna, R; Takahashi, WY, 1994) |
| "We prospectively investigated the postoperative intraocular pressure (IOP) level, visual prognosis, and complications of trabeculectomy with adjunctive mitomycin C in normal-tension glaucoma." | 3.69 | [Trabeculectomy for normal-tension glaucoma]. ( Ichien, M; Kitazawa, Y; Suemori-Matsushita, H; Yamamoto, T, 1994) |
| "Mitomycin C (MMC) was used as a perioperative adjunct during trabeculectomy for 51 consecutive cases of complicated glaucoma." | 3.69 | Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months. ( Krieglstein, GK; Mietz, H, 1994) |
| "In patients with uncertain prognosis for the intraocular pressure after trabeculectomy, the intraoperative application of Mitomycin C seems to improve considerably the operative success rate." | 3.69 | [Experiences with mitomycin C]. ( Flammer, J; Gaspar, AZ; Orgül, S, 1994) |
| "Intraoperative mitomycin-C application has been well accepted recently as a useful adjunctive procedure to enhance the filtering effect in glaucoma surgery." | 3.69 | Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery. ( Hsieh, JW; Hung, PT; Lin, LL; Wang, TH, 1995) |
| "To evaluate the timing, efficacy, and complications of laser suture lysis (LSL) after mitomycin C trabeculectomy in patients with glaucoma at high risk for failure of filtering surgery." | 3.69 | Laser suture lysis after mitomycin C trabeculectomy. ( Baerveldt, G; Heuer, DK; LaBree, L; Lee, PP; Minckler, DS; Morinelli, EN; Sidoti, PA, 1996) |
| "To evaluate intraocular pressure (IOP) control and surgical complications following trabeculectomy with 5-fluorouracil (5-FU) or mitomycin at the inferior limbus." | 3.69 | Trabeculectomy at the inferior limbus. ( Caronia, RM; Cohen, H; Friedman, R; Liebmann, JM; Ritch, R, 1996) |
| "To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin." | 3.69 | Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996) |
| "The purpose of this study was to assess the effects of intraoperative mitomycin-C (MMC) on the function of Baerveldt glaucoma implants in rabbits." | 3.69 | Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. ( Baerveldt, G; Mermoud, A; Minckler, DS; Prata, JA, 1996) |
| "Thirteen patients with normal-tension glaucoma with a cystic filtering bleb who had undergone unilateral trabeculectomy with mitomycin C only once at least 1 year previously were subjected to the study." | 3.69 | Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C. ( Haque, MS; Kinoshita, S; Kitazawa, Y; Komuro, A; Mochizuki, K; Taniguchi, T; Yamamoto, T; Yokoi, N, 1996) |
| "An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC)." | 3.69 | Experimentally designed glaucoma implant surgery with mitomycin C in rabbit. ( Kee, C; Youn, DH, 1995) |
| "To evaluate acute retinal vein occlusion as a potential complication of trabeculectomy with mitomycin C in cases of advanced glaucoma." | 3.69 | Retinal vein occlusion after trabeculectomy with mitomycin C. ( Dev, S; Herndon, L; Shields, MB, 1996) |
| "Both large- and small-incision phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative Mitomycin-C provide good intermediate range (1 year) postoperative IOP in eyes with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative mitomycin-C: comparison between 3.2- and 6.0-mm incisions. ( Wand, M, 1996) |
| "Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure." | 3.69 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996) |
| "To determine the surgical outcome of mitomycin trabeculectomy in patients with refractory glaucoma." | 3.69 | Surgery for refractory glaucoma. ( Hagiwara, Y; Kitazawa, Y; Sawada, A; Yamamoto, T, 1996) |
| "The records of 157 eyes of 157 consecutive patients, aged 18 or older, who underwent mitomycin C trabeculectomies for uncontrolled glaucoma of various causes were reviewed." | 3.69 | Intermediate-term outcome of variable dose mitomycin C filtering surgery. ( Cheung, JC; Murali, S; Pederson, JE; Wright, MM, 1997) |
| "The authors studied the effect of topical mitomycin-C administration on the maintenance of filter function and intraocular pressure (IOP) following laser sclerostomy." | 3.69 | Mitomycin-C in laser sclerostomy: benefit and complications. ( Birngruber, R; Dröge, G; Schmidt-Erfurth, U; Wetzel, W, 1997) |
| " Combined phacoemulsification and mitomycin C trabeculectomy appears to be safe and effective for treating selected patients with coexisting glaucoma and cataract." | 3.69 | Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. ( Berestka, JS; Brown, SV, 1997) |
| "Hypotony maculopathy after glaucoma filtering surgery with adjunctive mitomycin C has been reported to occur in 3% to 14% of cases." | 3.69 | Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. ( Greenfield, DS; Miller, MP; Nicolela, MT; Palmberg, PF; Suñer, IJ, 1997) |
| "To inhibit the wound healing process and to achieve a better intraocular pressure lowering effect, we applied mitomycin-C (MMC) topically in trabeculectomy at different time sequences." | 3.69 | Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. ( Bair, JS; Chen, CW, 1997) |
| "Animal studies suggest that the decrease of intraocular pressure after application of mitomycin C is particularly mediated by toxic effects on the substance of ciliary body." | 3.69 | [Effect of local administration of mitomycin C on intraocular pressure]. ( Anders, N; Walkow, T; Wollensak, J, 1996) |
| "After trabeculectomy with mitomycin C, the filtering blebs of 117 eyes from 117 patients with various types of glaucoma were examined using ultrasound biomicroscopy." | 3.69 | An ultrasound biomicroscopic study of filtering blebs after mitomycin C trabeculectomy. ( Kitazawa, Y; Sakuma, T; Yamamoto, T, 1995) |
| "Twenty-nine consecutive eyes of 26 patients with cataract and glaucoma that had undergone combined phacoemulsification, posterior chamber lens implantation, and limbus-based trabeculectomy with mitomycin-C applied after the cataract removal and trabeculectomy had a minimal follow-up time of 12 months (mean follow-up 20 +/- 6." | 3.69 | Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure. ( Belyea, DA; Dan, JA; Lieberman, MF; Stamper, RL, 1997) |
| " Also, to elucidate time-dependent changes in corneal epithelium barrier function, we measured fluorescein uptake before and after trabeculectomy prospectively in the central and peripheral cornea of six glaucomatous eyes in six patients." | 3.69 | Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy. ( Honda, Y; Kinoshita, S; Komuro, A; Tanihara, H; Yokoi, N, 1997) |
| "The authors studied the efficacy and complications of intraoperative mitomycin-C in glaucoma associated with ocular inflammation." | 3.69 | Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. ( McGehee, RF; Pederson, JE; Wright, MM, 1997) |
| "The purpose of the study is to determine the safety and efficacy of mitomycin C-augmented trabeculectomy in children with developmental glaucoma treated previously by conventional procedures." | 3.69 | Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. ( Jayagandan, A; John, T; Mandal, AK; Walton, DS, 1997) |
| "The revision of a failed filtering bleb using mitomycin C was performed in 40 eyes (28 eyes with primary open angle glaucoma and 12 eyes with secondary open angle glaucoma) in which the previous trabeculectomy using 5-fluorouracil had failed to control intraocular pressure (IOP)." | 3.69 | [Surgical revision of failed filtering bleb with mitomycin C]. ( Hara, T; Shirato, S, 1997) |
| "We performed ultrasonography on a patient who, after trabeculectomy with mitomycin C, had an intraocular pressure of 1 mm Hg, an opaque cataract, and suspected hypotonous maculopathy in the left eye." | 3.69 | Echographic diagnosis of scleral fold in hypotony. ( DiBernardo, C; Loewenstein, A; McKinnon, S, 1997) |
| "To evaluate the effectiveness of combined phacoemulsification and trabeculectomy with mitomycin-C with respect to visual rehabilitation and control of intraocular pressure in patients with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification and trabeculectomy with mitomycin-C. ( Schuman, JS; Zacharia, PT, 1997) |
| "(1) Since the interval between reoperation and intraocular pressure increase was very short in all cases, overfiltration is at least one major reason for hypotony, not only ciliary body failure; (2) in cases of persistent hypotony after filtering surgery with mitomycin C, surgical reintervation can be recommended." | 3.69 | [Surgical revision for hypotonia after glaucoma operation with mitomycin C]. ( Funk, J, 1997) |
| "To evaluate the safety and efficacy of trabeculectomy with mitomycin-C in the management of postkeratoplasty glaucoma." | 3.69 | Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study. ( Gupta, A; Kumar, S; Ram, J; Sharma, A, 1997) |
| "The purpose of the study is to assess the effect of adjunctive intraoperative mitomycin C (MMC) in Molteno drainage device implantation for patients with recalcitrant glaucomas." | 3.69 | The effect of adjunctive mitomycin C in Molteno implant surgery. ( Birt, CM; Khatana, AK; Kim, C; Kupin, TH; Lee, D; Olivier, MM; Reed, SY; Shin, DH, 1997) |
| "To evaluate the outcome of Baerveldt implantation with adjunctive mitomycin-C in cases of complicated glaucoma." | 3.69 | Simultaneous use of mitomycin-C with Baerveldt implantation. ( Azuara-Blanco, A; Moster, MR; Schmidt, CM; Wilson, RP, 1997) |
| "To evaluate the long-term intraocular pressure (IOP) reduction effect and safety of adjunctive mitomycin C (MMC) (0." | 3.69 | Combined trabeculectomy and extracapsular cataract extraction with mitomycin C. ( Chou, JC; Liu, CJ; Liu, JH; Tsei, CC, 1997) |
| "We studied the efficacy and safety of using topical mitomycin C (MMC) as an adjunct to glaucoma filtration surgery." | 3.68 | Effects of topical mitomycin C on glaucoma filtration surgery. ( Hong, C; Hyung, SM; Kim, DM; Song, KY; Youn, DH, 1993) |
| "A short-term pilot study used mitomycin C at the time of trabeculectomy in a population of southern Indians with various forms of glaucoma." | 3.68 | Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study. ( Krishnadas, R; Michon, J; Ramakrishnan, R; Robin, AL, 1993) |
| "We measured aqueous flare in 16 glaucomatous eyes after trabeculectomy in which 5-fluorouracil (5-FU) or mitomycin C (MMC) had been used as an adjunctive therapy." | 3.68 | Anterior chamber reaction after mitomycin and 5-fluorouracil trabeculectomy: a comparative study. ( Jikihara, S; Kawase, K; Kitazawa, Y; Nishimura, K; Yamamoto, T, 1993) |
| "In this study, an experimental model of glaucoma filtration surgery was used to evaluate the clinical and histologic effects of a single intraoperative topical application of mitomycin C." | 3.68 | Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. ( Dorman-Pease, ME; Jampel, HD; Pasquale, LR; Quigley, HA; Thibault, D, 1992) |
| " 1989 trabeculectomy with per-operative topical application of mitomycin C was performed on eyes with refractory glaucoma." | 3.68 | Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. ( Bair, JS; Chen, CW; Huang, HT; Lee, CC, 1990) |
| "Astigmatism was measured using objective refraction and corneal topography, IOP and visual acuity were also assessed." | 2.90 | Suture Removal After Trabeculectomy With Fornix-based Conjunctival Flap Leads to Faster Visual Recovery but Not Reduced Astigmatism. ( Hoffmann, E; Laspas, P; Leichsenring, V; Pfeiffer, N; Preussner, R; Wahl, J, 2019) |
| "Patients with primary open angle glaucoma, not controlled with medication, were selected from the outpatient department." | 2.87 | Comparison of Mean Corneal Endothelial Cell Loss after Trabeculectomy with and without Mitomycin C. ( Ahmed, N; Amjad, A; Shaheer, M, 2018) |
| "Mean intraocular pressure was significantly reduced compared with baseline in both groups (P < 0." | 2.79 | Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). ( Ahmed, II; Condon, G; Moster, MR; Netland, PA; Salim, S; Sarkisian, SR; Sherwood, MB; Siegfried, CJ, 2014) |
| "Mitomycin C was used in 25 procedures (83." | 2.77 | CO2 laser-assisted sclerectomy surgery, part II: multicenter clinical preliminary study. ( Assia, EI; Degani, J; Geffen, N; Ton, Y, 2012) |
| "In this pilot study with a small number of subjects, short-term outcomes suggest that subconjunctival bevacizumab is equally effective in reducing intraocular pressure with a better safety profile compared with MMC in the dosing schedule studied." | 2.77 | Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. ( Ravindran, RD; Sengupta, S; Venkatesh, R, 2012) |
| "The primary endpoint measured was bleb morphology and vascularity using the Moorfields Bleb Grading System." | 2.75 | Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. ( Kahook, MY, 2010) |
| "New-onset persistent diplopia was reported in 5 patients (5%) in the tube group and no patients in the trabeculectomy group at 1 year (P = ." | 2.74 | Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up. ( Barton, K; Feuer, WJ; Gedde, SJ; Lee, RK; Rauscher, FM; Schiffman, JC, 2009) |
| "The filtering blebs were evaluated clinically and with SL-OCT on day 1 and 1, 2, 4 and 12 weeks following surgery." | 2.73 | A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs. ( Keunen, JE; Klevering, BJ; Theelen, T; Wesseling, P, 2007) |
| "Mean intraocular pressure was significantly lower in both groups." | 2.72 | Estimation of risk-benefit ratio and comparison of post-operative efficacy results between trabeculectomy and canaloplasty. ( Fili, S; Gatzioufas, Z; Kohlhaas, M; Perdikakis, G; Vastardis, I, 2021) |
| "Mitomycin C (MMC) is an alkylating agent with extraordinary ability to crosslink DNA, preventing DNA synthesis." | 2.72 | History, presence, and future of mitomycin C in glaucoma filtration surgery. ( Al Majidi, R; Beckers, HJM; Gorgels, TGMF; Pinchuk, L; van Mechelen, RJS; Webers, CAB; Wolters, JEJ, 2021) |
| "To study the clinical effect of trabeculectomy combined with Mitomycin C and removed suture." | 2.71 | [Trabeculectomy combined with mitomycin C and removed suture in glaucoma]. ( Feng, Y, 2003) |
| "The intraocular pressure was significantly decreased by 7." | 2.70 | Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. ( Christodoulakis, EV; Kozobolis, VP; Pallikaris, IG; Tzanakis, N; Zacharopoulos, I, 2002) |
| "The mean intraocular pressures were significantly (P < ." | 2.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "5-Fluorouracil and MMC were found to be equally safe and effective adjuncts to primary trabeculectomy in the short- and medium-term postoperative periods." | 2.69 | Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. ( Baerveldt, GS; Budenz, DL; Chen, PP; Cohen, JS; Greenfield, DS; Mehta, K; Moster, MR; Shaikh, NM; Shaikh, S; Singh, K; Tsai, JC, 2000) |
| "Late postoperative complications are similar with the exception of an increased incidence of Tenon cyst formation in the MMC-treated eyes." | 2.68 | Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. ( Bergstrom, TJ; Higginbotham, EJ; Johnson, AT; Katz, GJ; Lichter, PR; Musch, DC; Skuta, GL, 1995) |
| "Mitomycin was applied for 5 minutes only once during trabeculectomy." | 2.67 | Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. ( Kawase, K; Kitazawa, Y; Suemori-Matsushita, H; Yamamoto, T, 1993) |
| "Trabeculectomy is performed as a treatment for glaucoma to lower intraocular pressure (IOP)." | 2.53 | Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery. ( Cheng, JW; Cheng, SW; Lu, GC; Wei, RL, 2016) |
| "Raised intraocular pressure is a risk factor for glaucoma." | 2.52 | Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. ( Cabourne, E; Clarke, JC; Evans, JR; Schlottmann, PG, 2015) |
| "In cases where such treatment fails, glaucoma-filtering surgery is considered, most commonly trabeculectomy surgery with variations in technique, for example, the type of conjunctival flap (fornix- or limbal-based)." | 2.52 | Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma. ( Abdulaal, M; Al-Haddad, C; Al-Moujahed, A; Ervin, AM, 2015) |
| "The healing and scarring determine the percentage of patients achieving low final intraocular pressures (IOPs) that are associated with virtually no glaucoma progression." | 2.44 | Modulation of wound healing during and after glaucoma surgery. ( Brocchini, S; Dahlmann-Noor, A; Georgoulas, S; Khaw, PT, 2008) |
| "The mean follow-up time after treatment for endophthalmitis was 6." | 2.41 | Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. ( Budenz, DL; Flynn, HW; Scott, IU; Song, A, 2002) |
| " New anti-glaucoma drugs, latanoprost and nipradilol, have been shown to effect a reduction in IOP equal to that achieved with the equivalent dosage of timolol, with no adverse systemic side effects." | 2.39 | [Current topics in glaucoma]. ( Masuda, K, 1996) |
| "The use of antiscarring agents, particularly the antimetabolites 5-fluorouracil and mitomycin C, have revolutionized glaucoma surgery over the past decade." | 2.39 | Current techniques in wound healing modulation in glaucoma surgery. ( Khaw, PT; Migdal, CS, 1996) |
| "Mitomycin C seems to be a better treatment than 5 fluorouracil." | 2.38 | [Mitomycin C in glaucoma surgery]. ( Collignon-Brach, J, 1993) |
| " Outcome measures included IOP reduction from baseline, mean IOP change from baseline at month 6, medication use at 6 months, complications, adverse events, and need for further procedures." | 1.91 | Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. ( Burgos-Blasco, B; Fernandez-Vigo, JI; García-Feijóo, J; Gines-Gallego, C; Martinez de la Casa, JM; Mendez-Hernandez, CD; Morales-Fernandez, L; Perucho-Gonzalez, L; Saenz-Frances, F, 2023) |
| "Post-surgical scarring is a known cause of trabeculectomy failure." | 1.91 | Clinical and Histopathological Effects of Intracameral Ranibizumab in Experimental Trabeculectomy. ( Azhany, Y; Che Hamzah, J; Jaafar, H; Liza-Sharmini, AT; Low, JH; Rahman, WFWA; Yusuf, WNW, 2023) |
| " The history obtained directly from the surgeon revealed that MMC dosing was 0." | 1.72 | Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1. ( Liaboe, C; Samuelson, TW, 2022) |
| "Mitomycin C (MMC) was used in 54,8% of the cases, collagen matrix (Ologen®, Aeon Astron Corporation, Taipei, Taiwan) was used alone in 8." | 1.72 | Survey of glaucoma surgical preferences among glaucoma specialists in Spain. ( Balboa Miró, M; Botella García, J; Duch, S; Loscos Arenas, J; Moreno-Montañés, J; Romera Romero, P, 2022) |
| "Eyes with primary open angle glaucoma (OAG), secondary OAG or pseudophakic primary angle closure glaucoma (PACG) were included." | 1.72 | Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique. ( Ang, GS; Chung, IY; Kong, YXG, 2022) |
| "Treatment of leakage with ocular hypotony after trabeculectomy with mitomycin C (MMC) can be safely achieved through conjunctival patch alone or combined with donor scleral graft in cases of melted underlying sclera." | 1.62 | Outcome of Bleb Revision With Autologous Conjunctival Graft Alone or Combined With Donor Scleral Graft for Late-onset Bleb Leakage With Hypotony After Standard Trabeculectomy With Mitomycin C. ( Chronopoulos, P; Grehn, F; Hoffmann, EM; Laspas, P; Peters, H; Pfeiffer, N; Prokosch-Willing, V; Wahl, J, 2021) |
| "To evaluate the effectiveness of repeat trabeculectomy with Mitomycin C (MMC) in isolation or combined with phacoemulsification, and to identify risk factors for failure over 1 year." | 1.62 | Outcome of repeat trabeculectomy with mitomycin C in isolation or combined with phacoemulsification. ( George, R; Jagannathan, J; Shantha, B; Vijaya, L, 2021) |
| "Mitomycin C is a routinely used antimetabolite which effectively limits the scarring process." | 1.62 | National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK. ( Arain, UR; Khan, SA; Razzaq, MA; Whittaker, K, 2021) |
| "Mitomycin C (MMC) has replaced 5-fluorouracil (5-FU) intraoperatively with comparable success rates and a decrease in postoperative antimetabolite administration." | 1.62 | Outcomes of Primary Trabeculectomy From Two Same-centre Cohorts 10 Years Apart. ( Au, L; Cristian, C; Fenerty, CH; Mercieca, KJ; Naqvi, S; Shiwani, HA; Spencer, AF, 2021) |
| "Choroidal detachment is a major postoperative complication of trabeculectomy." | 1.56 | Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report. ( Abe, T; Sakurai, Y; Takayama, K; Takeuchi, M, 2020) |
| "Low postoperative complications were recorded." | 1.56 | Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma. ( Kalogianni, E; Kozobolis, V; Sideroudi, H, 2020) |
| "Mean intraocular pressure was significantly reduced from 21." | 1.51 | One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. ( Arrieta-Los Santos, A; Chacón-González, M; Del Río Mayor, JL; Ibáñez-Muñoz, A; Lizuain-Abadía, ME; Rúa-Galisteo, O; Soto-Biforcos, VS, 2019) |
| "Mitomycin C was used in all eyes." | 1.51 | One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma. ( Ge, J; Gong, R; Lin, M; Lin, S; Liu, Y; Wu, K; Zuo, C, 2019) |
| "For Taiwanese children, the combined trabeculotomy-trabeculectomy using the modified Safer Surgery System offered an efficient and safe surgical option for treating glaucoma with long-term satisfactory control of IOP." | 1.48 | Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children. ( Chen, YH; Hsu, CR; Lu, DW; Tai, MC, 2018) |
| "Crouzon syndrome is the most common form of craniosynostosis, and mutations in the fibroblast growth factor receptor 2 and 3 (FGFR2 and FGFR3) genes are implicated in its pathogenesis." | 1.48 | Glaucoma With Crouzon Syndrome. ( Al-Shahwan, S; Alshamrani, AA, 2018) |
| "Mitomycin C was used in 15/19 eyes." | 1.46 | Intermediate Term Outcomes of Early Posttrabeculectomy Bleb Leaks Managed by Large Diameter Soft Bandage Contact Lens. ( Garudadri, CS; Gollakota, S; Mohamed, A; Senthil, S, 2017) |
| "Main postoperative complications were transient: 4 eyes with seidel phenomenon at 24 hours (10." | 1.46 | Two-year Results After Deep Sclerectomy With Nonabsorbable Uveoscleral Implant (Esnoper-Clip): Surgical Area Analysis Using Anterior Segment Optical Coherence Tomography. ( Castellvi-Manent, J; Loscos-Arenas, J; Moll-Udina, A; Romanic-Bubalo, N; Romera-Romero, P; Valldeperas, X, 2017) |
| "To determine the long-term outcomes of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C (MMC) for primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) in an Asian population." | 1.46 | Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population. ( Aduan, J; Aquino, CM; Chee, LS; Chen, D; Chew, P; Koh, V; Sng, C, 2017) |
| "Trabeculectomy is a safe and effective method for achieving single-digit IOP targets in NTG eyes with progression at low IOP." | 1.43 | Safety And Efficacy Of Achieving Single-Digit Intraocular Pressure Targets With Filtration Surgery In Eyes With Progressive Normal-Tension Glaucoma. ( Greenfield, DS; Iverson, SM; Schultz, SK; Shi, W, 2016) |
| "Mitomycin-C was used in most cases." | 1.43 | The Long-term Outcomes of Glaucoma Drainage Device in Pediatric Glaucoma. ( Mandalos, A; Parmar, T; Sung, V; Tailor, R, 2016) |
| "Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage)." | 1.43 | Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies. ( Ang, GS; Meagher, P; Wang, BZ, 2016) |
| "To report the 5-year incidence of visual impairment after mitomycin C-augmented trabeculectomy (MMC trabeculectomy) and the risk factors for visual impairment." | 1.43 | Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. ( Araie, M; Chiba, T; Kashiwagi, K; Kogure, S; Kuwayama, Y; Mabuchi, F; Yamamoto, T, 2016) |
| "To determine the efficacy of safe surgery system trabeculectomy combined with manual small incision cataract surgery/phacoemulsification in primary glaucoma coexistent with cataract." | 1.42 | Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction. ( Agashe, A; Khandelwal, R; Khandelwal, RR; Majumdar, M; Raje, D; Rathi, A, 2015) |
| "Forty-eight eyes of 41 patients with open angle glaucoma (OAG), who underwent DS with supraciliary hema implant (Esnoper(®) V-2000), were included in this study." | 1.42 | Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications. ( de la Cámara, J; Langhor, K; Langohr, K; Loscos, J; Parera, À; Romera, P; Sabala, A; Valldeperas, X, 2015) |
| "The majority of patients with juvenile idiopathic arthritis-related uveitic glaucoma require surgery to control intraocular pressure." | 1.42 | Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis. ( Kivelä, T; Kotaniemi, K; Leinonen, S; Majander, A, 2015) |
| "Mitomycin-c (MMC) was used in 75 (77." | 1.40 | Can intraoperative intraocular pressure during primary trabeculectomy predict early postoperative pressure? ( Chang, X; Cui, HY; Fan, SJ; He, Y; Huang, Y; Li, SZ; Liang, YB; Liu, LR; Meng, HL; Rong, SS; Thomas, R; Wang, NL; Wang, R; Zhang, ZH, 2014) |
| "Only pseudophakia was significantly associated with outcome in the multivariable analysis for criterion A (relative risk, 9." | 1.40 | Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study. ( Inatani, M; Inoue, T; Iwao, K; Kawai, M; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2014) |
| "Secondary glaucoma is a serious complication in patients with transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP)." | 1.40 | Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. ( Ando, Y; Eiki, D; Hara, R; Inoue, T; Kawaji, T; Tanihara, H, 2014) |
| "Both cataract and glaucoma are significant public health problems." | 1.40 | Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy. ( Kunhammad, S; Singh, P, 2014) |
| "MMC-augmented revision appears to be a safe and useful tool in reducing intraocular pressure after trabeculectomy failure." | 1.39 | Efficacy and safety of mitomycin C--augmented revisions of non-functioning filtering blebs after trabeculectomy--7 year results. ( Kosior-Jarecka, E; Tomaszewska, J; Tulidowicz-Bielak, M; Zarnowski, T, 2013) |
| " Low dosage MMC was applied beneath the superficial scleral flap before dissecting the second, deep scleral flap and accessing Schlemm canal." | 1.39 | Canaloplasty with intraoperative low dosage mitomycin C: a retrospective case series. ( Barnebey, HS, 2013) |
| " Additional postoperative treatments, such as bleb needling, and adverse events were secondary outcomes." | 1.39 | Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. ( Aung, T; Hoh, ST; Htoon, HM; Narayanaswamy, A; Perera, SA; Seah, SK; Wong, TT, 2013) |
| "the Wuerzburg bleb classification score (WBCS) aims at an objective and standardized assessment of the developing filtering bleb after trabeculectomy, in order to detect and treat bleb scarring at the earliest possible stage of development." | 1.37 | The prognostic value of the wuerzburg bleb classification score for the outcome of trabeculectomy. ( Ellinger, P; Grehn, F; Guthoff, R; Kann, G; Klink, J; Klink, T, 2011) |
| "Needling revision with adjunctive MMC is effective for reviving flat filtering blebs and controlling IOP, even several years after the original trabeculectomy, and seems to be safe for the corneal endothelium." | 1.37 | Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium. ( Cronemberger, S; Diniz, AF; Ferreira, GA; Filho, AD; Maestrini, HA; Matoso, HD; Mérula, RV; Reis, JR; Sakurai, E, 2011) |
| "Mean intraocular pressure was significantly reduced from 15." | 1.37 | Effect of trabeculectomy on ocular and corneal higher order aberrations. ( Amano, S; Araie, M; Fukuoka, S; Honda, N; Mimura, T; Usui, T, 2011) |
| "Mean intraocular pressure was 28." | 1.37 | Needling augmented with topical application of mitomycin C for management of bleb failure. ( Abd El Hameed, M; Ghoneim, EM, 2011) |
| "Bleb wall reflectivity of developing blebs on AS-OCT 2 weeks postoperatively was correlated with mature bleb function at 6-month postoperative visit." | 1.36 | Early trabeculectomy bleb walls on anterior-segment optical coherence tomography. ( Hangai, M; Hirose, F; Inoue, R; Nakanishi, H; Nakano, N; Ojima, T; Unoki, N; Yoshimura, N, 2010) |
| "Mitomycin C(MMC) was administered to 15 patients (58%) with needling being performed on 10 (38%) of these patients." | 1.36 | Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma. ( Bissig, A; Feusier, M; Mermoud, A; Roy, S, 2010) |
| " Based on the Wuerzburg bleb classification score (WBCS) for postoperative wound healing evaluation, 30 of these operations of group A (group B: n = 26) did not receive 5 FU postoperatively (controls), 67 (93) received up to 7 postoperative injections of 5 mg 5 FU (normal dosage group), and 72 (93) received more than 7 injections (high dosage group)." | 1.36 | [Corneal epitheliopathy following trabeculectomy with postoperative adjunctive 5-fluorouracil]. ( Geerling, G; Grehn, F; Klink, T; Reiter, C; Schultheiss, A; Wimmer, S, 2010) |
| "Thirty-one blebs of 24 patients underwent noncontact in vivo confocal microscopy using the Rostock Cornea Module of the Heidelberg Retina Tomograph II (50x noncontact Nikon lens, 1-2 mum resolution, field of view: 500x500 mum)." | 1.35 | Noncontact in vivo scanning laser microscopy of filtering blebs. ( Liebmann, JM; Palmiero, PM; Ritch, R; Sbeity, Z; Tello, C, 2009) |
| "Intraocular pressure was measured before and three weeks after surgery." | 1.35 | Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model. ( Fukmoto, M; Ikeda, T; Ishida, O; Jin, D; Miyazaki, M; Okada, K; Oku, H; Sugiyama, T; Takai, S, 2009) |
| "No patients presented recurrence of the bleb leak or AMT-related complications during entire follow-up." | 1.35 | Long-term results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. ( Fujioka, M; Nagai-Kusuhara, A; Nakamura, M; Negi, A, 2008) |
| "The mean intraocular pressure was significantly decreased from 22." | 1.33 | [Clinical results of fornix-based trabeculectomy with a scleral tunnel]. ( Kano, K; Kuwayama, Y; Mizunoya, H, 2005) |
| "Within this group, blebs were classified into three different categories according to their optical coherence tomography pattern: type A (featuring a thick wall and a single large fluid-filled space), type B (featuring a thin wall and multiple large fluid-filled spaces) and type C (featuring multiple, irregular and flattened fluid-filled spaces)." | 1.33 | Filtering blebs imaging by optical coherence tomography. ( Barboni, P; Savini, G; Zanini, M, 2005) |
| "Each bleb was incised segmentally and the cut edges of the conjunctiva and Tenon capsule were sutured to the underlying sclera." | 1.33 | Surgical reduction of symptomatic, circumferential, filtering blebs. ( Anis, S; Liebmann, J; Ritch, R; Shihadeh, W, 2006) |
| "A case of early-onset sclerolimbal ectasia following low-dose topical mitomycin C application during uveitic glaucoma surgery is reported." | 1.33 | Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient. ( Jockin, Y; O'Halloran, H; Pirouzian, A; Scher, C, 2006) |
| "Two additional filtering blebs were treated with balanced saline solution (BSS), two received mitomycin-C (MMC) (0." | 1.33 | A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). ( Sherwood, MB, 2006) |
| "To assess the efficacy of a bleb revision technique with regard to improvement in intraocular pressure (IOP) and visual acuity after hypotony maculopathy and to evaluate the influence of duration of hypotony on visual outcome." | 1.32 | Bleb revision for hypotony maculopathy after trabeculectomy. ( Bashford, KP; Shafranov, G; Shields, MB, 2004) |
| "Mitomycin C could cause the degeneration of lens epithelial cells." | 1.31 | [The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract]. ( Huang, J; Liu, Y; Zheng, D; Zheng, H, 2001) |
| " The dosage of mitomycin-C was 0." | 1.31 | Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000) |
| "Intraocular pressure was significantly lower and an avascular area was more frequent in eyes with oozing or leak than in eyes without (P <." | 1.31 | Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb after trabeculectomy. ( Araie, M; Matsuo, H; Shirato, S; Suzuki, Y; Tomidokoro, A, 2002) |
| "Mitomycin C was administered intraoperatively in the dose of 0." | 1.31 | [Antimetabolites in glaucoma surgery--long-term results]. ( Ferková, S; Jakabovicová, E; Michalíková, L; Strmen, P, 2002) |
| "Mitomycin-C (MMC) has been shown to improve the surgical success of trabeculectomy; however, the advantages of MMC have been evaluated almost entirely as an adjunct to limbal-based trabeculectomy." | 1.30 | Fornix-based trabeculectomy with mitomycin-C. ( Goldenfeld, M; Levkovitch-verbin, H; Melamed, S, 1997) |
| "04% MMC thus showed no evident toxic effects on the function of the ciliary body and other pathological changes were minor." | 1.30 | [The cytotoxic effect of topical mitomycin C on the ciliary body in rabbits]. ( Araie, M; Hara, T; Obata, H; Shirato, S, 1998) |
| " A dose-response effect of the concentration of MMC and IOP levels is present, suggesting that the higher concentration leads to lower IOP values." | 1.30 | Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. ( Krieglstein, GK; Mietz, H, 1998) |
| "Intraocular pressures were lower in the group that received MMC compared to the 5-FU group, but not in the group that did not receive antimetabolites, at all time intervals measured (P < ." | 1.30 | Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. ( Budenz, DL; Gordon, J; Keates, EU; Piltz-Seymour, J; Pyfer, M; Singh, K, 1999) |
| "At a dosage of 0." | 1.30 | Effects of subconjunctival injection of mitomycin-C on iridial circulation in rabbits. ( Araie, M; Muta, K; Tamaki, Y; Tomidokoro, A, 1999) |
| "These findings suggest a toxic effect of MMC on the NECs of ciliary body, possibly that can decrease the aqueous production and intraocular pressure, even causing persistent hypotony." | 1.30 | [Cytotoxic effect of mitomycin C on the nonpigmented epithelium of ciliary body in rabbit eyes]. ( Huang, P; Jiang, Y; Wen, J; Wu, Z; Xia, X; Zeng, Q, 1998) |
| "In these eyes, intraocular pressure is between 8 and 12 mmHg." | 1.29 | Treatment of postfiltration bleb leaks with autologous blood. ( Betchkal, J; Doyle, JW; Magauran, RG; Smith, MF, 1995) |
| "A 71-year-old white woman with primary open angle glaucoma received trabeculectomy with antimetabolite." | 1.29 | Profound long-term hypotony without maculopathy after trabeculectomy with antimetabolite. ( Kaufman, PL; Kee, C, 1994) |
| "Mitomycin is an antibiotic with antineoplastic activity which inhibits fibroblast proliferation in the operative field in glaucoma filtering surgery." | 1.29 | Filtering surgery with mitomycin-C in uncomplicated (primary open angle) glaucoma. ( Doğan, H; Erkiliç, K; Karaküçük, S; Mirza, GE, 1994) |
| "Intraocular pressure was controlled successfully in 97." | 1.29 | Effects of topical mitomycin C on primary trabeculectomies and combined procedures. ( Costa, VP; Gandham, S; Moster, MR; Schmidt, CM; Smith, M; Wilson, RP, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 168 (18.83) | 18.2507 |
| 2000's | 245 (27.47) | 29.6817 |
| 2010's | 312 (34.98) | 24.3611 |
| 2020's | 167 (18.72) | 2.80 |
| Authors | Studies |
|---|---|
| Alagöz, N | 1 |
| Erdoğdu, E | 1 |
| Yaşar, T | 1 |
| Chelerkar, VJ | 1 |
| Agrawal, D | 1 |
| S Kalyani, VK | 1 |
| Deshpande, M | 1 |
| Wagner, FM | 2 |
| Schuster, AK | 3 |
| Munder, A | 1 |
| Muehl, M | 1 |
| Chronopoulos, P | 3 |
| Pfeiffer, N | 13 |
| Hoffmann, EM | 12 |
| Kingston, EJ | 1 |
| Zagora, SL | 1 |
| Symes, RJ | 1 |
| Raman, P | 1 |
| McCluskey, PJ | 1 |
| Lusthaus, JA | 2 |
| Kandarakis, S | 1 |
| Kontaxakis, A | 1 |
| Doumazos, L | 1 |
| Petrou, P | 1 |
| Droutsas, K | 1 |
| Papaconstantinou, D | 1 |
| Georgalas, I | 1 |
| Wong, YL | 1 |
| Walkden, A | 1 |
| Mercieca, K | 5 |
| Kido, A | 1 |
| Akagi, T | 2 |
| Ikeda, HO | 2 |
| Kameda, T | 1 |
| Suda, K | 1 |
| Miyake, M | 1 |
| Hasegawa, T | 1 |
| Numa, S | 1 |
| Tsujikawa, A | 1 |
| Liaboe, C | 1 |
| Samuelson, TW | 2 |
| Seet, LF | 1 |
| Yap, ZL | 1 |
| Chu, SWL | 1 |
| Toh, LZ | 1 |
| Ibrahim, FI | 1 |
| Teng, X | 1 |
| Wong, TT | 5 |
| Shah, C | 1 |
| Sen, P | 2 |
| Mohan, A | 1 |
| Peeush, P | 1 |
| Jain, E | 1 |
| Prasad, K | 2 |
| Sen, A | 1 |
| Tripathi, S | 1 |
| Ichhpujani, P | 1 |
| Singla, E | 1 |
| Kalra, G | 1 |
| Bhartiya, S | 1 |
| Kumar, S | 3 |
| van Mechelen, RJS | 2 |
| Wolters, JE | 1 |
| Bertens, CJF | 1 |
| Webers, CAB | 2 |
| van den Biggelaar, FJHM | 1 |
| Gorgels, TGMF | 2 |
| Beckers, HJM | 2 |
| Senthil, S | 7 |
| Rao, HL | 7 |
| Ali, MH | 1 |
| Krishnamurthy, R | 1 |
| Dikshit, S | 1 |
| Choudhari, N | 2 |
| Sastry, R | 1 |
| Garudadri, C | 2 |
| Monja-Alarcón, N | 1 |
| Perucho-Martínez, S | 1 |
| Buenasmañanas-Maeso, M | 1 |
| Toledano-Fernández, N | 1 |
| Romera Romero, P | 1 |
| Duch, S | 1 |
| Moreno-Montañés, J | 2 |
| Botella García, J | 1 |
| Balboa Miró, M | 1 |
| Loscos Arenas, J | 1 |
| Paul, C | 1 |
| Divya, J | 1 |
| Kamal, R | 1 |
| Paul, A | 1 |
| Szigiato, AA | 2 |
| Touma, S | 1 |
| Jabbour, S | 1 |
| Lord, F | 1 |
| Agoumi, Y | 1 |
| Singh, H | 1 |
| Tanner, A | 1 |
| Haddad, F | 1 |
| Fajardo-Sanchez, J | 1 |
| Nguyen, E | 1 |
| Thong, KX | 1 |
| Ah-Moye, S | 1 |
| Perl, N | 1 |
| Abu-Bakra, M | 1 |
| Kulkarni, A | 1 |
| Trikha, S | 1 |
| Lascaratos, G | 1 |
| Parnell, M | 1 |
| Kailani, O | 1 |
| King, AJ | 3 |
| Agrawal, P | 1 |
| Stead, R | 1 |
| Giannouladis, K | 1 |
| Rodrigues, I | 1 |
| Goyal, S | 6 |
| Hysi, PG | 1 |
| Lim, S | 1 |
| Yu-Wai-Man, C | 1 |
| Gietzelt, C | 1 |
| Lüke, JN | 2 |
| Adler, W | 1 |
| Dietlein, TS | 8 |
| Lappas, A | 3 |
| Prokosch-Willing, V | 7 |
| Roters, S | 1 |
| Heindl, LM | 1 |
| Cursiefen, C | 2 |
| Enders, P | 2 |
| Dooling, V | 1 |
| Lee, GA | 3 |
| Liu, L | 2 |
| Casson, RJ | 3 |
| Danesh-Meyer, HV | 3 |
| Shah, P | 2 |
| Almobarak, FA | 6 |
| Alharbi, AH | 6 |
| Aljadaan, I | 6 |
| Aldhibi, H | 2 |
| Tekcan, H | 1 |
| Mangan, MS | 1 |
| Alpogan, O | 1 |
| Imamoglu, S | 1 |
| Kose, AO | 1 |
| Ercalık, NY | 1 |
| Ibarz Barberá, M | 2 |
| Martínez-Galdón, F | 1 |
| Caballero-Magro, E | 1 |
| Rodríguez-Piñero, M | 1 |
| Tañá-Rivero, P | 1 |
| Dias, DT | 1 |
| Almeida, I | 1 |
| Ushida, M | 1 |
| Lopes, FS | 1 |
| Kanadani, FN | 1 |
| Gracitelli, CPB | 1 |
| Prata, TS | 3 |
| Al-Mugheiry, TS | 1 |
| Clark, A | 1 |
| Broadway, DC | 1 |
| Mandal, AK | 7 |
| Gothwal, VK | 2 |
| Gedde, SJ | 24 |
| Feuer, WJ | 18 |
| Lim, KS | 4 |
| Barton, K | 6 |
| Ahmed, II | 5 |
| Brandt, JD | 10 |
| Saeed, E | 1 |
| Zalewska, R | 1 |
| Konopińska, J | 1 |
| Wong, MOM | 1 |
| Yu, AHY | 1 |
| Chan, CKM | 1 |
| Carré, C | 1 |
| Baudin, F | 1 |
| Buteau, B | 1 |
| Martine, L | 1 |
| Grégoire, S | 1 |
| Vasku, G | 1 |
| Berdeaux, O | 1 |
| Béduneau, A | 1 |
| Pellequer, Y | 1 |
| Jamoussi, J | 1 |
| Desrumeaux, C | 1 |
| Aho, S | 1 |
| Bron, AM | 1 |
| Acar, N | 1 |
| Creuzot-Garcher, C | 1 |
| Gabrielle, PH | 1 |
| Muñoz-Negrete, FJ | 4 |
| Aguado-Casanova, V | 1 |
| Huelin, FJ | 1 |
| Rebolleda, G | 4 |
| Senthilkumar, VA | 2 |
| Kumar, MR | 1 |
| Wijesinghe, HK | 2 |
| Uduman, MS | 3 |
| Krishna, SM | 1 |
| Odayappan, A | 1 |
| Puthuran, GV | 3 |
| Tara, TD | 1 |
| Nagdev, N | 1 |
| Ramesh, S | 1 |
| Mani, I | 1 |
| Krishnadas, SR | 4 |
| Lee, JY | 1 |
| Wu, J | 1 |
| Liu, Y | 3 |
| Saraswathy, S | 1 |
| Zhou, L | 2 |
| Bu, Q | 1 |
| Su, Y | 1 |
| Choi, D | 1 |
| Park, E | 1 |
| Strohmaier, CA | 1 |
| Weinreb, RN | 3 |
| Hong, YK | 1 |
| Pan, X | 1 |
| Huang, AS | 1 |
| Mambo, Y | 1 |
| Higashide, T | 7 |
| Ohkubo, S | 4 |
| Udagawa, S | 1 |
| Yamashita, Y | 1 |
| Tsuchiya, S | 1 |
| Okayama, M | 1 |
| Wajima, R | 1 |
| Sugiyama, K | 8 |
| Khairy, MA | 1 |
| Kenawy, S | 1 |
| Fawzi, KM | 1 |
| Al-Nashar, HY | 1 |
| Mizuno, Y | 1 |
| Okada, N | 1 |
| Onoe, H | 1 |
| Tokumo, K | 1 |
| Okumichi, H | 1 |
| Hirooka, K | 3 |
| Kiuchi, Y | 7 |
| Cutolo, CA | 5 |
| Bonzano, C | 5 |
| Catti, C | 3 |
| Pizzorno, C | 4 |
| Bagnis, A | 5 |
| Traverso, CE | 6 |
| Iester, M | 5 |
| Burgos-Blasco, B | 1 |
| García-Feijóo, J | 1 |
| Gines-Gallego, C | 1 |
| Perucho-Gonzalez, L | 1 |
| Fernandez-Vigo, JI | 1 |
| Martinez de la Casa, JM | 1 |
| Saenz-Frances, F | 1 |
| Morales-Fernandez, L | 1 |
| Mendez-Hernandez, CD | 1 |
| Sharma, R | 2 |
| Nappi, V | 1 |
| Empeslidis, T | 1 |
| Pillai, M | 1 |
| Kalegore, AA | 1 |
| Mathews, AM | 1 |
| Winuntamalakul, Y | 1 |
| Chansangpetch, S | 1 |
| Ratanawongphaibul, K | 1 |
| Itthipanichpong, R | 1 |
| Manassakorn, A | 1 |
| Tantisevi, V | 1 |
| Rojanapongpun, P | 1 |
| Vinod, K | 4 |
| Prum, BE | 2 |
| Kianusch, K | 1 |
| Stingl, J | 1 |
| Seuthe, AM | 1 |
| Erokhina, M | 1 |
| Szurman, P | 1 |
| Haus, A | 1 |
| Lappa, A | 1 |
| Awad-Allah, MAA | 1 |
| Mousa, AS | 1 |
| Ashour, DM | 1 |
| Yüksel, R | 1 |
| Yüksel, N | 1 |
| Yazır, Y | 1 |
| Öztürk, A | 1 |
| Furat Rençber, S | 1 |
| Demirci Küçük, K | 1 |
| Angmo, D | 4 |
| Mahalingam, K | 1 |
| Gowtham, L | 1 |
| Elancheliyan, P | 1 |
| Velpandian, T | 1 |
| Sihota, R | 11 |
| Dada, T | 5 |
| Shih, EJ | 1 |
| Chen, YY | 1 |
| Yadgari, M | 2 |
| Ghanbarnia, MJ | 1 |
| de Waard, P | 1 |
| Wubbels, RJ | 1 |
| Lo, WJ | 1 |
| Kuang, TM | 1 |
| Chen, SJ | 1 |
| Hwang, DK | 1 |
| Azhany, Y | 1 |
| Rahman, WFWA | 1 |
| Jaafar, H | 1 |
| Low, JH | 1 |
| Yusuf, WNW | 1 |
| Liza-Sharmini, AT | 1 |
| Che Hamzah, J | 1 |
| Fang, CEH | 1 |
| Hakim, MT | 1 |
| Siddiqui, MM | 1 |
| Armstrong, D | 1 |
| Shankar, V | 2 |
| Kim, NE | 1 |
| Kim, SS | 1 |
| Lee, JS | 1 |
| Lee, K | 1 |
| Bae, HW | 2 |
| Lee, SY | 1 |
| Choi, W | 1 |
| Kim, CY | 2 |
| Van Swol, JM | 1 |
| Walden, DN | 1 |
| Van Swol, EG | 1 |
| Nguyen, SA | 1 |
| Nutaitis, MJ | 1 |
| Kassm, TM | 1 |
| Ramesh, PV | 1 |
| Ramesh, SV | 1 |
| Kodnani, A | 1 |
| Velumani, V | 1 |
| Sainath, D | 1 |
| Pannerselvam, P | 1 |
| Strzalkowska, A | 2 |
| Strzalkowski, P | 2 |
| Arish, M | 1 |
| Sargazi, M | 1 |
| Dehghani, S | 1 |
| Sahami, M | 1 |
| Dashipour, A | 1 |
| Sarhadi, S | 1 |
| Rouientan, H | 1 |
| Sun, CQ | 1 |
| McSoley, MJ | 1 |
| Lum, F | 1 |
| Chang, TC | 2 |
| Vanner, EA | 1 |
| Seresirikachorn, K | 1 |
| Thiamthat, W | 1 |
| Annopawong, K | 1 |
| Wanichwecharungruang, B | 1 |
| Friedman, DS | 2 |
| Vu, DM | 1 |
| Hwang, SY | 1 |
| Ahn, HB | 1 |
| Jin, SW | 1 |
| Baeg, JY | 1 |
| Choi, HS | 1 |
| Lee, SH | 2 |
| Maheshwari, D | 6 |
| Pillai, MR | 3 |
| Kanduri, S | 6 |
| Nair, IJ | 1 |
| Kader, MA | 1 |
| Ramakrishnan, R | 5 |
| Majtanova, N | 1 |
| Keri, P | 1 |
| Kriskova, P | 1 |
| Kurilova, V | 1 |
| Cholevik, D | 1 |
| Majtan, J | 1 |
| Kolar, P | 1 |
| Daniel, MC | 1 |
| Mohamed-Noriega, J | 2 |
| Petchyim, S | 1 |
| Brookes, J | 1 |
| Lin, MM | 1 |
| Morgan, WH | 1 |
| Kolomeyer, NN | 1 |
| Moster, SJ | 1 |
| Zheng, CX | 1 |
| Giubilato, A | 1 |
| Moster, MR | 12 |
| El Sayed, YM | 3 |
| Elhusseiny, AM | 2 |
| Albalkini, AS | 2 |
| El Sheikh, RH | 2 |
| Osman, MA | 2 |
| Lenzhofer, M | 2 |
| Strohmaier, C | 1 |
| Hohensinn, M | 1 |
| Hitzl, W | 1 |
| Steiner, V | 1 |
| Baca, B | 1 |
| Moussa, S | 1 |
| Motloch, K | 1 |
| Reitsamer, HA | 1 |
| Glandorf, K | 1 |
| Lommatzsch, C | 2 |
| Heinz, C | 2 |
| Koch, JM | 2 |
| Salimi, A | 2 |
| Kovalyuk, N | 1 |
| Harasymowycz, PJ | 2 |
| Arimura, S | 1 |
| Iwasaki, K | 1 |
| Gozawa, M | 1 |
| Takamura, Y | 1 |
| Inatani, M | 12 |
| Midha, N | 2 |
| Gillmann, K | 2 |
| Chaudhary, A | 2 |
| Mermoud, A | 9 |
| Mansouri, K | 5 |
| Ahmed, IIK | 4 |
| Gupta, C | 1 |
| Mathews, D | 1 |
| Pathak-Ray, V | 2 |
| Kadar, MA | 5 |
| Nemoto, E | 1 |
| Kojima, S | 2 |
| Sugiyama, T | 2 |
| Jin, D | 2 |
| Takai, S | 2 |
| Maeda, M | 1 |
| Kohmoto, R | 1 |
| Ueki, M | 1 |
| Oku, H | 2 |
| Ikeda, T | 2 |
| Camp, AS | 1 |
| Grover, DS | 5 |
| Kornmann, HL | 3 |
| Fellman, RL | 4 |
| Sakurai, Y | 1 |
| Takayama, K | 1 |
| Abe, T | 2 |
| Takeuchi, M | 1 |
| Borgohain, M | 2 |
| Tayab, S | 3 |
| Sarma, P | 3 |
| Sangma, CA | 2 |
| Kumari, N | 1 |
| Chiraniya, P | 1 |
| Mano, SS | 1 |
| Esteves, RM | 1 |
| Ferreira, NP | 1 |
| Abegão Pinto, L | 2 |
| Holmes, D | 1 |
| Hui, MMP | 1 |
| Clement, C | 1 |
| Jóhannesson, G | 1 |
| Gottfredsdóttir, MS | 1 |
| Ásgrimsdóttir, GM | 1 |
| Loftsson, T | 1 |
| Stefánsson, E | 1 |
| Chan, PP | 1 |
| Wong, LYN | 1 |
| Chan, TCY | 1 |
| Lai, G | 1 |
| Baig, N | 2 |
| Allam, RSHM | 1 |
| Raafat, KA | 1 |
| Abdel-Hamid, RM | 1 |
| Bravetti, GE | 1 |
| Chu, CK | 1 |
| Liebmann, JM | 6 |
| Cioffi, GA | 1 |
| Blumberg, DM | 1 |
| Al-Aswad, LA | 1 |
| Lim, MC | 1 |
| Hom, B | 1 |
| Watnik, MR | 1 |
| Altman, AR | 1 |
| Paul, T | 1 |
| Tong, MG | 1 |
| Schlenker, MB | 2 |
| Durr, GM | 1 |
| Michaelov, E | 1 |
| Rengappa, R | 3 |
| Negri, L | 1 |
| Olivari, S | 1 |
| Cappelli, F | 1 |
| Testa, V | 1 |
| Sindaco, D | 1 |
| Scotto, R | 2 |
| Saccheggiani, M | 1 |
| Barequet, D | 1 |
| Rosenfeld, E | 1 |
| Rabina, G | 1 |
| Shemesh, G | 1 |
| Kurtz, S | 1 |
| Vastardis, I | 1 |
| Fili, S | 2 |
| Perdikakis, G | 1 |
| Gatzioufas, Z | 1 |
| Kohlhaas, M | 2 |
| Martins, TGDS | 1 |
| Halili, A | 1 |
| Kessel, L | 1 |
| Subhi, Y | 1 |
| Bach-Holm, D | 2 |
| Sugimoto, K | 1 |
| Asano-Shimizu, K | 1 |
| Murata, H | 2 |
| Yamashita, T | 1 |
| Asaoka, R | 1 |
| Venkataraman, P | 1 |
| Manapakkam, M | 1 |
| Mohan, N | 1 |
| Rolim-de-Moura, C | 1 |
| Esporcatte, BLB | 1 |
| F Netto, C | 1 |
| Paranhos, A | 1 |
| de Oliveira, CM | 1 |
| Ferreira, JLM | 1 |
| Chen, PP | 8 |
| Heuer, DK | 5 |
| Singh, K | 11 |
| Wright, MM | 4 |
| Hengerer, F | 1 |
| Klabe, K | 1 |
| Schargus, M | 2 |
| Thieme, H | 1 |
| Voykov, B | 2 |
| Do, JL | 1 |
| Xu, BY | 1 |
| Wong, B | 1 |
| Camp, A | 1 |
| Ngai, P | 1 |
| Long, C | 1 |
| Proudfoot, J | 1 |
| Moghimi, S | 3 |
| Yan, D | 1 |
| Welsbie, DS | 1 |
| Hamdi, MM | 1 |
| Hamdi, IM | 1 |
| Pillunat, KR | 2 |
| Orphal, J | 1 |
| Haase, M | 1 |
| Pillunat, LE | 2 |
| Herber, R | 1 |
| Gagrani, M | 1 |
| Garg, I | 1 |
| Ghate, D | 1 |
| Craig, JE | 1 |
| Gutiérrez-Ortiz, C | 4 |
| Rodrigo-Rey, S | 2 |
| Chen, X | 2 |
| Hong, Y | 1 |
| Zhang, C | 1 |
| El Maamoun, TA | 1 |
| Shalaby, HS | 2 |
| Fontana, L | 1 |
| De Maria, M | 1 |
| Caristia, A | 1 |
| Mastrofilippo, V | 1 |
| Braglia, L | 1 |
| Iannetta, D | 1 |
| Scarale, GP | 1 |
| Batlle, JF | 2 |
| Corona, A | 1 |
| Albuquerque, R | 1 |
| Swogger, J | 2 |
| Conner, IP | 2 |
| Rosano, M | 1 |
| Kemmerer, M | 1 |
| Happ-Smith, C | 2 |
| Wells, A | 2 |
| Schuman, JS | 6 |
| Yates, CC | 2 |
| Theilig, T | 1 |
| Rehak, M | 1 |
| Busch, C | 1 |
| Bormann, C | 1 |
| Unterlauft, JD | 1 |
| Laspas, P | 4 |
| Wahl, J | 4 |
| Peters, H | 2 |
| Grehn, F | 7 |
| Chiu, HI | 1 |
| Su, HI | 1 |
| Ko, YC | 1 |
| Liu, CJ | 3 |
| Bedar, MS | 1 |
| Kellner, U | 1 |
| Al Yousef, Y | 1 |
| Hillenkamp, J | 1 |
| Loewen, NA | 3 |
| Wolters, JEJ | 1 |
| Al Majidi, R | 1 |
| Pinchuk, L | 3 |
| Klapstova, A | 1 |
| Horakova, J | 1 |
| Tunak, M | 1 |
| Shynkarenko, A | 1 |
| Erben, J | 1 |
| Hlavata, J | 1 |
| Bulir, P | 1 |
| Chvojka, J | 1 |
| Jagannathan, J | 1 |
| George, R | 2 |
| Shantha, B | 1 |
| Vijaya, L | 1 |
| Bansal, T | 1 |
| Gandhi, M | 2 |
| Dubey, S | 5 |
| Latsaheb, B | 1 |
| Sangma, C | 1 |
| Nilforushan, N | 2 |
| Es'haghi, A | 1 |
| Miraftabi, A | 2 |
| Abolfathzadeh, N | 1 |
| Banifatemi, M | 1 |
| Gurney, SP | 1 |
| Ahmad, M | 1 |
| Makanjuola, T | 1 |
| Ramm, L | 1 |
| Parulekar, MV | 1 |
| Kumari, P | 1 |
| Khan, SA | 1 |
| Whittaker, K | 1 |
| Razzaq, MA | 1 |
| Arain, UR | 1 |
| Kemmerer, MC | 1 |
| Julian, DR | 1 |
| Davis, R | 1 |
| Sayed, KM | 1 |
| Moreno-Salgueiro, A | 2 |
| González-Mesa, A | 2 |
| Pérez-Rico, C | 2 |
| Ho, DCW | 1 |
| Perera, SA | 5 |
| Hla, MH | 1 |
| Ho, CL | 4 |
| Kasar, K | 1 |
| Demir, T | 1 |
| Akin, MM | 1 |
| Gungor Kobat, S | 1 |
| de Leon, JMS | 1 |
| Pionela, CMG | 1 |
| Lim, FPM | 1 |
| Ponnusamy, V | 1 |
| Nguyen, V | 1 |
| An, JA | 1 |
| Dwivedi, R | 1 |
| Somerville, T | 1 |
| Cheeseman, R | 1 |
| Rogers, C | 1 |
| Batterbury, M | 1 |
| Choudhary, A | 1 |
| Elksne, E | 1 |
| Rattanasirivilai, P | 1 |
| Ali, ZC | 1 |
| Khoo, DI | 1 |
| Durai, I | 1 |
| Pallamparthy, S | 1 |
| Robin, AL | 3 |
| Palmberg, P | 2 |
| Michaels, L | 1 |
| Holland, L | 1 |
| Morales Fernández, L | 1 |
| Tañá Rivero, P | 1 |
| Gómez de Liaño, R | 1 |
| Teus, MA | 4 |
| Guo, X | 1 |
| Wang, Y | 1 |
| Yang, L | 1 |
| Wang, P | 1 |
| Chen, K | 1 |
| Wu, Y | 2 |
| Mudhol, R | 1 |
| Bansal, R | 1 |
| Nakajima, K | 1 |
| Sakata, R | 1 |
| Ueda, K | 1 |
| Fujita, A | 1 |
| Fujishiro, T | 1 |
| Honjo, M | 2 |
| Shirato, S | 8 |
| Aihara, M | 3 |
| José, P | 1 |
| Teixeira, FJ | 1 |
| Barão, R | 1 |
| Sousa, DC | 1 |
| Marques, RE | 1 |
| Barata, ADO | 1 |
| Marques-Neves, C | 1 |
| Alves, M | 1 |
| Papoila, AL | 1 |
| Stalmans, I | 5 |
| Silva, JP | 1 |
| Choudhari, NS | 2 |
| Mokkarala, AJR | 1 |
| Tone, B | 1 |
| Khanna, R | 1 |
| Garudadri, CS | 6 |
| Promelle, V | 1 |
| Lyons, CJ | 1 |
| Denkel, L | 1 |
| Hohberger, B | 1 |
| Lämmer, R | 1 |
| Shiwani, HA | 1 |
| Naqvi, S | 1 |
| Cristian, C | 1 |
| Au, L | 1 |
| Spencer, AF | 1 |
| Fenerty, CH | 1 |
| Mercieca, KJ | 1 |
| Baker, ND | 3 |
| Barnebey, HS | 2 |
| Stiles, MC | 1 |
| Vold, SD | 2 |
| Khatana, AK | 3 |
| Flowers, BE | 1 |
| Strouthidis, NG | 2 |
| Panarelli, JF | 4 |
| Sharma, A | 4 |
| Gupta, S | 4 |
| Vahedian, Z | 2 |
| Fakhraie, G | 4 |
| Faraji, M | 1 |
| Tabatabaei, SM | 1 |
| Dangeti, D | 1 |
| Battula, M | 1 |
| Hashem, NH | 1 |
| Kong, YXG | 1 |
| Chung, IY | 1 |
| Ang, GS | 3 |
| Harasymowycz, P | 2 |
| Yazgan, S | 1 |
| Tekin, IO | 1 |
| Akpolat, N | 1 |
| Koc, O | 1 |
| Desai, R | 1 |
| Jampol, LM | 1 |
| Selvan, H | 1 |
| Azmira, K | 1 |
| Gupta, A | 3 |
| Upadhyay, A | 1 |
| Garg, P | 1 |
| Komae, K | 1 |
| Takamoto, M | 1 |
| Tanaka, R | 1 |
| Ohtomo, K | 1 |
| Okinaga, K | 1 |
| Matsuda, J | 1 |
| Nakahara, H | 1 |
| Fujino, Y | 1 |
| Kaburaki, T | 2 |
| Siggel, R | 1 |
| Dietlein, T | 1 |
| Culmann, PD | 1 |
| Grus, FH | 1 |
| Poplawksi, A | 1 |
| Gulamhusein, H | 1 |
| Conrad-Hengerer, I | 1 |
| Somers, A | 1 |
| Reitsamer, H | 1 |
| Hengerer, FH | 1 |
| Bayoumi, NH | 2 |
| Parrish, RK | 4 |
| Mafi, M | 1 |
| Zarei, R | 3 |
| Eslami, Y | 3 |
| Ghadimi, H | 1 |
| Mohebbi, M | 1 |
| Gollakota, S | 1 |
| Mohamed, A | 1 |
| Harju, M | 3 |
| Suominen, S | 3 |
| Allinen, P | 1 |
| Vesti, E | 4 |
| Naito, T | 1 |
| Fujiwara, M | 1 |
| Miki, T | 1 |
| Araki, R | 1 |
| Fujiwara, A | 1 |
| Shiode, Y | 1 |
| Morizane, Y | 1 |
| Nagayama, M | 1 |
| Shiraga, F | 2 |
| Sobeih, DH | 1 |
| Cotran, PR | 2 |
| Abe, RY | 1 |
| Shigueoka, LS | 1 |
| Vasconcellos, JPC | 1 |
| Costa, VP | 6 |
| Nikita, E | 1 |
| Murdoch, I | 1 |
| Wasielica-Poslednik, J | 1 |
| Schmeisser, J | 1 |
| Weyer-Elberich, V | 1 |
| Bell, K | 1 |
| Lorenz, K | 1 |
| Romera-Romero, P | 1 |
| Loscos-Arenas, J | 1 |
| Moll-Udina, A | 1 |
| Romanic-Bubalo, N | 1 |
| Castellvi-Manent, J | 1 |
| Valldeperas, X | 2 |
| Morales, J | 5 |
| Castejón, MA | 1 |
| Bolivar, G | 1 |
| Paz-Moreno-Arrones, J | 1 |
| Castaño, B | 1 |
| Yadava, U | 1 |
| Jaisingh, K | 1 |
| Dangda, S | 2 |
| Thacker, P | 1 |
| Goel, Y | 1 |
| Quist, MS | 1 |
| Brown, N | 1 |
| Bicket, AK | 1 |
| Herndon, LW | 6 |
| Alizadeh, R | 2 |
| Akil, H | 1 |
| Tan, J | 1 |
| Law, SK | 11 |
| Caprioli, J | 14 |
| Romero, P | 3 |
| Hirunpatravong, P | 2 |
| Kim, EA | 2 |
| Nouri-Mahdavi, K | 8 |
| Morales, E | 4 |
| Schiffman, JC | 10 |
| Shi, W | 5 |
| Jo, SH | 1 |
| Seo, JH | 1 |
| Garris, WJ | 1 |
| Le, C | 2 |
| Zurakowski, D | 5 |
| Ayyala, RS | 7 |
| Salinas, L | 1 |
| Yung, ES | 1 |
| Sanvicente, C | 1 |
| Pluta, J | 1 |
| Rahmatnejad, K | 1 |
| Patel, AS | 1 |
| Williams, A | 1 |
| Abramowitz, B | 1 |
| Katz, LJ | 4 |
| Pro, M | 1 |
| Pimentel, E | 1 |
| Schmidt, J | 1 |
| Klezlova, A | 1 |
| Liebezeit, S | 1 |
| Gericke, A | 1 |
| Lamparter, J | 1 |
| Ul Hassan, SN | 1 |
| Toshev, AP | 1 |
| Brandt, J | 1 |
| Kerr, NM | 1 |
| Wang, J | 3 |
| Sandhu, A | 1 |
| Hsu, CR | 1 |
| Chen, YH | 1 |
| Tai, MC | 1 |
| Lu, DW | 3 |
| Alshamrani, AA | 1 |
| Al-Shahwan, S | 2 |
| Hoang, TKH | 1 |
| Kim, YK | 1 |
| Jeoung, JW | 1 |
| Park, KH | 3 |
| Thakur, SKD | 1 |
| Seddig, S | 1 |
| Shaheer, M | 1 |
| Amjad, A | 1 |
| Ahmed, N | 1 |
| Sarker, BK | 1 |
| Abdullahi, SM | 1 |
| Hassan, Z | 1 |
| Kabir, J | 1 |
| Badmus, S | 1 |
| Alam, S | 1 |
| Rahman, M | 1 |
| Malek, MI | 1 |
| Mahatma, M | 1 |
| Koike, KJ | 1 |
| Chang, PT | 1 |
| Gizzi, C | 1 |
| Elkarmouty, A | 1 |
| Scott, A | 1 |
| Nguyen, AH | 1 |
| Fatehi, N | 1 |
| Kim, E | 1 |
| Giaconi, J | 1 |
| Coleman, AL | 4 |
| Rangel, HMDA | 1 |
| Rolim, HT | 1 |
| Vidigal, P | 1 |
| Araújo, ID | 1 |
| Cronemberger, S | 2 |
| Mittal, D | 1 |
| Bhoot, M | 1 |
| Ibáñez-Muñoz, A | 1 |
| Soto-Biforcos, VS | 1 |
| Chacón-González, M | 1 |
| Rúa-Galisteo, O | 1 |
| Arrieta-Los Santos, A | 1 |
| Lizuain-Abadía, ME | 1 |
| Del Río Mayor, JL | 1 |
| Lin, S | 2 |
| Byles, D | 2 |
| Smith, M | 4 |
| Rezkallah, A | 1 |
| Mathis, T | 1 |
| Denis, P | 1 |
| Kodjikian, L | 1 |
| Bhattacharyya, M | 1 |
| Mutreja, A | 1 |
| Abdalrahman, O | 1 |
| Rodriguez, AE | 1 |
| Alio Del Barrio, JL | 1 |
| Alio, JL | 1 |
| Penaud, B | 1 |
| Leleu, I | 1 |
| Laplace, O | 1 |
| Akesbi, J | 1 |
| Blumen-Ohana, E | 1 |
| Nordmann, JP | 1 |
| Nishino, T | 1 |
| Sakaguchi, K | 1 |
| Yamada, Y | 1 |
| Perumal, D | 1 |
| Darcy, K | 1 |
| Anand, N | 14 |
| Moeller, KL | 1 |
| Esfandiari, H | 4 |
| Hassanpour, K | 2 |
| Fatourechi, A | 2 |
| Yazdani, S | 5 |
| Wang, C | 2 |
| Yaseri, M | 4 |
| Pakravan, M | 5 |
| Elving-Kokke, KH | 1 |
| Sas-Meertens, MAV | 1 |
| de Beer, FM | 1 |
| van Rijn, LJ | 1 |
| de Boer, JH | 1 |
| Visser, ES | 1 |
| Charles, R | 1 |
| Abdel-Hay, A | 1 |
| Shah, B | 1 |
| Lim, LA | 1 |
| Rossiter, J | 1 |
| Kuo, CH | 1 |
| Chapman, P | 1 |
| Robertson, S | 1 |
| Rajendrababu, S | 1 |
| Shroff, S | 1 |
| Patil, SV | 1 |
| Vardhan, A | 1 |
| Paletta Guedes, RA | 1 |
| Gravina, DM | 1 |
| Paletta Guedes, VM | 1 |
| Chaoubah, A | 1 |
| Mostafaei, A | 1 |
| Taheri, N | 1 |
| Ghojazadeh, M | 1 |
| Latifi, A | 1 |
| Moghaddam, N | 1 |
| Artini, W | 1 |
| Bani, AP | 1 |
| Zuo, C | 1 |
| Wu, K | 2 |
| Gong, R | 1 |
| Lin, M | 1 |
| Ge, J | 2 |
| Waibel, S | 1 |
| Spoerl, E | 1 |
| Furashova, O | 1 |
| Rothaus, K | 1 |
| Kozobolis, V | 1 |
| Kalogianni, E | 1 |
| Sideroudi, H | 1 |
| Swann, FB | 1 |
| Singh, S | 1 |
| Blake, D | 1 |
| John, V | 1 |
| Fullerton, M | 1 |
| Margo, C | 1 |
| Zhang, Z | 2 |
| Muddasani, N | 1 |
| Wall, J | 1 |
| Satija, C | 1 |
| Greenberg, E | 1 |
| Mancera, N | 1 |
| Díez-Álvarez, L | 1 |
| Garcia, CF | 1 |
| Paul, S | 1 |
| Leichsenring, V | 1 |
| Hoffmann, E | 1 |
| Preussner, R | 1 |
| Wlaź, A | 1 |
| Wilkos-Kuc, A | 1 |
| Rozegnał-Madej, A | 1 |
| Żarnowski, T | 4 |
| El Mazar, HM | 1 |
| Mandour, SS | 2 |
| Mostafa, MI | 1 |
| Elmorsy, OA | 1 |
| Klifto, MR | 1 |
| Fleischman, D | 1 |
| Babiker, S | 1 |
| Elsayed, ME | 1 |
| Dhaygude, A | 1 |
| Madgula, I | 1 |
| Del Noce, C | 1 |
| Vagge, A | 1 |
| Wadke, V | 1 |
| Lingam, V | 2 |
| George, AE | 1 |
| Ganesh, SK | 1 |
| Biswas, J | 1 |
| Balekudaru, S | 2 |
| E Graf, N | 1 |
| Müller, M | 2 |
| Gerlach, F | 1 |
| M Meyer, L | 1 |
| Philipp, S | 1 |
| Distelmaier, P | 1 |
| Klink, T | 4 |
| Schönfeld, CL | 1 |
| Bayraktar, S | 1 |
| Oray, M | 1 |
| Altan, C | 1 |
| Basarir, B | 1 |
| Izgi, B | 1 |
| Tugal-Tutkun, I | 1 |
| Gupta, V | 6 |
| Shaikh, NF | 1 |
| Chan, G | 1 |
| Coste-Verdier, V | 1 |
| Chan, H | 1 |
| Schweitzer, C | 1 |
| Delyfer, MN | 1 |
| Korobelnik, JF | 1 |
| Yuasa, Y | 1 |
| Sugimoto, Y | 2 |
| Rong, SS | 2 |
| Meng, HL | 1 |
| Fan, SJ | 1 |
| Wang, NL | 1 |
| Liang, YB | 2 |
| Huang, Y | 1 |
| Wang, R | 2 |
| He, Y | 1 |
| Chang, X | 1 |
| Cui, HY | 1 |
| Zhang, ZH | 1 |
| Li, SZ | 1 |
| Liu, LR | 1 |
| Thomas, R | 2 |
| Bong, C | 1 |
| Okimoto, S | 1 |
| Akita, T | 1 |
| Tanaka, J | 1 |
| You, YA | 2 |
| Hu, S | 1 |
| Besley, J | 1 |
| Whitehead, K | 1 |
| Babu, JG | 1 |
| El Sayed, Y | 1 |
| Awadein, A | 2 |
| Singh, D | 1 |
| Chandra, A | 2 |
| Ogata-Iwao, M | 6 |
| Takihara, Y | 9 |
| Inoue, T | 9 |
| Iwao, K | 7 |
| Tanihara, H | 16 |
| Brüggemann, A | 1 |
| Despouy, JT | 1 |
| Wegent, A | 1 |
| Elmekawey, H | 1 |
| Khafagy, A | 1 |
| Akkan, JU | 1 |
| Cilsim, S | 1 |
| Khan, N | 1 |
| Khaleque, MA | 1 |
| Hossain, MS | 1 |
| Islam, MS | 1 |
| Uddin, MS | 1 |
| Rosentreter, A | 3 |
| Butler, MR | 1 |
| Prospero Ponce, CM | 1 |
| Weinstock, YE | 1 |
| Orengo-Nania, S | 2 |
| Chevez-Barrios, P | 1 |
| Frankfort, BJ | 1 |
| Awai-Kasaoka, N | 3 |
| Samarai, V | 1 |
| Mohammadi, M | 1 |
| Eslami, S | 1 |
| Rao, A | 2 |
| Chatterjee, S | 1 |
| Ono, T | 1 |
| Yuki, K | 1 |
| Shiba, D | 1 |
| Kouyama, K | 1 |
| Tsubota, K | 2 |
| Rulli, E | 1 |
| Biagioli, E | 1 |
| Riva, I | 1 |
| Gambirasio, G | 1 |
| De Simone, I | 1 |
| Floriani, I | 1 |
| Quaranta, L | 2 |
| Netland, PA | 3 |
| Sarkisian, SR | 3 |
| Condon, G | 1 |
| Salim, S | 2 |
| Sherwood, MB | 4 |
| Siegfried, CJ | 1 |
| Dean, WH | 1 |
| Turner, SA | 1 |
| McNaught, AI | 1 |
| Kawai, M | 1 |
| Schoenberg, ED | 1 |
| Chaudhry, AL | 2 |
| Chod, R | 1 |
| Olawoye, O | 1 |
| Lee, M | 1 |
| Kuwayama, Y | 5 |
| Kee, C | 4 |
| Johnson, MS | 1 |
| De Fendi, LI | 1 |
| Arruda, GV | 1 |
| Scott, IU | 4 |
| Paula, JS | 1 |
| Susanna, R | 7 |
| De Moraes, CG | 4 |
| Alencar, LM | 1 |
| Ritch, R | 10 |
| Vandekerckhove, G | 1 |
| Kestelyn, P | 2 |
| Kurvinen, L | 1 |
| Holló, G | 2 |
| Gaki, S | 1 |
| Dulku, S | 2 |
| Kivelä, T | 2 |
| Kujala, E | 1 |
| Forsman, E | 1 |
| Kwong, A | 1 |
| Kule, RR | 1 |
| Giaconi, JA | 3 |
| Saheb, H | 1 |
| Tang, W | 1 |
| Wang, Q | 1 |
| Zhang, Q | 1 |
| Sun, S | 1 |
| Zhang, Y | 2 |
| Wu, Z | 2 |
| Yip, KP | 1 |
| Ngai, LY | 1 |
| Kumarasamy, M | 1 |
| Darian-Smith, E | 1 |
| Toh, T | 1 |
| Tulidowicz-Bielak, M | 2 |
| Tomaszewska, J | 1 |
| Kosior-Jarecka, E | 3 |
| Napoli, PE | 1 |
| Zucca, I | 1 |
| Fossarello, M | 1 |
| Ma, J | 1 |
| Li, X | 1 |
| Zhang, W | 1 |
| Huang, L | 1 |
| Chen, M | 1 |
| Xi, L | 1 |
| Duan, L | 1 |
| Quan, D | 1 |
| Kawaji, T | 2 |
| Hara, R | 1 |
| Eiki, D | 1 |
| Ando, Y | 1 |
| Khairy, HA | 2 |
| Elsawy, MF | 2 |
| Menda, SA | 1 |
| Lowry, EA | 1 |
| Porco, TC | 2 |
| Stamper, RL | 3 |
| Rubin, MR | 1 |
| Han, Y | 2 |
| Pro, MJ | 1 |
| Freidl, KB | 1 |
| Neylan, CJ | 1 |
| Sawchyn, AK | 1 |
| Wizov, SS | 1 |
| Zhou, M | 1 |
| Wang, W | 1 |
| Huang, W | 1 |
| Zhang, X | 1 |
| Sethi, P | 1 |
| Patel, RN | 1 |
| Goldhardt, R | 1 |
| Schultz, SK | 1 |
| Iverson, SM | 1 |
| Greenfield, DS | 8 |
| Koukkoulli, A | 1 |
| Musa, F | 1 |
| Naruo-Tsuchisaka, A | 1 |
| Maruyama, K | 1 |
| Arimoto, G | 1 |
| Goto, H | 1 |
| Mandalos, A | 1 |
| Tailor, R | 1 |
| Parmar, T | 1 |
| Sung, V | 1 |
| Vaiano, AS | 1 |
| Salgarello, T | 2 |
| Giudiceandrea, A | 1 |
| Riso, M | 1 |
| Sammarco, MG | 1 |
| Caramello, G | 1 |
| Karolina, C | 1 |
| Baril, C | 1 |
| Bourret-Massicotte, D | 1 |
| Anctil, JL | 1 |
| Caron, L | 1 |
| Goyette, A | 1 |
| Des Marchais, B | 1 |
| Rafuse, PE | 1 |
| Temkar, S | 1 |
| Pujari, A | 1 |
| Nakashima, K | 1 |
| Fukushima, A | 1 |
| Hirakawa, S | 1 |
| Bouhenni, RA | 1 |
| Al Jadaan, I | 1 |
| Rassavong, H | 1 |
| Al Shahwan, S | 1 |
| Al Katan, H | 1 |
| Dunmire, J | 1 |
| Krasniqi, M | 1 |
| Edward, DP | 1 |
| Khandelwal, RR | 1 |
| Raje, D | 1 |
| Rathi, A | 1 |
| Agashe, A | 1 |
| Majumdar, M | 1 |
| Khandelwal, R | 1 |
| Yun, ST | 1 |
| Chua, B | 1 |
| Clement, CI | 1 |
| Foulsham, WS | 1 |
| Fu, L | 1 |
| Tatham, AJ | 1 |
| Kobayashi, S | 1 |
| Inoue, M | 1 |
| Yamane, S | 1 |
| Sakamaki, K | 1 |
| Arakawa, A | 1 |
| Kadonosono, K | 1 |
| Loscos, J | 1 |
| Langohr, K | 1 |
| Langhor, K | 1 |
| Parera, À | 1 |
| Romera, P | 1 |
| Sabala, A | 1 |
| de la Cámara, J | 1 |
| Aoyama, Y | 1 |
| Arnalich-Montiel, F | 1 |
| Casado, A | 1 |
| Rohrbach, JM | 1 |
| Kam, KW | 1 |
| Belin, MW | 1 |
| Young, AL | 1 |
| Li, B | 1 |
| Zhang, M | 1 |
| Liu, W | 1 |
| Lee, N | 1 |
| Ma, KT | 1 |
| Hong, S | 1 |
| Seong, GJ | 1 |
| Hong, YJ | 1 |
| Pandey, RM | 1 |
| Chandran, P | 1 |
| Chihara, E | 5 |
| Hayashi, K | 3 |
| Mahboobipour, H | 1 |
| Doozandeh, A | 1 |
| Ghahari, E | 1 |
| Van Bergen, T | 2 |
| Vandewalle, E | 2 |
| Moons, L | 2 |
| Kaplan, A | 1 |
| Kocatürk, T | 1 |
| Dayanır, V | 1 |
| Kinast, RM | 1 |
| Akula, KK | 1 |
| DeBarber, AE | 1 |
| Barker, GT | 1 |
| Gardiner, SK | 1 |
| Whitson, E | 1 |
| Mansberger, SL | 1 |
| Takahashi, N | 1 |
| Sawada, A | 6 |
| Mochizuki, K | 2 |
| Katada, T | 1 |
| Yamamoto, T | 15 |
| Cherof, AM | 1 |
| SooHoo, JR | 2 |
| Kahook, MY | 3 |
| Seibold, LK | 2 |
| Jayaram, H | 1 |
| Scawn, R | 1 |
| Pooley, F | 1 |
| Chiang, M | 1 |
| Bunce, C | 4 |
| Khaw, PT | 7 |
| Papadopoulos, M | 1 |
| Allan, EJ | 1 |
| Jones, JM | 1 |
| Ding, K | 1 |
| Khaimi, MA | 1 |
| Shevade, B | 1 |
| Riss, I | 2 |
| Batlle, J | 1 |
| Kato, YP | 2 |
| Weber, BA | 2 |
| Parel, JM | 2 |
| Bettin, P | 1 |
| Di Matteo, F | 1 |
| Rabiolo, A | 1 |
| Fiori, M | 1 |
| Ciampi, C | 1 |
| Bandello, F | 1 |
| Michael, KB | 1 |
| Montgomery, DM | 2 |
| Li Yim, JF | 1 |
| Kwong, TQ | 1 |
| Mahroo, O | 1 |
| Scoppettuolo, E | 1 |
| Ansari, E | 1 |
| Leinonen, S | 1 |
| Kotaniemi, K | 1 |
| Majander, A | 1 |
| Mochizuki, H | 2 |
| Mahdy, RA | 2 |
| Al-Mosallamy, SM | 1 |
| Al-Aswad, MA | 1 |
| Bor'i, A | 1 |
| El-Haig, WM | 1 |
| Li, H | 1 |
| Liu, T | 1 |
| Xie, L | 1 |
| Cabourne, E | 1 |
| Clarke, JC | 1 |
| Schlottmann, PG | 1 |
| Evans, JR | 1 |
| David, RL | 1 |
| George, RJ | 1 |
| Al-Haddad, C | 1 |
| Abdulaal, M | 1 |
| Al-Moujahed, A | 1 |
| Ervin, AM | 1 |
| Lim, SH | 1 |
| Cha, SC | 2 |
| Banitt, MR | 1 |
| Fantes, F | 1 |
| Alburquerque, R | 1 |
| Arrieta, E | 1 |
| Peralta, AC | 1 |
| Cheng, JW | 4 |
| Cheng, SW | 2 |
| Wei, RL | 3 |
| Lu, GC | 1 |
| Dunn, HP | 1 |
| Zheng, L | 1 |
| White, AJ | 1 |
| Healey, PR | 2 |
| Singh, P | 1 |
| Kunhammad, S | 1 |
| Cillino, S | 4 |
| Casuccio, A | 4 |
| Di Pace, F | 4 |
| Cagini, C | 1 |
| Ferraro, LL | 1 |
| Cillino, G | 3 |
| Huang, G | 1 |
| Sidoti, PA | 4 |
| Pérez-Torregrosa, VT | 1 |
| Olate-Pérez, Á | 1 |
| Cerdà-Ibáñez, M | 1 |
| Gargallo-Benedicto, A | 1 |
| Osorio-Alayo, V | 1 |
| Barreiro-Rego, A | 1 |
| Duch-Samper, A | 1 |
| Wang, BZ | 1 |
| Meagher, P | 1 |
| Khalil, DH | 1 |
| Abdelhakim, MA | 2 |
| Liu, X | 2 |
| Du, L | 1 |
| Li, N | 1 |
| Kashiwagi, K | 1 |
| Kogure, S | 1 |
| Mabuchi, F | 1 |
| Chiba, T | 1 |
| Araie, M | 10 |
| Hashemi, H | 1 |
| Asgari, S | 1 |
| Mortazavi, M | 1 |
| Ghaffari, R | 1 |
| El-Saied, HM | 1 |
| Kaushik, J | 1 |
| Parihar, JK | 1 |
| Jain, VK | 1 |
| Nath, P | 1 |
| Durgapal, P | 1 |
| Ram, J | 2 |
| Issa de Fendi, L | 1 |
| Cena de Oliveira, T | 1 |
| Bigheti Pereira, C | 1 |
| Pereira Bigheti, C | 1 |
| Viani, GA | 1 |
| Cui, QN | 1 |
| Hsia, YC | 1 |
| Lin, SC | 2 |
| Rose-Nussbaumer, J | 1 |
| Mehta, N | 1 |
| Naseri, A | 1 |
| Reza, A | 1 |
| Song, BJ | 1 |
| Ramanathan, M | 1 |
| Tanaka, D | 1 |
| Nakanishi, H | 2 |
| Hangai, M | 3 |
| Morooka, S | 1 |
| Yoshimura, N | 3 |
| Yang, K | 1 |
| Jin, L | 1 |
| Li, L | 1 |
| Zeng, S | 1 |
| Wei, R | 1 |
| Li, G | 3 |
| Man, P | 1 |
| Congdon, N | 2 |
| Jonckx, B | 1 |
| Feyen, JH | 1 |
| Schultheiss, M | 1 |
| Schnichels, S | 1 |
| Konrad, EM | 1 |
| Bartz-Schmidt, KU | 1 |
| Zahn, G | 1 |
| Caldirola, P | 1 |
| Fsadni, MG | 1 |
| Caram-Lelham, N | 1 |
| Spitzer, MS | 1 |
| Ding, C | 1 |
| Said-Ahmed, K | 1 |
| Schlenker, M | 1 |
| Tanna, AP | 1 |
| Rademaker, AW | 1 |
| Godfrey, DG | 1 |
| Douzandeh, A | 1 |
| Amouhashemi, N | 1 |
| Pakravan, P | 1 |
| Rodriguez-Una, I | 1 |
| Rotchford, AP | 1 |
| Nash, DL | 1 |
| Crouch, ER | 3 |
| Nakakura, S | 1 |
| Noguchi, A | 1 |
| Tabuchi, H | 1 |
| Koh, V | 1 |
| Chen, D | 1 |
| Aquino, CM | 1 |
| Aduan, J | 1 |
| Sng, C | 1 |
| Chee, LS | 1 |
| Chew, P | 1 |
| El-Sayyad, F | 1 |
| El-Saied, HMA | 1 |
| Abdelhakim, MASE | 1 |
| Minckler, DS | 3 |
| Francis, BA | 3 |
| Hodapp, EA | 1 |
| Jampel, HD | 5 |
| Samples, JR | 2 |
| Smith, SD | 3 |
| Alvarado, JA | 1 |
| Hollander, DA | 1 |
| Juster, RP | 1 |
| Lee, LC | 1 |
| Al Obeidan, SA | 1 |
| Osman, EA | 1 |
| Al-Muammar, AM | 1 |
| Abu El-Asrar, AM | 1 |
| Kymionis, GD | 1 |
| Diakonis, VF | 1 |
| Charisis, S | 1 |
| Pallikaris, AI | 1 |
| Bouzoukis, DI | 1 |
| Yoo, SH | 1 |
| Naoumidi, I | 1 |
| Tsilimbaris, MK | 1 |
| Onol, M | 4 |
| Aktaş, Z | 1 |
| Hasanreisoğlu, B | 4 |
| Giampani, J | 1 |
| Borges-Giampani, AS | 1 |
| Carani, JC | 1 |
| Oltrogge, EW | 1 |
| Reibaldi, A | 2 |
| Uva, MG | 2 |
| Longo, A | 1 |
| Tham, CC | 3 |
| Kwong, YY | 4 |
| Leung, DY | 4 |
| Lam, SW | 2 |
| Li, FC | 3 |
| Chiu, TY | 2 |
| Chan, JC | 2 |
| Chan, CH | 1 |
| Poon, AS | 1 |
| Yick, DW | 3 |
| Chi, CC | 1 |
| Lam, DS | 6 |
| Lai, JS | 3 |
| Georgoulas, S | 1 |
| Dahlmann-Noor, A | 1 |
| Brocchini, S | 1 |
| Palanca-Capistrano, AM | 2 |
| Hall, J | 1 |
| Cantor, LB | 3 |
| Morgan, L | 1 |
| Hoop, J | 3 |
| WuDunn, D | 4 |
| Caça, I | 1 |
| Ari, S | 1 |
| Sakalar, YB | 1 |
| Unlü, K | 1 |
| Dogan, E | 1 |
| Mavrikakis, E | 1 |
| Buys, YM | 1 |
| Díaz, L | 1 |
| Villegas, VM | 1 |
| Emanuelli, A | 1 |
| Izquierdo, NJ | 1 |
| Rauscher, FM | 1 |
| Lee, RK | 1 |
| Saricaoglu, MS | 1 |
| Kalayci, D | 1 |
| Guven, D | 1 |
| Karakurt, A | 1 |
| Hasiripi, H | 1 |
| Shahabi, C | 1 |
| Chin, S | 1 |
| Yoshida, K | 1 |
| Shinmei, Y | 1 |
| Aoyagi, M | 1 |
| Saito, A | 1 |
| Ohno, S | 1 |
| Lloyd, M | 1 |
| Giegengack, M | 1 |
| Morrison, JC | 1 |
| Lee, E | 1 |
| Doyle, E | 1 |
| Jenkins, C | 1 |
| Storr-Paulsen, T | 1 |
| Norregaard, JC | 2 |
| Ahmed, S | 1 |
| Storr-Paulsen, A | 2 |
| Xi, GL | 1 |
| Cai, JP | 2 |
| Li, Y | 6 |
| Fukushima, M | 2 |
| Iwao, M | 3 |
| Palmiero, PM | 2 |
| Tello, C | 3 |
| Liebmann, J | 2 |
| Khan, A | 1 |
| Okazaki, K | 1 |
| Takahashi, H | 1 |
| Shoji, T | 1 |
| Adachi, H | 1 |
| Okuda, T | 2 |
| Fukuhira, Y | 2 |
| Sumi, Y | 1 |
| Shimomura, M | 2 |
| Budenz, DL | 10 |
| Radcliffe, N | 1 |
| Blumenthal, EZ | 1 |
| Yang, JG | 1 |
| Sun, NX | 1 |
| Cui, LJ | 1 |
| Wang, XH | 1 |
| Feng, ZH | 1 |
| Ravinet, E | 2 |
| Macdonald, E | 1 |
| Mukherjee, S | 1 |
| Jay, J | 1 |
| Takagishi, M | 1 |
| Baba, T | 1 |
| Koshino, T | 1 |
| Kawashima, H | 1 |
| Numaga, J | 1 |
| Tomidokoro, A | 4 |
| Ciancaglini, M | 3 |
| Carpineto, P | 3 |
| Agnifili, L | 1 |
| Nubile, M | 1 |
| Fasanella, V | 1 |
| Mattei, PA | 1 |
| Mastropasqua, L | 3 |
| Al-Mobarak, F | 1 |
| Khan, AO | 2 |
| Prasad, A | 1 |
| Sabour, S | 1 |
| Sbeity, Z | 1 |
| Saito, Y | 3 |
| Takeda, H | 1 |
| Ihanamäki, T | 1 |
| Okada, K | 2 |
| Ishida, O | 1 |
| Fukmoto, M | 1 |
| Miyazaki, M | 1 |
| Goodkin, ML | 1 |
| Grewal, DS | 1 |
| Ollikainen, ML | 1 |
| Puustjärvi, TJ | 1 |
| Rekonen, PK | 1 |
| Uusitalo, HM | 1 |
| Teräsvirta, ME | 1 |
| Nazm, N | 1 |
| Pegu, J | 1 |
| Iyer, JV | 1 |
| Aung, T | 4 |
| Srinivasan, G | 1 |
| Hamid, M | 1 |
| Moubayed, SP | 1 |
| Duval, R | 1 |
| Fortin, E | 1 |
| Lesk, M | 1 |
| Pérez-López, M | 1 |
| Nozal, CC | 1 |
| López, MM | 1 |
| García-Pérez, JL | 1 |
| Negrete, FM | 1 |
| Maheshwari, R | 1 |
| Prasad, KK | 1 |
| Schwartz, AL | 2 |
| Albano, M | 1 |
| Folgar, FA | 1 |
| Teng, CC | 1 |
| Kumar, A | 1 |
| Alkawas, AA | 1 |
| Shahien, EA | 1 |
| Hussein, AM | 1 |
| Nakano, N | 1 |
| Inoue, R | 1 |
| Unoki, N | 1 |
| Hirose, F | 1 |
| Ojima, T | 1 |
| Breusegem, C | 1 |
| Spielberg, L | 1 |
| Van Ginderdeuren, R | 1 |
| Renier, C | 1 |
| Van de Veire, S | 1 |
| Fieuws, S | 1 |
| Zeyen, T | 1 |
| Aoyama, A | 1 |
| Ishida, K | 1 |
| Mavrakanas, N | 1 |
| Mendrinos, E | 1 |
| Shaarawy, T | 3 |
| Nada, WM | 1 |
| Almasalamy, SM | 1 |
| Anany, HA | 1 |
| Almasary, AM | 1 |
| Crowston, JG | 2 |
| Wells, AP | 2 |
| Bissig, A | 1 |
| Feusier, M | 1 |
| Roy, S | 1 |
| Kubay, O | 1 |
| Karim, R | 1 |
| Wechsler, D | 3 |
| Booth, F | 1 |
| Razeghinejad, MR | 2 |
| Nowroozzadeh, MH | 1 |
| Boey, PY | 2 |
| Narayanaswamy, A | 2 |
| Zheng, C | 1 |
| Htoon, HM | 2 |
| Tun, TA | 1 |
| Seah, SK | 2 |
| Kann, G | 1 |
| Ellinger, P | 1 |
| Klink, J | 2 |
| Guthoff, R | 1 |
| Emarah, AM | 1 |
| El-Helw, MA | 1 |
| Coote, MA | 1 |
| Vasudevan, S | 1 |
| Schild, AM | 2 |
| Jordan, JF | 3 |
| Krieglstein, GK | 11 |
| Suh, YW | 1 |
| Yoo, C | 1 |
| Park, JH | 1 |
| Jung, JH | 1 |
| Kim, YY | 4 |
| Sen, E | 1 |
| Balikoglu-Yilmaz, M | 1 |
| Bozdag-Pehlivan, S | 1 |
| Sungu, N | 1 |
| Aksakal, FN | 1 |
| Altinok, A | 1 |
| Tuna, T | 1 |
| Unlu, N | 1 |
| Ustun, H | 1 |
| Koklu, G | 1 |
| Öztürk, F | 1 |
| Maestrini, HA | 1 |
| Matoso, HD | 1 |
| Reis, JR | 1 |
| Mérula, RV | 1 |
| Filho, AD | 1 |
| Diniz, AF | 1 |
| Sakurai, E | 1 |
| Ferreira, GA | 1 |
| Reiter, C | 1 |
| Wimmer, S | 1 |
| Schultheiss, A | 1 |
| Geerling, G | 1 |
| Stead, RE | 1 |
| Geffen, N | 1 |
| Ton, Y | 1 |
| Degani, J | 1 |
| Assia, EI | 1 |
| Bochmann, F | 1 |
| Kaufmann, C | 1 |
| Becht, CN | 1 |
| Guber, I | 1 |
| Kaiser, M | 1 |
| Bachmann, LM | 1 |
| Thiel, MA | 1 |
| Seto, T | 2 |
| Kasaoka, N | 1 |
| Murakami, A | 1 |
| Futa, R | 1 |
| Zhong, H | 1 |
| Sun, G | 1 |
| Lin, X | 1 |
| Yu, M | 1 |
| Tan, YL | 1 |
| Tsou, PF | 1 |
| Tan, GS | 1 |
| Sengupta, S | 1 |
| Venkatesh, R | 1 |
| Ravindran, RD | 1 |
| Supawavej, C | 1 |
| Fukuoka, S | 1 |
| Amano, S | 1 |
| Honda, N | 1 |
| Mimura, T | 1 |
| Usui, T | 1 |
| Hong, B | 1 |
| Winarko, J | 1 |
| Kawji, S | 1 |
| Dustin, L | 1 |
| Chopra, V | 1 |
| Wei, H | 1 |
| Okogbaa, CB | 1 |
| Ghoneim, EM | 1 |
| Abd El Hameed, M | 1 |
| Kish, SK | 1 |
| Nassiri, N | 2 |
| Jea, SY | 1 |
| Vakili, G | 1 |
| Filippopoulos, T | 1 |
| Rhee, DJ | 1 |
| Levkovitch-Verbin, H | 3 |
| Katz, G | 1 |
| Kalev-Landoi, M | 1 |
| Goldenfeld, M | 2 |
| Lin, ZJ | 1 |
| Lu, XH | 1 |
| Kapoor, KG | 1 |
| Syed, MF | 1 |
| Cankaya, AB | 1 |
| Elgin, U | 3 |
| Kawaguchi, A | 1 |
| Mehta, JS | 2 |
| Tan, DT | 1 |
| Laing, AE | 1 |
| Zare, M | 1 |
| Feizi, S | 1 |
| Azimzadeh, A | 1 |
| Kaneko, H | 1 |
| Okinami, S | 2 |
| Hogewind, BF | 1 |
| Pijl, B | 1 |
| Hoyng, CB | 1 |
| Theelen, T | 2 |
| Marey, HM | 1 |
| Ellakwa, AF | 1 |
| Sponsel, WE | 1 |
| Groth, SL | 1 |
| de Klerk, TA | 1 |
| Moriarty, AP | 1 |
| Al-Obeidan, SA | 1 |
| Osman, Eel-D | 1 |
| Dewedar, AS | 1 |
| Mousa, A | 1 |
| Zahid, S | 1 |
| Musch, DC | 2 |
| Niziol, LM | 1 |
| Lichter, PR | 2 |
| Min, JK | 1 |
| Kee, CW | 1 |
| Sohn, SW | 1 |
| Lee, HJ | 1 |
| Woo, JM | 2 |
| Yim, JH | 1 |
| Hoh, ST | 1 |
| Feng, MY | 1 |
| Wang, N | 1 |
| Meng, H | 1 |
| Fan, S | 1 |
| Wang, X | 1 |
| Tang, X | 1 |
| Hosseini, H | 1 |
| Saidi, E | 1 |
| Neelakanta, G | 1 |
| Ceballos, EM | 1 |
| Beck, AD | 3 |
| Lynn, MJ | 2 |
| Kozobolis, VP | 2 |
| Christodoulakis, EV | 2 |
| Tzanakis, N | 1 |
| Zacharopoulos, I | 1 |
| Pallikaris, IG | 2 |
| Taglia, DP | 1 |
| Perkins, TW | 4 |
| Gangnon, R | 3 |
| Heatley, GA | 3 |
| Kaufman, PL | 5 |
| Shin, DH | 12 |
| Iskander, NG | 1 |
| Ahee, JA | 1 |
| Singal, IP | 1 |
| Kim, C | 8 |
| Hughes, BA | 5 |
| Eliassi-Rad, B | 1 |
| Nguyen, QH | 2 |
| Feuer, W | 1 |
| Nicolela, MT | 4 |
| Bueche, M | 1 |
| Palmberg, PF | 7 |
| Alvi, NP | 1 |
| Finley, C | 1 |
| Lakhani, V | 1 |
| Burnstein, A | 1 |
| Knotts, SL | 1 |
| Siganos, CS | 1 |
| Lazarov, NP | 1 |
| Koutentaki, MG | 1 |
| Lubomski, LH | 1 |
| Kempen, JH | 1 |
| Quigley, H | 1 |
| Robinson, KA | 1 |
| Bass, EB | 1 |
| Georgopoulos, M | 2 |
| Vass, C | 3 |
| Vatanparast, Z | 1 |
| Kim, Y | 1 |
| Choi, S | 1 |
| Lee, S | 1 |
| Ahn, B | 1 |
| Majji, AB | 2 |
| Mandal, SP | 1 |
| Das, T | 1 |
| Jalali, S | 1 |
| Jain, SS | 1 |
| Nutheti, R | 1 |
| Jonas, JB | 1 |
| Dugrillon, A | 1 |
| Klüter, H | 1 |
| Kamppeter, B | 1 |
| Zheng, D | 1 |
| Huang, J | 1 |
| Zheng, H | 1 |
| Hu, CY | 1 |
| Matsuo, H | 2 |
| Tomita, G | 1 |
| Suzuki, Y | 2 |
| Tanaka, S | 1 |
| Beckers, HJ | 1 |
| Kinders, KC | 1 |
| Webers, CA | 2 |
| Ng, PW | 2 |
| Yeung, BY | 2 |
| Tsang, CW | 1 |
| Yang, S | 1 |
| Ma, X | 1 |
| Iwach, AG | 1 |
| Delgado, MF | 1 |
| Novack, GD | 2 |
| Nguyen, N | 1 |
| Wong, PC | 1 |
| Kobayashi, H | 2 |
| Kobayashi, K | 2 |
| Hill, R | 1 |
| Ohanesian, R | 1 |
| Voskanyan, L | 1 |
| Malayan, A | 1 |
| Akarsu, C | 2 |
| Akman, A | 1 |
| Bilezikçi, B | 1 |
| Küçükerdönmez, C | 1 |
| Demirhan, B | 1 |
| Aydin, P | 1 |
| Feng, Y | 1 |
| Duan, X | 1 |
| Jiang, Y | 2 |
| Qing, G | 1 |
| Aydin, A | 1 |
| Wollstein, G | 1 |
| Price, LL | 1 |
| Fujimoto, JG | 1 |
| Oguz, H | 2 |
| Sacu, S | 1 |
| Rainer, G | 2 |
| Findl, O | 1 |
| Laube, T | 1 |
| Ritters, B | 1 |
| Selbach, M | 1 |
| Hudde, T | 1 |
| Cordeiro, MF | 1 |
| Fagerli, M | 1 |
| Løfors, KT | 1 |
| Elsås, T | 1 |
| Willoch, CM | 1 |
| Nicolaissen, B | 2 |
| Hirata, A | 1 |
| Kimura, A | 1 |
| Sonoda, S | 1 |
| Freedman, S | 2 |
| Kammer, J | 1 |
| Jin, J | 1 |
| Zalish, M | 2 |
| Oron, Y | 1 |
| Geyer, O | 1 |
| Westfall, AC | 1 |
| Ng, JD | 1 |
| Weissman, JL | 1 |
| Kawashima, M | 1 |
| Yamazaki, Y | 1 |
| Mizuki, K | 1 |
| Hayamizu, F | 1 |
| Nakagami, T | 1 |
| Tanaka, C | 1 |
| Tsai, YY | 1 |
| Tseng, SH | 1 |
| Swamynathan, K | 1 |
| Capistrano, AP | 1 |
| Awwad, ST | 1 |
| Ma'luf, RN | 1 |
| Noureddin, B | 1 |
| Yoon, KC | 1 |
| Seo, MS | 1 |
| Park, YG | 1 |
| Yang, KJ | 4 |
| Rodrigues, AM | 1 |
| Júnior, AP | 1 |
| Montezano, FT | 1 |
| de Arruda Melo, PA | 1 |
| Prata, J | 1 |
| Bashford, KP | 1 |
| Shafranov, G | 1 |
| Shields, MB | 4 |
| Oyakhire, JO | 1 |
| Moroi, SE | 1 |
| Das, J | 1 |
| Sharma, P | 1 |
| Chaudhuri, Z | 1 |
| Azuara-Blanco, A | 6 |
| Lesk, MR | 2 |
| Arcieri, ES | 1 |
| Mandić, Z | 2 |
| Bencić, G | 1 |
| Zorić Geber, M | 1 |
| Bojić, L | 2 |
| Muckley, ED | 1 |
| Lehrer, RA | 1 |
| O'Brart, DP | 2 |
| Shiew, M | 1 |
| Edmunds, B | 1 |
| Schwenn, O | 1 |
| Springer, C | 1 |
| Troost, A | 1 |
| Yun, SH | 1 |
| Alwitry, A | 1 |
| Patel, V | 1 |
| King, AW | 1 |
| Zaleska-Zmijewska, A | 1 |
| Szaflik, J | 1 |
| Gierek-Lapińska, A | 1 |
| Leszczyński, R | 2 |
| Wróbel, A | 1 |
| Ye, W | 1 |
| Sun, J | 1 |
| Zhong, Y | 1 |
| Yalvac, IS | 3 |
| Sungur, G | 1 |
| Turhan, E | 1 |
| Eksioglu, U | 2 |
| Duman, S | 3 |
| Alzafiri, Y | 1 |
| Shetty, RK | 1 |
| Wartluft, L | 1 |
| Ehrlich, R | 1 |
| Snir, M | 1 |
| Lusky, M | 1 |
| Weinberger, D | 1 |
| Friling, R | 1 |
| Gaton, DD | 1 |
| Atherley, C | 1 |
| Kano, K | 2 |
| Mizunoya, H | 1 |
| Al-Hazmi, A | 1 |
| Awad, A | 1 |
| Zwaan, J | 2 |
| Al-Mesfer, SA | 1 |
| Al-Jadaan, I | 1 |
| Al-Mohammed, A | 1 |
| Sony, P | 1 |
| Maquet, JA | 1 |
| Dios, E | 1 |
| Aragón, J | 1 |
| Bailez, C | 1 |
| Ussa, F | 1 |
| Laguna, N | 1 |
| Sari, A | 1 |
| Ozdek, S | 1 |
| Ozogul, C | 1 |
| Agarwal, HC | 3 |
| Saigal, D | 1 |
| Funnell, CL | 1 |
| Clowes, M | 2 |
| Vysniauskiene, I | 1 |
| Flammer, J | 3 |
| Haefliger, IO | 1 |
| Landa, G | 1 |
| Pollack, A | 1 |
| Rachmiel, R | 1 |
| Bukelman, A | 1 |
| Marcovich, A | 1 |
| Mansury, AM | 1 |
| Vasudev, D | 1 |
| Detry-Morel, M | 1 |
| Pourjavan, S | 1 |
| Savini, G | 1 |
| Zanini, M | 1 |
| Barboni, P | 1 |
| Novak-Laus, K | 1 |
| Iveković, R | 1 |
| Korsić, J | 1 |
| Tedeschi-Reiner, E | 1 |
| Masnec-Paskvalin, S | 1 |
| Topouzis, F | 1 |
| Tranos, P | 1 |
| Koskosas, A | 1 |
| Pappas, T | 1 |
| Anastasopoulos, E | 1 |
| Dimitrakos, S | 1 |
| Wilson, MR | 2 |
| Moster, ML | 1 |
| Modjtahedi, SP | 1 |
| Mansury, A | 1 |
| Lattanzio, FA | 1 |
| Mitrev, PV | 1 |
| Williams, PB | 1 |
| Allen, RC | 1 |
| Polikoff, LA | 1 |
| Taglienti, A | 1 |
| Chanis, RA | 1 |
| Ramos-Esteban, JC | 1 |
| Donas, N | 1 |
| Tsong, J | 1 |
| Gagliuso, DJ | 1 |
| Danias, J | 2 |
| Serle, JB | 1 |
| Tello, CA | 1 |
| Ralli, M | 2 |
| Arora, S | 2 |
| Lin, YC | 1 |
| Kau, HC | 1 |
| Kao, SC | 1 |
| Hsu, WM | 2 |
| Tsai, CC | 1 |
| Yuen, HK | 1 |
| Murthy, SK | 1 |
| Damji, KF | 1 |
| Pan, Y | 1 |
| Hodge, WG | 1 |
| Euswas, A | 1 |
| Warrasak, S | 1 |
| Mielke, C | 1 |
| Dawda, VK | 1 |
| Fontana, H | 2 |
| Mietz, H | 8 |
| Kessing, SV | 2 |
| Flesner, P | 1 |
| Jensen, PK | 1 |
| Cabarga, C | 1 |
| Miyake, T | 1 |
| Miyake, K | 2 |
| Kitazawa, Y | 10 |
| Nakae, K | 2 |
| Ito, S | 2 |
| Ito, N | 1 |
| Lumba, J | 1 |
| Hesse, RJ | 1 |
| Ophir, A | 2 |
| Karatas, M | 1 |
| Shingleton, BJ | 2 |
| Price, RS | 1 |
| O'Donoghue, MW | 2 |
| Anis, S | 1 |
| Shihadeh, W | 1 |
| Shigeeda, T | 1 |
| Chen, YN | 1 |
| Wedrich, A | 1 |
| Kasner, O | 1 |
| Alsheikheh, A | 1 |
| Steffen, H | 1 |
| Heegaard, S | 1 |
| Nissen, OI | 1 |
| Berker, N | 2 |
| Batman, A | 2 |
| Simsek, T | 1 |
| Cankaya, B | 1 |
| Schallenberg, M | 1 |
| Steuhl, KP | 1 |
| Selbach, JM | 1 |
| Park, UC | 1 |
| Ahn, JK | 1 |
| Yu, HG | 1 |
| Ben Simon, GJ | 1 |
| Glovinsky, Y | 1 |
| Maurino, V | 1 |
| Patel, H | 1 |
| Kirwin, J | 1 |
| Murdoch, IE | 1 |
| Drolsum, L | 1 |
| Willoch, C | 1 |
| Wang, LN | 1 |
| Fang, F | 1 |
| Chen, LX | 1 |
| Zhao, TH | 1 |
| Xiao, L | 1 |
| Tang, H | 1 |
| Sugimoto, R | 1 |
| Pirouzian, A | 1 |
| O'Halloran, H | 1 |
| Scher, C | 1 |
| Jockin, Y | 1 |
| Wesseling, P | 1 |
| Keunen, JE | 1 |
| Klevering, BJ | 1 |
| Wang, L | 1 |
| Zhang, P | 1 |
| Lin, J | 1 |
| Jamil, AL | 1 |
| Mills, RP | 2 |
| Palop, JA | 1 |
| García-Gómez, P | 1 |
| Heras, H | 1 |
| Cristóbal, JA | 1 |
| Soykan, E | 1 |
| Chakraborty, D | 1 |
| Dutta Choudhury, B | 1 |
| Satana, B | 1 |
| Ozkan, G | 1 |
| Goldberg, I | 1 |
| Noble, J | 1 |
| Derzko-Dzulynsky, L | 1 |
| Rabinovitch, T | 1 |
| Birt, C | 1 |
| Ramamurthi, S | 1 |
| Girma, T | 1 |
| Courtright, P | 1 |
| Mengistu, F | 1 |
| Tamirat, T | 1 |
| Birhanu, Z | 1 |
| Anand, S | 1 |
| Aykan, U | 1 |
| Bilge, AH | 1 |
| Akin, T | 1 |
| Certel, I | 1 |
| Bayer, A | 1 |
| Sisto, D | 1 |
| Vetrugno, M | 1 |
| Trabucco, T | 1 |
| Cantatore, F | 1 |
| Ruggeri, G | 1 |
| Sborgia, C | 1 |
| Jones, LD | 1 |
| Ramanathan, S | 1 |
| Sandramouli, S | 1 |
| Kyprianou, I | 1 |
| Nessim, M | 1 |
| Kumar, V | 1 |
| O'Neill, E | 1 |
| Al-Harthi, E | 1 |
| Al-Turkmani, S | 1 |
| Nguyen, AM | 1 |
| Roh, S | 1 |
| McGwin, G | 1 |
| Takahashi, Y | 2 |
| Ataka, S | 1 |
| Wada, S | 1 |
| Nomura, Y | 1 |
| Kohno, T | 1 |
| Shiraki, K | 1 |
| Herndon, L | 2 |
| Smiddy, W | 1 |
| Arevalo, JF | 1 |
| Mendoza, AJ | 1 |
| Millan, FA | 1 |
| Fuenmayor-Rivera, D | 1 |
| Zeppa, L | 1 |
| Morreale, D | 1 |
| Bocchetta, F | 1 |
| Lodato, G | 2 |
| Mohammadpour, M | 1 |
| Jabbarvand, M | 1 |
| Javadi, MA | 1 |
| Nagai-Kusuhara, A | 1 |
| Nakamura, M | 1 |
| Fujioka, M | 1 |
| Negi, A | 1 |
| Gierek-Ciaciura, S | 1 |
| Forminśka-Kapuścik, M | 1 |
| Mrukwa-Kominek, E | 1 |
| Rokita-Wala, I | 1 |
| Konen, W | 1 |
| Papchenko, T | 1 |
| Tan, YW | 1 |
| Gamble, GD | 1 |
| El-Saheb, H | 1 |
| Kim, TH | 1 |
| Kim, SW | 1 |
| Rho, JH | 1 |
| Lee, DJ | 1 |
| Park, JM | 1 |
| Jeong, WJ | 1 |
| Park, WC | 1 |
| Yoo, YH | 1 |
| Rho, SH | 1 |
| Eha, J | 1 |
| Diestelhorst, M | 2 |
| Schmidt-Erfurth, U | 2 |
| Wetzel, W | 2 |
| Dröge, G | 2 |
| Häring, G | 1 |
| Behrendt, S | 1 |
| Birngruber, R | 2 |
| Glover, TL | 1 |
| Nasisse, MP | 1 |
| Davidson, MG | 1 |
| Annen, DJ | 1 |
| Stürmer, J | 1 |
| Schnyder, CC | 1 |
| Bernasconi, O | 1 |
| Faggioni, R | 1 |
| Suemori-Matsushita, H | 3 |
| Okabe, I | 1 |
| Hayakawa, T | 1 |
| Kondo, Y | 1 |
| Süveges, I | 1 |
| Smith, MF | 5 |
| Magauran, RG | 1 |
| Betchkal, J | 1 |
| Doyle, JW | 5 |
| Gray, TB | 1 |
| Munden, PM | 1 |
| Alward, WL | 4 |
| Kupin, TH | 4 |
| Juzych, MS | 5 |
| Olivier, MM | 3 |
| Joos, KM | 1 |
| Bueche, MJ | 1 |
| Grajewski, AL | 1 |
| Mégevand, GS | 1 |
| Salmon, JF | 6 |
| Scholtz, RP | 1 |
| Murray, AD | 4 |
| Cardakli, UF | 1 |
| Eisele, JR | 1 |
| Takahashi, WY | 1 |
| Duker, JS | 1 |
| Ichien, M | 1 |
| Gaspar, AZ | 2 |
| Orgül, S | 1 |
| Mirza, GE | 1 |
| Karaküçük, S | 1 |
| Doğan, H | 1 |
| Erkiliç, K | 1 |
| Nuyts, RM | 1 |
| Greve, EL | 1 |
| Geijssen, HC | 1 |
| Langerhorst, CT | 1 |
| Karp, CL | 1 |
| Higginbotham, EJ | 2 |
| Griffin, EO | 1 |
| Choi, WS | 1 |
| Park, SJ | 1 |
| Kim, DM | 2 |
| Haynes, WL | 2 |
| McKinney, JK | 1 |
| Collignon-Brach, J | 1 |
| Hong, C | 1 |
| Hyung, SM | 2 |
| Song, KY | 1 |
| Youn, DH | 3 |
| Michon, J | 1 |
| Krishnadas, R | 2 |
| Kawase, K | 2 |
| Scroggs, MW | 1 |
| Sloop, CM | 1 |
| Simmons, RB | 3 |
| Wilson, RP | 6 |
| Schmidt, CM | 4 |
| Gandham, S | 1 |
| Nishida, A | 1 |
| Kodo, M | 1 |
| Matsumura, M | 1 |
| Yamamoto, M | 1 |
| Tsukada, T | 1 |
| Pappa, KS | 1 |
| Derick, RJ | 2 |
| Weber, PA | 1 |
| Kapetansky, FM | 2 |
| Lehmann, DM | 1 |
| Nishimura, K | 1 |
| Jikihara, S | 1 |
| McGorray, S | 1 |
| Keller, C | 1 |
| To, K | 1 |
| Spaeth, GL | 4 |
| Eiferman, RA | 1 |
| McDermott, ML | 1 |
| Barron, A | 2 |
| Straker, C | 1 |
| Hung, PT | 1 |
| Lin, LL | 1 |
| Hsieh, JW | 1 |
| Wang, TH | 1 |
| Morinelli, EN | 1 |
| Baerveldt, G | 2 |
| LaBree, L | 1 |
| Lee, PP | 1 |
| Caronia, RM | 1 |
| Friedman, R | 1 |
| Cohen, H | 1 |
| Miller, MP | 3 |
| Suner, IJ | 3 |
| Kangas, TA | 1 |
| Flynn, HW | 2 |
| Lee, JJ | 1 |
| Prata, JA | 1 |
| Comegno, PE | 1 |
| Vasconcelos, JP | 1 |
| Malta, RF | 2 |
| José, NK | 1 |
| Taniguchi, T | 1 |
| Haque, MS | 1 |
| Yokoi, N | 2 |
| Komuro, A | 2 |
| Kinoshita, S | 2 |
| Tressler, CS | 1 |
| Cyrlin, MN | 1 |
| Rosenshein, JS | 1 |
| Fazio, R | 1 |
| Hendrickson, P | 1 |
| Gebhardt, DO | 1 |
| Dev, S | 1 |
| Wand, M | 1 |
| Takahashi, W | 1 |
| Nicolela, M | 1 |
| Ruderman, JM | 1 |
| Fundingsland, B | 1 |
| Meyer, MA | 1 |
| Figueiredo, RS | 1 |
| Araujo, SV | 2 |
| Cohen, EJ | 1 |
| Rapuano, CJ | 1 |
| Song, MS | 3 |
| Shah, MI | 1 |
| Obertynski, T | 1 |
| Cohen, JS | 2 |
| Greff, LJ | 1 |
| Wind, BE | 1 |
| Mardelli, PG | 1 |
| Lederer, CM | 1 |
| Murray, PL | 1 |
| Pastor, SA | 1 |
| Hassanein, KM | 1 |
| Hagiwara, Y | 2 |
| Cheung, JC | 1 |
| Murali, S | 1 |
| Pederson, JE | 2 |
| Masuda, K | 1 |
| Berestka, JS | 1 |
| Brown, SV | 1 |
| Bair, JS | 2 |
| Chen, CW | 2 |
| Walkow, T | 1 |
| Anders, N | 1 |
| Wollensak, J | 1 |
| Katz, GJ | 1 |
| Skuta, GL | 3 |
| Bergstrom, TJ | 2 |
| Johnson, AT | 1 |
| Simone, PA | 1 |
| Reed, SY | 3 |
| Sakuma, T | 1 |
| Belyea, DA | 1 |
| Dan, JA | 1 |
| Lieberman, MF | 1 |
| Carlson, DW | 1 |
| Barad, JP | 1 |
| Zimmerman, MB | 1 |
| Carney, BL | 1 |
| Honda, Y | 3 |
| Matsuda, T | 1 |
| McGehee, RF | 1 |
| Walton, DS | 1 |
| John, T | 1 |
| Jayagandan, A | 1 |
| Hara, T | 3 |
| Tezel, G | 2 |
| Kolker, AE | 2 |
| Kass, MA | 2 |
| Wax, MB | 2 |
| Katz, JD | 1 |
| Selvaraj, S | 1 |
| Bhatnagar, R | 1 |
| Loewenstein, A | 1 |
| McKinnon, S | 1 |
| DiBernardo, C | 2 |
| Choi, MY | 1 |
| Kang, SW | 1 |
| Zacharia, PT | 2 |
| Funk, J | 1 |
| Nuijts, RM | 1 |
| Vernimmen, RC | 1 |
| Lemon, LC | 3 |
| Lee, JH | 1 |
| Bendel, RE | 2 |
| Bond, JB | 1 |
| Melamed, S | 2 |
| Urban, RC | 1 |
| Krishnamurthy, MS | 1 |
| Mendelblatt, DJ | 1 |
| Lee, D | 2 |
| Birt, CM | 2 |
| Waheed, S | 1 |
| Ritterband, DC | 1 |
| Sood, NN | 1 |
| Sanga, L | 1 |
| Honavar, SG | 2 |
| Kasahara, N | 1 |
| Smith, TJ | 1 |
| Sibayan, SA | 1 |
| Montenegro, MH | 1 |
| Simmons, RJ | 2 |
| Tsei, CC | 1 |
| Chou, JC | 2 |
| Liu, JH | 2 |
| MacLeod, JD | 1 |
| Wallace, DK | 1 |
| Plager, DA | 1 |
| Snyder, SK | 1 |
| Raiesdana, A | 1 |
| Helveston, EM | 1 |
| Ellis, FD | 1 |
| Stone, RT | 1 |
| Allingham, RR | 1 |
| Obata, H | 1 |
| Schiffman, J | 1 |
| Rueda, JC | 1 |
| Tsai, JC | 3 |
| Sheth, N | 1 |
| Ren, J | 2 |
| Shah, M | 1 |
| Byrd, S | 1 |
| Egbert, PR | 1 |
| Budenz, D | 1 |
| Ladd, W | 2 |
| Libby, CM | 1 |
| Harrison, DA | 1 |
| Wheeler, DT | 1 |
| Gallenga, PE | 2 |
| Zuppardi, E | 2 |
| Colotto, A | 1 |
| Falsini, B | 1 |
| Cesari, L | 1 |
| Cermola, S | 1 |
| Iarossi, G | 1 |
| Scullica, L | 1 |
| Good, D | 1 |
| Moon, JI | 1 |
| Beatty, S | 1 |
| Potamitis, T | 1 |
| Kheterpal, S | 1 |
| O'Neill, EC | 1 |
| Yamamoto, S | 1 |
| Chua, JK | 1 |
| Fan, DS | 1 |
| Daugeliene, L | 1 |
| Kent, AR | 1 |
| Dubiner, HB | 1 |
| Whitaker, R | 1 |
| Mundorf, TK | 1 |
| Stewart, JA | 1 |
| Cate, EA | 1 |
| Stewart, WC | 1 |
| Pieroth, L | 1 |
| Vinals, AF | 1 |
| Goldstein, MH | 1 |
| Dreyer, EB | 1 |
| Cooper, ML | 1 |
| Mattox, C | 1 |
| Frangie, JP | 1 |
| Wu, HK | 1 |
| Cantor, L | 1 |
| Burgoyne, J | 1 |
| Sanders, S | 1 |
| Bhavnani, V | 1 |
| Brizendine, E | 1 |
| Weene, LE | 1 |
| Evans, J | 1 |
| Menapace, R | 1 |
| Strenn, K | 1 |
| Jacobi, PC | 3 |
| Basich, FM | 1 |
| Khadem, E | 1 |
| Nurözler, A | 1 |
| Kahraman, C | 1 |
| Kasim, R | 1 |
| Ustundag, C | 1 |
| Wilson, WR | 1 |
| Lynch, MG | 1 |
| Noe, R | 1 |
| Lobefalo, L | 1 |
| Gammon, RR | 1 |
| Avery, N | 1 |
| Mintz, PD | 1 |
| Trible, JR | 1 |
| Brown, DB | 1 |
| Sexton, RM | 1 |
| Ginde, SA | 1 |
| Goyal, M | 1 |
| Sen, PK | 1 |
| Naduvilath, T | 1 |
| Dandona, L | 1 |
| Leen, MM | 1 |
| Stewart, JF | 1 |
| Alfonso, E | 1 |
| Augsburger, JJ | 2 |
| Gandolfi, S | 1 |
| Migdal, CS | 1 |
| Mullaney, PB | 1 |
| Selleck, C | 1 |
| Al-Awad, A | 1 |
| Al-Mesfer, S | 1 |
| Freedman, SF | 1 |
| McCormick, K | 1 |
| Cox, TA | 1 |
| Ozdemir, Y | 1 |
| Onder, F | 1 |
| Coşar, CB | 1 |
| Usubütün, A | 1 |
| Kural, G | 1 |
| Pyfer, M | 1 |
| Gordon, J | 1 |
| Piltz-Seymour, J | 1 |
| Keates, EU | 1 |
| Oshima, Y | 1 |
| Sakamoto, T | 1 |
| Nakamura, T | 1 |
| Tahara, Y | 1 |
| Goto, Y | 1 |
| Ishibashi, T | 1 |
| Inomata, H | 1 |
| Chowers, I | 1 |
| Ticho, U | 1 |
| Naduvilath, TJ | 1 |
| Hitchings, RA | 3 |
| Quaranta, CA | 1 |
| Tamaki, Y | 1 |
| Muta, K | 1 |
| Gayton, JL | 1 |
| Van Der Karr, M | 1 |
| Sanders, V | 1 |
| Su, HC | 1 |
| Lanzl, IM | 1 |
| Dudley, D | 1 |
| Aslanides, IM | 1 |
| El Sayyad, F | 1 |
| Belmekki, M | 1 |
| Helal, M | 1 |
| Khalil, M | 1 |
| El-Hamzawey, H | 1 |
| Hisham, M | 1 |
| Belmonte, SJ | 1 |
| Rahman, A | 1 |
| Mendonca, M | 1 |
| Nakaizumi, T | 1 |
| Tsuji, H | 1 |
| Kapetansky, SD | 1 |
| Membrey, WL | 2 |
| Poinoosawmy, DP | 2 |
| Ishioka, M | 1 |
| Shimazaki, J | 1 |
| Yamagami, J | 1 |
| Fujishima, H | 1 |
| Shimmura, S | 1 |
| Quigley, HA | 2 |
| Buhrmann, RR | 1 |
| West, SK | 1 |
| Isseme, I | 1 |
| Scudder, M | 1 |
| Oliva, MS | 1 |
| Rosenbaum, J | 1 |
| Podos, SM | 1 |
| Ober, MD | 1 |
| Nootheti, P | 1 |
| Kim, PH | 2 |
| Mendis, U | 1 |
| Paliwal, A | 1 |
| Gupta, SD | 1 |
| Sharma, S | 1 |
| Arora, R | 1 |
| Mehta, K | 1 |
| Shaikh, NM | 1 |
| Baerveldt, GS | 1 |
| Shaikh, S | 1 |
| Yu, CB | 1 |
| Rockwood, EJ | 1 |
| Larive, B | 1 |
| Hahn, J | 1 |
| Chang, CJ | 1 |
| Chiang, CH | 1 |
| Yeh, MK | 1 |
| Chou, PI | 1 |
| Mutsch, YA | 1 |
| Manners, T | 1 |
| Willies, C | 1 |
| Pikkel, J | 1 |
| Wu, SC | 1 |
| Kook, MS | 1 |
| Kim, HB | 1 |
| Lee, SU | 1 |
| Traverso, C | 1 |
| Alm, A | 1 |
| Casson, R | 1 |
| Rahman, R | 1 |
| Fitzke, FW | 1 |
| Barboza, WL | 1 |
| Vasconcellos, JP | 1 |
| Tsukamoto, H | 1 |
| Masumoto, M | 1 |
| Jian, K | 1 |
| Okada, M | 1 |
| Mishima, HK | 1 |
| Mutlukan, E | 1 |
| Stamper, R | 1 |
| Doe, EA | 1 |
| Imami, NR | 1 |
| Sivak-Callcott, JA | 1 |
| Haik, BG | 1 |
| Zhang, J | 1 |
| McLean, IW | 1 |
| Vandenbelt, SM | 1 |
| Gross, JP | 1 |
| Keole, NS | 1 |
| Li, J | 1 |
| Pang, L | 1 |
| Xia, X | 1 |
| Huang, P | 1 |
| Zeng, Q | 1 |
| Wen, J | 1 |
| Gu, YS | 1 |
| Fang, CT | 1 |
| Ma, XQ | 1 |
| Yamin, M | 1 |
| Quentin, CD | 1 |
| Vergés, C | 1 |
| Llevat, E | 1 |
| Bardavio, J | 1 |
| Song, A | 1 |
| Chaudhry, IM | 1 |
| Hwang, JM | 1 |
| Rowlands, E | 1 |
| Islam, N | 1 |
| Noury, AM | 1 |
| Michalíková, L | 1 |
| Ferková, S | 1 |
| Jakabovicová, E | 1 |
| Strmen, P | 1 |
| Bindlish, R | 1 |
| Condon, GP | 1 |
| Schlosser, JD | 1 |
| D'Antonio, J | 1 |
| Lauer, KB | 1 |
| Lehrer, R | 1 |
| Weiss, HS | 1 |
| Pasquale, LR | 2 |
| Thibault, D | 1 |
| Dorman-Pease, ME | 1 |
| Wilkinson, WS | 1 |
| Watnick, RL | 1 |
| Elner, VM | 1 |
| Huang, HT | 1 |
| Lee, CC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| Primary Tube Versus Trabeculectomy Study[NCT00666237] | Phase 4 | 242 participants (Actual) | Interventional | 2008-04-01 | Completed | ||
| Effectiveness and Safety of Trabeculectomy and Peripheral Iridectomy Plus Goniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Non-inferiority Randomized Controlled Trial[NCT05163951] | 88 participants (Anticipated) | Interventional | 2022-01-05 | Recruiting | |||
| Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms[NCT00772330] | 23 participants (Actual) | Interventional | 2007-10-31 | Completed | |||
| Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)[NCT00494923] | 2,500 participants (Anticipated) | Observational | 1999-01-31 | Recruiting | |||
| Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation - a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt[NCT06174324] | 100 participants (Anticipated) | Observational | 2021-10-12 | Recruiting | |||
| A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShunt® Glaucoma Drainage System to Standard Trabeculectomy In Subjects With Primary Open Angle Glaucoma[NCT01881425] | 732 participants (Actual) | Interventional | 2015-12-15 | Completed | |||
| Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement[NCT04454138] | 142 participants (Actual) | Observational | 2019-06-25 | Completed | |||
| Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C[NCT04750447] | 30 participants (Anticipated) | Observational [Patient Registry] | 2020-11-09 | Recruiting | |||
| The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device[NCT02016898] | Phase 2 | 100 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for the Treatment of Open Angle Glaucoma in Patients With Cataract - a Randomised Controlled Trial[NCT04295122] | Phase 4 | 160 participants (Anticipated) | Interventional | 2020-03-15 | Not yet recruiting | ||
| Glycerin-Preserved, Human-Donor, Corneoscleral Patch Grafts for Glaucoma Drainage Devices[NCT04949347] | 100 participants (Actual) | Observational | 2017-02-22 | Completed | |||
| Deep Sclerectomy vs Xen in Solo Procedure: Comparative Study, Efficacy and Safety Profile[NCT05201378] | 282 participants (Actual) | Observational | 2021-07-15 | Completed | |||
| [NCT02665884] | 40 participants (Anticipated) | Observational | 2016-02-29 | Not yet recruiting | |||
| A Multi Center Study Comparing the Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma[NCT00444080] | 120 participants (Actual) | Interventional | 2006-10-31 | Completed | |||
| Prospective Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma[NCT03323138] | 40 participants (Anticipated) | Interventional | 2012-07-01 | Recruiting | |||
| Combined Phacoemulsification and Viscocanalostomy With Ologen Implant Versus Combined Phacoemulsification and Viscocanalostomy[NCT03782051] | 81 participants (Actual) | Interventional | 2013-08-01 | Completed | |||
| Tube Versus Trabeculectomy (TVT) Study[NCT00306852] | 212 participants (Actual) | Interventional | 1999-10-31 | Completed | |||
| Lucentis Versus Mitomycin C as Adjunctive Agent During Trabeculectomy Surgery[NCT00626782] | Phase 2/Phase 3 | 24 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular[NCT04970251] | 5 participants (Actual) | Interventional | 2018-11-01 | Completed | |||
| Comparison of Effectiveness and Safety of Eye Fixation Types During Combined Glaucoma Procedures[NCT03797846] | 41 participants (Actual) | Interventional | 2018-01-01 | Completed | |||
| Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas[NCT04647929] | 0 participants (Actual) | Interventional | 2020-12-01 | Withdrawn (stopped due to Funding for the study could not be found.) | |||
| Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647] | 61 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| XEN45 Gel Stent Implantation in Glaucoma Surgery[NCT03138928] | 15 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Effect of WeChat Application Combined Phone Reminder on Follow-up Adherence Improvement in Congenital Ectopia Lentis Patients : A Randomized Controlled Trial[NCT05628129] | 104 participants (Anticipated) | Interventional | 2022-12-05 | Recruiting | |||
| A Randomized Controlled Trail to Determine the Impact of a SMS Reminder Associated With Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China[NCT02328456] | 209 participants (Actual) | Interventional | 2014-12-31 | Completed | |||
| Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery[NCT01440751] | Phase 4 | 99 participants (Actual) | Interventional | 2011-09-30 | Completed | ||
| Bleb Function and Morphology With Intratendon Injection of 0.1 mg MMC in Comparison With Conventional Subtenon Application of 0.02% MMC Soaked Sponges in Trabeculectomy[NCT02385370] | Phase 3 | 126 participants (Anticipated) | Interventional | 2014-12-31 | Recruiting | ||
| Comparison of Combined Phacotrabeculectomy and Trabeculectomy Only in the Treatment of Primary Angle-closure Glaucoma[NCT01298635] | 31 participants (Actual) | Interventional | 2005-01-31 | Completed | |||
| Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma[NCT02964676] | 246 participants (Anticipated) | Interventional | 2017-01-31 | Not yet recruiting | |||
| Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Primary Open Angle Glaucoma: a Three-year Comparative Study[NCT01633775] | 100 participants (Actual) | Observational | 2007-12-31 | Completed | |||
| Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma[NCT01922154] | Phase 4 | 15 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| Comparison of ExPress Implantation Versus Partial Deep Sclerectomy Combined With ExPress Implantation With Simultaneously Phacoemulsification[NCT03800589] | 186 participants (Actual) | Interventional | 2010-12-01 | Completed | |||
| Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS Study)[NCT00661583] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study[NCT02691455] | 50 participants (Actual) | Interventional | 2016-02-29 | Terminated (stopped due to Difficulty in recruiting participants) | |||
| Effectiveness and Safety of Phacotrabeculectomy and Phacogoniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Randomized Controlled Trial[NCT04878458] | 124 participants (Actual) | Interventional | 2021-05-31 | Active, not recruiting | |||
| Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.[NCT00346489] | Phase 4 | 70 participants | Interventional | 2004-09-30 | Completed | ||
| IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient[NCT04052165] | 150 participants (Actual) | Interventional | 2015-07-01 | Completed | |||
| The Ahmed Versus Baerveldt (AVB) Study: Prospective, Multicenter Trial Comparing the Ahmed-FP7 Valve With the Baerveldt-350 Implant in Treating Refractory Glaucoma[NCT00940823] | 238 participants (Actual) | Interventional | 2005-07-31 | Completed | |||
| Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients[NCT00665756] | 40 participants (Actual) | Interventional | 2006-01-31 | Active, not recruiting | |||
| Anterior Segment Optical Coherence Tomography Findings in Patients With Ahmed Glaucoma Drainage Implants With Either a Pericardial Patch Graft and Fibrin Tissue Glue or a Partial-Thickness Scleral Flap and Conventional Sutures[NCT00453024] | Phase 2 | 40 participants (Anticipated) | Interventional | 2007-02-28 | Recruiting | ||
| Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy[NCT00695747] | 95 participants (Actual) | Interventional | 1998-01-31 | Completed | |||
| Modified Trabeculectomy With an Extended Subscleral Tunnel Versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma (POAG)[NCT03480711] | 40 participants (Actual) | Interventional | 2018-07-10 | Completed | |||
| The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy[NCT01255306] | 60 participants (Actual) | Observational | 2010-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The number of participants requiring reoperation for glaucoma will be reported (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Tube Shunt Surgery Group | 21 |
| Trabeculectomy With Mitomycin C | 12 |
Intraocular pressure will be reported in mmHg and measured using Goldmann applanation tonometry or a Tono-Pen. (NCT00666237)
Timeframe: At baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years
| Intervention | mmHg (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Intraocular Pressure: Baseline | Intraocular Pressure: 1 year | Intraocular Pressure: 18 months | Intraocular Pressure: 2 years | Intraocular Pressure: 3 years | Intraocular Pressure: 4 years | Intraocular Pressure: 5 years | |
| Trabeculectomy With Mitomycin C | 23.9 | 12.4 | 12.8 | 12.9 | 12.1 | 13.5 | 13.0 |
| Tube Shunt Surgery Group | 23.3 | 13.8 | 13.5 | 13.6 | 13.9 | 13.5 | 13.4 |
The need for supplemental glaucoma medications will be reported as the number of glaucoma medications used (NCT00666237)
Timeframe: At Baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years
| Intervention | glaucoma medications used (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | 1 year | 18 months | 2 years | 3 years | 4 years | 5 years | |
| Trabeculectomy With Mitomycin C | 3.2 | 0.9 | 0.8 | 1.0 | 1.2 | 1.3 | 1.3 |
| Tube Shunt Surgery Group | 3.1 | 2.1 | 2.1 | 2.2 | 2.1 | 2.3 | 2.2 |
Number of participants with early and late postoperative complications will be reported as per treating physician assessment (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Early Postoperative Complications | Late Postoperative Complications | |
| Trabeculectomy With Mitomycin C | 40 | 32 |
| Tube Shunt Surgery Group | 24 | 27 |
"Surgical failure is defined as:~Inadequate Intraocular Pressure (IOP) Reduction (IOP > 21 mmHg or reduced < 20% below baseline on 2 consecutive follow-up visits after 3 months)~Reoperation for glaucoma~Persistent hypotony (IOP ≤ 5 mmHg on 2 consecutive visits after 3 months)~Loss of light perception vision" (NCT00666237)
Timeframe: Up to 5 years
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Inadequate IOP reduction | Reoperation for Glaucoma | Loss of light perception vision | Persistent Hypotony | |
| Trabeculectomy With Mitomycin C | 23 | 9 | 1 | 5 |
| Tube Shunt Surgery Group | 31 | 18 | 0 | 0 |
Visual acuity will be reported as the number of correctly identified letters on the Early Treatment Diabetic Retinopathy Study (EDTRS) chart. Total score ranges from 0-100 with the higher score indicating better visual acuity. (NCT00666237)
Timeframe: At baseline, At 5 years
| Intervention | letters (Mean) | |
|---|---|---|
| Baseline | 5 years | |
| Trabeculectomy With Mitomycin C | 73 | 66 |
| Tube Shunt Surgery Group | 73 | 69 |
Visual acuity will be measured using a Snellen chart on logMAR (Logarithm of Minimal Angle of Resolution) scale. Letter-by letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20. (NCT00666237)
Timeframe: At Baseline, At 5 years
| Intervention | logMAR (Mean) | |
|---|---|---|
| Baseline | 5 years | |
| Trabeculectomy With Mitomycin C | 0.25 | 0.42 |
| Tube Shunt Surgery Group | 0.20 | 0.30 |
Cases requiring glaucoma re-operation (NCT00772330)
Timeframe: 60 Months
| Intervention | participants (Number) |
|---|---|
| MIDI Arrow | 2 |
The mean surgical procedure time from the time the incision was made in the conjunctiva to the time peritomy closure (NCT00772330)
Timeframe: Day 1
| Intervention | Minutes (Mean) |
|---|---|
| MIDI Arrow | 25.3 |
The number of glaucoma supplemental medications required after the MicroShunt procedure. (NCT00772330)
Timeframe: Day 1 thru Month 3, Month 6, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | Medications (Median) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | Day 1 thru Month 3 | Month 6 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| The Number of Glaucoma Supplemental Medication | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Maintenance of pressure control throughout the follow-up period, as measured by IOP at each post-operative visit (NCT00772330)
Timeframe: Day 1, Day 7, Week 3, Week 6, Month 3, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | mmHg (Mean) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline IOP | Day 1 | Day 7 | Week 3 | Week 6 | Month 3 | Month 6 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| To Assess Safety and Performance of the MIDI Arrow in Patients w Glaucoma | 23.78 | 9.6 | 7.8 | 7.4 | 8.9 | 10.8 | 12 | 11.2 | 11.3 | 12 | 11.8 | 12 | 11.5 |
Success: IOP < 15 mmHg or IOP reduced from baseline (pre-operative level) by ≥ 20% (without glaucoma reoperation, such as a trabeculectomy to improve aqueous drainage or implantation of another drainage implant). (NCT00772330)
Timeframe: Day 1, Day 7, Week 3, Week 6, Month 3, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | Participants (Count of Participants) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 1 | Day 7 | Week 3 | Week 6 | Month 3 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| To Assess Safety and Performance of the MIDI Arrow in Patients w Glaucoma | 22 | 23 | 23 | 23 | 22 | 23 | 22 | 21 | 20 | 17 | 18 |
Defined by ease of insertion of the device into the anterior chamber, based on an Investigator evaluation rating (5-point scale, with 1 being difficult and 5 being easy); (NCT00772330)
Timeframe: Day 1
| Intervention | Participants (Number) | ||||
|---|---|---|---|---|---|
| 1 - Difficult | 2 | 3 | 4 | 5 - Easy | |
| MIDI Arrow | 0 | 0 | 0 | 6 | 17 |
Visual acuity measured at each post-operative visit from baseline. (NCT00772330)
Timeframe: Day 1, Day 7, Week 3, Week 6, Month 3, Month 9, Month 12, Month 24, Month 36, Month 48 and Month 60
| Intervention | LogMar (Mean) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Day 1 | Day7 | Week 3 | Week 6 | Month 3 | Month 6 | Month 9 | Month 12 | Month 24 | Month 36 | Month 48 | Month 60 | |
| MIDI Arrow | .94 | 1.28 | .99 | .87 | .76 | .92 | .85 | .85 | .79 | .90 | .69 | .44 | .43 |
Secondary Effectiveness Endpoint #1 is the mean diurnal change in IOP from Screening at 12 months. (NCT01881425)
Timeframe: 12 months
| Intervention | mmHg (Mean) |
|---|---|
| InnFocus MicroShunt | -6.46 |
| Trabeculectomy | -9.80 |
Secondary Effectiveness Endpoint #1 is the mean diurnal change in IOP from Screening at 24 months (NCT01881425)
Timeframe: 24 months
| Intervention | mmHg (Mean) |
|---|---|
| InnFocus MicroShunt | -6.55 |
| Trabeculectomy | -9.85 |
The primary effectiveness outcome is ≥ 20% reduction in mean diurnal IOP without increasing number of glaucoma medications from baseline to 24 months follow-up (NCT01881425)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 200 |
| Trabeculectomy | 85 |
The primary effectiveness outcome is ≥ 20% reduction in mean diurnal IOP without increasing number of glaucoma medications from baseline to 12 months follow-up (NCT01881425)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 216 |
| Trabeculectomy | 96 |
The Secondary Effectiveness Endpoint #2 was having any physical or medical postoperative intervention (other than eye massage) intended to alter IOP by the Month 12 follow-up visit. (NCT01881425)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 161 |
| Trabeculectomy | 89 |
The Secondary Effectiveness Endpoint #2 was having any physical or medical postoperative intervention (other than eye massage) intended to alter IOP by the Month 24 follow-up visit. (NCT01881425)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| InnFocus MicroShunt | 219 |
| Trabeculectomy | 93 |
"Presence or absence of the following complications:~i. Starting after POM1: shallow AC w/ iridocorneal touch, any hyphema, corneal edema, wound leak/dehiscience, choroidal effusion, malignant glaucoma, dellen/non-healing epithelial defect, ptosis, diplopia.~ii. At any point: additional glaucoma surgery, loss of light perception vision, vitreous hemorrhage, ≥2mm hyphema, hypotony maculopathy, implant migration/blockage/exposure/extrusion, macular edema, choroidal effusion/hemorrhage requiring drainage, suprachoroidal hemorrhage, retinal detachment, suture abscess/blebitis/endophthalmitis" (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 35 |
| Targeted Supratenon's Placement of XEN 45 | 48 |
Presence or absence of the following management interventions (not considered complications): bleb needling, AC reformation, suture release, digital ocular compression, use of glaucoma medications, or laser/tpa to blocked ostomy or lumen. (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 32 |
| Targeted Supratenon's Placement of XEN 45 | 40 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) +/- Medications (NCT04454138)
Timeframe: Post op Year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 33 |
| Targeted Supratenon's Placement of XEN 45 | 22 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤17 (mmHg) on no medications (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 28 |
| Targeted Supratenon's Placement of XEN 45 | 18 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤17 (mmHg) +/- medication (NCT04454138)
Timeframe: Post op Year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 41 |
| Targeted Supratenon's Placement of XEN 45 | 26 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤21 (mmHg) on no medications (NCT04454138)
Timeframe: Post op Year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 31 |
| Targeted Supratenon's Placement of XEN 45 | 19 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) +/- medications (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 47 |
| Targeted Supratenon's Placement of XEN 45 | 28 |
Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) on no medications (NCT04454138)
Timeframe: Post op year 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Non-targeted Placement of XEN 45 | 20 |
| Targeted Supratenon's Placement of XEN 45 | 15 |
To assess final intraocular pressure lowering between patients who receive mitomycin-C using a sponge versus irrigation (NCT02016898)
Timeframe: post-operative day 1 to month 6
| Intervention | mmHg (millimeters of mercury) (Mean) |
|---|---|
| Sponge Placement of Mitomycin-C | -8.4 |
| Irrigation Placement of MMC | -8.2 |
To assess complication rates between patients who receive mitomycin-C using a sponge versus irrigation (NCT02016898)
Timeframe: post-operative day 1 to month 6
| Intervention | Participants (Count of Participants) |
|---|---|
| Sponge Placement of Mitomycin-C | 29 |
| Irrigation Placement of MMC | 28 |
The secondary effectiveness measure will be qualified and complete success rate defined as IOP≤18mmHg with or without medications in the test group as compared to qualified and complete success rate in the concurrent control group at 24 month (NCT00444080)
Timeframe: 24 months
| Intervention | participants (Number) |
|---|---|
| Control Arm | 48 |
| Treatment Arm | 49 |
(NCT00444080)
Timeframe: assessed at 1d, 1w, 1m, 3m, 6m, 12m, 18m, 24m; 24 months reported
| Intervention | number of medications (Mean) |
|---|---|
| Control Arm | 0.7 |
| Treatment Arm | 0.9 |
Mean postoperative intraocular pressure (NCT00444080)
Timeframe: assessed at 1d, 1w, 1m, 3m, 6m, 12m, 18m, 24m. 24 months reported
| Intervention | mmHg (Mean) |
|---|---|
| Control Arm | 14.6 |
| Treatment Arm | 14.7 |
Comparison of the incidence of all adverse events that occur during the intra-operative and postoperative periods between the two study arms. More than 1 complication may have occurred in the same subject. (NCT00444080)
Timeframe: 24 months
| Intervention | complications (Number) |
|---|---|
| Control Arm | 25 |
| Treatment Arm | 11 |
The data value from the Baseline visit and 5 year follow-up visit were combined. Specifically, values were calculated by subtracting the 5 Year Intraocular Pressure from the Baseline Intraocular Pressure. (NCT00306852)
Timeframe: Baseline to 5 years
| Intervention | mm Hg (Mean) |
|---|---|
| Trabeculectomy | 12.6 |
| Implant | 14.4 |
Failure was prospectively defined as IOP greater than 21 mm Hg or less than 20 percent reduction below baseline on 2 consecutive follow-up visits after 3 months, IOP less than or equal to 5 mm Hg on 2 consecutive follow-up visits after 3 months, re-operation for glaucoma, or loss of light perception vision. (NCT00306852)
Timeframe: 5 years
| Intervention | percentage of participants (Number) |
|---|---|
| Trabeculectomy | 46.9 |
| Implant | 29.8 |
The number of supplemental glaucoma medications required in the Implant Group and Trabeculectomy Group at 5 years (NCT00306852)
Timeframe: 5 years
| Intervention | number of medications (Mean) |
|---|---|
| Trabeculectomy | 1.2 |
| Implant | 1.4 |
Reoperations for glaucoma was defined as additional glaucoma surgery requiring a return to the operating room. (NCT00306852)
Timeframe: 5 years
| Intervention | participants (Number) |
|---|---|
| Trabeculectomy | 15 |
| Implant | 20 |
Complications associated with both surgical procedures (NCT00306852)
Timeframe: 5 years
| Intervention | participants (Number) | |
|---|---|---|
| EARLY POSTOPERATIVE COMPLICATIONS | LATE POSTOPERATIVE COMPLICATIONS | |
| Implant | 33 | 36 |
| Trabeculectomy | 39 | 38 |
Visual acuity was measured by the total number of letters read (correctly) using a ETDRS eye chart (NCT00306852)
Timeframe: 5 years
| Intervention | Letters (Mean) | |
|---|---|---|
| PATIENTS WITH COMPLICATIONS | PATIENTS WITHOUT COMPLICATIONS | |
| Implant | 33 | 46 |
| Trabeculectomy | 56 | 44 |
Percentage of participants with ocular adverse events and other adverse events as identified by eye examination, physical examination, subject reporting and changes in vital signs one year post-operatively. (NCT00626782)
Timeframe: 12 months
| Intervention | percentage of participants (Number) |
|---|---|
| Treatment 1 (Ranibizumab 0.5mg) | 100 |
| Treatment 2 (Mitomycin C 0.4 mg/ml) | 16.67 |
Mean number of glaucoma medications used by each participant over the course of one year post-operatively. (NCT00626782)
Timeframe: 1 day, 2 wks, 1, 3, 6 and 12 months
| Intervention | number of glaucoma medications used (Mean) | |||||
|---|---|---|---|---|---|---|
| 1 Day | 2 wks | 1 month | 3 months | 6 months | 12 months | |
| A: Ranibizumab 0.5mg (0.05mL) Injection | 0.01 | 0.0 | 0.13 | 0.66 | 0.34 | 0.15 |
| B: Mitomycin C 0.4 mg/ml Sponge | 0.0 | 0.01 | 0.01 | 0.08 | 0.06 | 0.06 |
To assess ocular adverse events of combination ranibizumab and MMC therapy at 6 months (NCT00661583)
Timeframe: 6 months
| Intervention | Number of Reported Adverse Events (Number) |
|---|---|
| Ranibizumab Alone | 0 |
| Ranibizumab and MMC | 0 |
| MMC Alone | 0 |
To determine percent of subjects with a qualified success and viable bleb at 6 months (IOP between 6mm Hg and 22 mm Hg with pressure controlled with and without adjunctive medications) (NCT00661583)
Timeframe: 6 months
| Intervention | percentage of subjects (Number) |
|---|---|
| Ranibizumab Alone | 100 |
| Ranibizumab and MMC | 100 |
| MMC Alone | 100 |
Mean change in in intraocular pressure at 3 months and at 6 months (NCT00661583)
Timeframe: 6 months
| Intervention | mmHg (Mean) | |
|---|---|---|
| month 3 minus baseline | month 6 minus baseline | |
| MMC Alone | -8.35 | -8.00 |
| Ranibizumab Alone | -6.40 | -6.60 |
| Ranibizumab and MMC | -6.40 | -4.90 |
Mean change in visual acuity in logMAR. (NCT00661583)
Timeframe: 6 months
| Intervention | logMAR (Mean) | |
|---|---|---|
| Month 3 minus baseline | Month 6 minus baseline | |
| MMC Alone | 0.13 | 0.13 |
| Ranibizumab Alone | -0.01 | -0.05 |
| Ranibizumab and MMC | 0.01 | 0.05 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 1 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 1
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.03 |
| Transscleral Cyclophotocoagulation | 0.12 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 12 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 12
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.06 |
| Transscleral Cyclophotocoagulation | 0.09 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 3 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 3
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.10 |
| Transscleral Cyclophotocoagulation | 0.08 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 6 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 6
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.03 |
| Transscleral Cyclophotocoagulation | 0.05 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The week 1 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, week 1
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | 0.16 |
| Transscleral Cyclophotocoagulation | 0.14 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The year 2 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, year 2
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.28 |
| Transscleral Cyclophotocoagulation | 0.24 |
The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The year 3 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, year 3
| Intervention | log MAgnification Requirement (logMAR) (Mean) |
|---|---|
| Second Aqueous Shunt | -0.23 |
| Transscleral Cyclophotocoagulation | 0.49 |
Number of participants who reported pain. (NCT02691455)
Timeframe: 1 month
| Intervention | Participants (Count of Participants) |
|---|---|
| Second Aqueous Shunt | 10 |
| Transscleral Cyclophotocoagulation | 10 |
Number of participants who reported pain. (NCT02691455)
Timeframe: 1 week
| Intervention | Participants (Count of Participants) |
|---|---|
| Second Aqueous Shunt | 12 |
| Transscleral Cyclophotocoagulation | 11 |
"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from month 12 to year 3
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 0 |
| Transscleral Cyclophotocoagulation | 0 |
"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from month 6 to month 12
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 3 |
| Transscleral Cyclophotocoagulation | 2 |
"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from time of intervention to month 6
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 0 |
| Transscleral Cyclophotocoagulation | 0 |
The Snellen visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). Loss of lines of vision indicates worsening visual acuity. (NCT02691455)
Timeframe: from time of intervention to year 3
| Intervention | eyes (Number) |
|---|---|
| Second Aqueous Shunt | 3 |
| Transscleral Cyclophotocoagulation | 8 |
(NCT02691455)
Timeframe: from baseline to 3 months
| Intervention | office visits per participant (Mean) |
|---|---|
| Second Aqueous Shunt | 3.73 |
| Transscleral Cyclophotocoagulation | 0.95 |
(NCT02691455)
Timeframe: from month 4 to year 3
| Intervention | office visits per participant per month (Mean) |
|---|---|
| Second Aqueous Shunt | 0.35 |
| Transscleral Cyclophotocoagulation | 0.13 |
Severity of pain was assessed by the Universal Pain Assessment Tool, and the score ranges from 0 to 10, with a higher score indicating greater pain. (NCT02691455)
Timeframe: 1 month
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 1.40 |
| Transscleral Cyclophotocoagulation | 1.28 |
Severity of pain was assessed by the Universal Pain Assessment Tool, and the score ranges from 0 to 10, with a higher score indicating greater pain. (NCT02691455)
Timeframe: 1 week
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 1.57 |
| Transscleral Cyclophotocoagulation | 1.44 |
The score on the National Eye Institute (NEI) Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 62.5 |
| Transscleral Cyclophotocoagulation | 48.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 86.4 |
| Transscleral Cyclophotocoagulation | 77.6 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 91.1 |
| Transscleral Cyclophotocoagulation | 76.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 50.2 |
| Transscleral Cyclophotocoagulation | 46.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 49.3 |
| Transscleral Cyclophotocoagulation | 54.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 65.8 |
| Transscleral Cyclophotocoagulation | 63.5 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 75.8 |
| Transscleral Cyclophotocoagulation | 63.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 63.1 |
| Transscleral Cyclophotocoagulation | 55.4 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 56.5 |
| Transscleral Cyclophotocoagulation | 65.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 58.9 |
| Transscleral Cyclophotocoagulation | 53.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 64.5 |
| Transscleral Cyclophotocoagulation | 63.2 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 64.3 |
| Transscleral Cyclophotocoagulation | 70.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 55.4 |
| Transscleral Cyclophotocoagulation | 56.9 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 57.6 |
| Transscleral Cyclophotocoagulation | 68.3 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 66.3 |
| Transscleral Cyclophotocoagulation | 62.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 71.2 |
| Transscleral Cyclophotocoagulation | 59.0 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 76.2 |
| Transscleral Cyclophotocoagulation | 70.4 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 83.0 |
| Transscleral Cyclophotocoagulation | 81.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 60.2 |
| Transscleral Cyclophotocoagulation | 59.2 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 62.5 |
| Transscleral Cyclophotocoagulation | 63.5 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 54.8 |
| Transscleral Cyclophotocoagulation | 61.8 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 63.4 |
| Transscleral Cyclophotocoagulation | 70.2 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 83.1 |
| Transscleral Cyclophotocoagulation | 82.7 |
The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12
| Intervention | score on a scale (Mean) |
|---|---|
| Second Aqueous Shunt | 83.3 |
| Transscleral Cyclophotocoagulation | 76.0 |
(NCT02691455)
Timeframe: from the time of intervention to year 3
| Intervention | eyes (Number) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hyphema | Hypotony persistent | Choroidal Effusion | Cystoid/Diabetic Macular Edema Progression | Primary Tube Complications | Cataract Progression | Macular Hole | Herpes Simplex Keratitis | Ectropion | Second Tube Migration Anteriorly | Vitreous Clogging Second glaucoma drainage device | Intraocular Lens Dislocation | Phacodonesis | |
| Second Aqueous Shunt | 2 | 2 | 1 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Transscleral Cyclophotocoagulation | 0 | 0 | 0 | 3 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
(NCT00940823)
Timeframe: 5 years
| Intervention | glaucoma medications (Mean) |
|---|---|
| Ahmed Group | 1.8 |
| Baerveldt Group | 1.2 |
(NCT00940823)
Timeframe: 5 years
| Intervention | mmHg (Mean) |
|---|---|
| Ahmed Group | 16.6 |
| Baerveldt Group | 13.6 |
Visual acuity (VA) was tested monocularly (one eye at a time) using the manifest refraction adjusted for optical infinity using a standard Snellen Visual Acuity chart at 20 feet. Normal vision, or 20/20 vision, means that the participant can see at 20 feet what a healthy control can also see at 20 feet. Legal blindness, or 20/200 vision, means the participant can see at 20 feet what a healthy control can see at 200 feet. Hence, an increasing denominator implies visual impairment. Counting fingers was designated as 20/2000 vision, hand motions was 20/16000, light perception was 20/32000 and no light perception was 20/64000. To allow for appropriate statistical analysis, logMAR Snellen Visual Acuity was calculated using the formula: -logMAR (Snellen Acuity). This means that normal vision (20/20) would correspond to a value of 0, legal blindness (20/200) would correspond to a value of 1, and no light perception (20/64000) would correspond to 3.5. (NCT00940823)
Timeframe: 5 years
| Intervention | logMAR units on a scale (Mean) |
|---|---|
| Ahmed Group | 1.6 |
| Baerveldt Group | 1.6 |
(NCT00940823)
Timeframe: 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Ahmed Group | 78 |
| Baerveldt Group | 79 |
(NCT00940823)
Timeframe: 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Ahmed Group | 64 |
| Baerveldt Group | 58 |
"IOP out of target range (5-18 mmHg inclusive) or <20% reduction from baseline for 2 consecutive visits after 3 months.~De novo glaucoma surgery required (e.g., cyclodestructive procedure, additional tube shunt).~Removal of the implant.~Severe vision loss related to the surgery (endophthalmitis, suprachoroidal hemorrhage with vision loss, enucleation, evisceration, or phthisis bulbi) or progression to no light perception for any reason." (NCT00940823)
Timeframe: 5 years
| Intervention | participants (Number) |
|---|---|
| Ahmed Group | 63 |
| Baerveldt Group | 40 |
Retinal nerve fiber layer thickness change measured by optical coherence tomography might be an additional parameter that could provide new insights into clinical decision making in patients with silicone oil tamponade. (NCT01255306)
Timeframe: 6 months
| Intervention | micrometer (Mean) | |||
|---|---|---|---|---|
| RNFL thickness at 7th postop. day | RNFL thickness at 30th postop. day | RNFL thickness at 90th postop. day | RNFL thickness at 180th postop. day | |
| CONTROL EYES | 87.07 | 87.93 | 87.37 | 88.93 |
| STUDY EYES | 96.23 | 96.09 | 97.56 | 100.40 |
To assess whether retinal nerve fiber layer thickness changes in patients with raised intraocular pressure secondary to silicone oil endotamponade. (NCT01255306)
Timeframe: 6 months
| Intervention | micrometer (Mean) | |||
|---|---|---|---|---|
| RNFL thickness at 7th postop. day | RNFL thickness at 30th postop. day | RNFL thickness at 90th postop. day | RNFL thickness at 180th postop. day | |
| CONTROL | 87.07 | 87.93 | 87.37 | 88.93 |
| NO IOP | 96.08 | 93.76 | 96.44 | 101.76 |
| RAISED IOP | 96.34 | 97.91 | 98.44 | 99.34 |
46 reviews available for mitomycin and Intraocular Pressure
| Article | Year |
|---|---|
[Surgical advancement in glaucoma in the past 10 years. German version].
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outcome | 2021 |
Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review.
Topics: Animals; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pressure; Mice; Mitomycin; Models, Anima | 2022 |
The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures.
Topics: Amnion; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2023 |
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.
Topics: Adolescent; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; M | 2023 |
[Revision of the PRESERFLO® MicroShunt with ologen and mitomycin C].
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy | 2023 |
Comparison of Repeat Trabeculectomy Versus Ahmed Valve Implantation After Initial Failed Trabeculectomy Surgery.
Topics: Follow-Up Studies; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Retrospectiv | 2023 |
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Alkylating Agents; Female; Filtering Surgery; Glaucoma; History, 20th Century; History, 21st Century | 2020 |
Estimation of risk-benefit ratio and comparison of post-operative efficacy results between trabeculectomy and canaloplasty.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Risk Assessmen | 2021 |
Needling after trabeculectomy - does augmentation by anti-metabolites provide better outcomes and is Mitomycin C better than 5-Fluoruracil? A systematic review with network meta-analyses.
Topics: Fluorouracil; Glaucoma; Humans; Immunosuppressive Agents; Intraocular Pressure; Mitomycin; Network M | 2020 |
Overview of cicatricial modulators in glaucoma fistulizing surgery.
Topics: Cicatrix; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Wound Healing | 2020 |
[Glaucoma surgery today].
Topics: Germany; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Quality of Life; Retrospective Studies; | 2021 |
Surgical interventions for primary congenital glaucoma.
Topics: Child, Preschool; Glaucoma; Glaucoma Drainage Implants; Humans; Hyphema; Infant; Infant, Newborn; In | 2020 |
History, presence, and future of mitomycin C in glaucoma filtration surgery.
Topics: Alkylating Agents; Drug Delivery Systems; Fibrosis; Filtering Surgery; Glaucoma; History, 20th Centu | 2021 |
Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma?
Topics: Antimetabolites; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Randomiz | 2018 |
[Trabeculectomy with mitomycin C : Video article].
Topics: Conjunctiva; Intraocular Pressure; Mitomycin; Tonometry, Ocular; Trabeculectomy; Treatment Outcome | 2018 |
Trabeculectomy: A Brief History and Review of Current Trends.
Topics: Angiogenesis Inhibitors; Fluorouracil; Glaucoma; History, 20th Century; History, 21st Century; Human | 2018 |
Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.
Topics: Antimetabolites; Databases, Factual; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pr | 2013 |
Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials.
Topics: Alkylating Agents; Antimetabolites; Chemotherapy, Adjuvant; Epithelium, Corneal; Fluorouracil; Glauc | 2013 |
[Current surgical methods for advanced glaucoma].
Topics: Cicatrix; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Humans; Hungary; Intraocular Pressure | 2013 |
The optimal trabeculectomy: patient and procedure.
Topics: Alkylating Agents; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Patient Selection; Trabecular | 2014 |
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.
Topics: Antimetabolites; Chemotherapy, Adjuvant; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Press | 2015 |
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.
Topics: Antihypertensive Agents; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Limbus Corneae; Mitom | 2015 |
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Topics: Angiogenesis Inhibitors; Bevacizumab; Cicatrix; Glaucoma; Humans; Intraocular Pressure; Mitomycin; R | 2016 |
The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Angiogenesis Inhibitors; Antimetabolites; Bevacizumab; Drug Therapy, Combination; Glaucoma; Humans; | 2016 |
Modulation of wound healing during and after glaucoma surgery.
Topics: Antibiotics, Antineoplastic; Cicatrix; Dendrimers; Fibroblasts; Filtering Surgery; Glaucoma; Humans; | 2008 |
Efficacy and tolerability of nonpenetrating glaucoma surgery augmented with mitomycin C in treatment of open-angle glaucoma: a meta-analysis.
Topics: Alkylating Agents; Clinical Trials as Topic; Combined Modality Therapy; Databases, Factual; Filterin | 2009 |
Review of results from the Tube Versus Trabeculectomy Study.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocu | 2010 |
Interpretation and misinterpretation of results from the tube versus trabeculectomy study.
Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Incidence; Intraocular Pressure; In | 2011 |
Systematic overview of the efficacy of nonpenetrating glaucoma surgery in the treatment of open angle glaucoma.
Topics: Filtering Surgery; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin | 2011 |
Intraoperative mitomycin C versus intraoperative 5-fluorouracil for trabeculectomy: a systematic review and meta-analysis.
Topics: Controlled Clinical Trials as Topic; Fluorouracil; Humans; Intraocular Pressure; Intraoperative Care | 2012 |
Current variations of glaucoma filtration surgery.
Topics: Alkylating Agents; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Surgical Flaps; | 2012 |
The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice.
Topics: Antihypertensive Agents; Cataract Extraction; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocu | 2012 |
Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review.
Topics: Antimetabolites, Antineoplastic; Cataract; Cataract Extraction; Evidence-Based Medicine; Fluorouraci | 2002 |
[Modulation of wound healing in filtration surgery for glaucoma].
Topics: Adolescent; Adult; Age Factors; Alkylating Agents; Animals; Antimetabolites; Child; Filtering Surger | 2003 |
[Mitomycin C in glaucoma surgery].
Topics: Adult; Aged; Aged, 80 and over; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Midd | 1993 |
Trabeculotomy ab externo: an alternative treatment in adult patients with primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open | 1993 |
Wound healing modulation in glaucoma filtration surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Fluorouracil; Glaucoma; Humans; Intraocular | 1993 |
[Current topics in glaucoma].
Topics: Adult; Animals; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; M | 1996 |
Mitomycin C primary trabeculectomy in primary glaucoma of white patients.
Topics: Antimetabolites; Cataract; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Intraoperati | 1997 |
Current techniques in wound healing modulation in glaucoma surgery.
Topics: Animals; Antimetabolites; Cataract Extraction; Cicatrix; Filtering Surgery; Fluorouracil; Glaucoma; | 1996 |
The toxicology of mitomycin C on the ciliary body.
Topics: Animals; Antibiotics, Antineoplastic; Aqueous Humor; Ciliary Body; Conjunctiva; Filtering Surgery; G | 1996 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; | 1999 |
Hypotony after glaucoma filtration surgery.
Topics: Alkylating Agents; Humans; Incidence; Intraocular Pressure; Mitomycin; Ocular Hypotension; Ophthalmi | 2000 |
The use of antimetabolites with trabeculectomy: a critical appraisal.
Topics: Antimetabolites; Combined Modality Therapy; Delivery of Health Care; Fluorouracil; Glaucoma; Humans; | 2001 |
Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Mitomy | 2001 |
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Bacteria; Endophthalmitis; Eye Infections, Bacteri | 2002 |
155 trials available for mitomycin and Intraocular Pressure
| Article | Year |
|---|---|
Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study.
Topics: Angiogenesis Inhibitors; Bevacizumab; Fluorouracil; Follow-Up Studies; Humans; Intraocular Pressure; | 2022 |
Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outc | 2022 |
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Topics: Alkylating Agents; Blindness; Cataract; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum | 2022 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Tr | 2022 |
Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.
Topics: Antiglaucoma Agents; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Prospecti | 2023 |
Long-term effects of intraoperative topical bevacizumab in sutureless scleral tunnel trabeculectomy: a prospective clinical trial.
Topics: Antiglaucoma Agents; Bevacizumab; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Press | 2023 |
Mitomycin C-augmented Phacotrabeculectomy Versus Phacoemulsification in Primary Angle-closure Glaucoma: A Randomized Controlled Study.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Glaucoma, Angle | 2019 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra | 2020 |
Can postoperative dexamethasone nanoparticle eye drops replace mitomycin C in trabeculectomy?
Topics: Aged; Aged, 80 and over; Alkylating Agents; Dexamethasone; Female; Glaucoma, Open-Angle; Glucocortic | 2020 |
Trabeculectomy With Extended Subscleral Tunnel Versus Conventional Trabeculectomy in the Management of POAG: A 1-Year Randomized-controlled Trial.
Topics: Adult; Aged; Antihypertensive Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ma | 2020 |
Intracameral tissue plasminogen activator in trabeculectomy: a 1-year prospective, randomized, controlled study.
Topics: Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Pros | 2020 |
Baerveldt implant versus trabeculectomy as the first filtering surgery for uncontrolled primary congenital glaucoma: a randomized clinical trial.
Topics: Adolescent; Child; Child, Preschool; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans | 2020 |
A Randomized Controlled Trial Comparing Subconjunctival Injection to Direct Scleral Application of Mitomycin C in Trabeculectomy.
Topics: Aged; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Injections; Intraocular | 2020 |
Combined Trabeculotomy-Trabeculectomy Versus Trabeculectomy for Treatment of Silicone Oil-induced Ocular Hypertension.
Topics: Adolescent; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Silicone Oils; Ton | 2021 |
Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetes Mellitus; Follow-Up Studies; Humans; Intraocula | 2022 |
Comparison of conbercept and ranibizumab combined mitomycin C-augmented trabeculectomy for neovascular glaucoma.
Topics: Angiogenesis Inhibitors; Glaucoma, Neovascular; Humans; Intraocular Pressure; Intravitreal Injection | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2021 |
Efficacy of Trabeculectomy Combined With Limited Deep Sclerectomy Versus Trabeculectomy Alone: A Randomized-controlled Trial.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy; Treatment Out | 2021 |
Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Double-Blind Metho | 2017 |
Long-term results of deep sclerectomy in normal-tension glaucoma.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Goniosco | 2018 |
Simultaneous use of amniotic membrane and Mitomycin C in trabeculectomy for primary glaucoma.
Topics: Adult; Aged; Alkylating Agents; Amnion; Combined Modality Therapy; Conjunctiva; Female; Glaucoma, Op | 2017 |
The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Glaucoma; Glaucoma Drainage | 2018 |
The Primary Tube Versus Trabeculectomy Study: Methodology of a Multicenter Randomized Clinical Trial Comparing Tube Shunt Surgery and Trabeculectomy with Mitomycin C.
Topics: Alkylating Agents; Antihypertensive Agents; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2018 |
Comparison of Mean Corneal Endothelial Cell Loss after Trabeculectomy with and without Mitomycin C.
Topics: Aged; Antimetabolites; Corneal Endothelial Cell Loss; Endothelium, Corneal; Female; Glaucoma, Open-A | 2018 |
Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh.
Topics: Adult; Antibiotics, Antineoplastic; Bangladesh; Collagen; Female; Glaucoma; Glycosaminoglycans; Huma | 2019 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma | 2018 |
Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study).
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Double-Blind Method; Female; Glaucoma | 2019 |
Bleb Morphology After Mitomycin-C Augmented Trabeculectomy: Comparison Between Clinical Evaluation and Anterior Segment Optical Coherence Tomography.
Topics: Aged; Anterior Eye Segment; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitom | 2019 |
Suture Removal After Trabeculectomy With Fornix-based Conjunctival Flap Leads to Faster Visual Recovery but Not Reduced Astigmatism.
Topics: Aged; Alkylating Agents; Astigmatism; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 2019 |
Phacotrabeculectomy using collagen matrix implant (Ologen
Topics: Aged; Alkylating Agents; Cataract; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma; Gly | 2019 |
Augmented Subscleral Trabeculectomy With Beta Radiation and Mitomycin C in Egyptian Glaucoma Patients.
Topics: Adult; Beta Particles; Combined Modality Therapy; Egypt; Female; Follow-Up Studies; Glaucoma; Humans | 2019 |
Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
Topics: Antibiotics, Antineoplastic; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma, Open-Angl | 2013 |
Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Co | 2015 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco | 2014 |
Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Humans; Intraocular Pressur | 2014 |
Trabeculectomy using mitomycin C versus an atelocollagen implant: clinical results of a randomized trial and histopathologic findings.
Topics: Absorbable Implants; Actins; Aged; Alkylating Agents; Collagen; Collagen Type III; Combined Modality | 2014 |
Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cohort Studies; Female; | 2014 |
Trabeculectomy With Mitomycin-C Versus Trabeculectomy With Amniotic Membrane Transplant: A Medium-term Randomized, Controlled Trial.
Topics: Aged; Alkylating Agents; Amnion; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; M | 2015 |
Ranibizumab versus mitomycin C in primary trabeculectomy--a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucom | 2015 |
Illuminated microcatheter circumferential trabeculotomy versus combined trabeculotomy-trabeculectomy for primary congenital glaucoma: a randomized controlled trial.
Topics: Catheters; Female; Humans; Hydrophthalmos; Infant; Infant, Newborn; Intraocular Pressure; Lighting; | 2015 |
Excision of Tenon Capsule in Pediatric Trabeculectomy: A Controlled Study.
Topics: Alkylating Agents; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Pressure; Male; M | 2016 |
Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Double-Blind Method; Female; Follow | 2015 |
Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial.
Topics: Adult; Aged; Alkylating Agents; Amnion; Double-Blind Method; Female; Glaucoma; Glaucoma Drainage Imp | 2016 |
Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctival Diseases; | 2015 |
Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Child, Preschool; Drug Therapy, Combination | 2016 |
Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Topics: Absorbable Implants; Adult; Aged; Alkylating Agents; Collagen; Exfoliation Syndrome; Female; Follow- | 2016 |
Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions.
Topics: Cataract; Collagen; Combined Modality Therapy; Gels; Glaucoma Drainage Implants; Glaucoma, Open-Angl | 2016 |
Primary trabeculotomy compared to combined trabeculectomy-trabeculotomy in congenital glaucoma: 3-year study.
Topics: Alkylating Agents; Female; Follow-Up Studies; Humans; Hydrophthalmos; Infant; Intraocular Pressure; | 2016 |
Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Bevacizumab; Conjunctiva; Dose-Re | 2017 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure | 2016 |
Sutureless Scleral Tunnel Trabeculectomy: Evaluation of Feasibility and Effectiveness versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma.
Topics: Aged; Antihypertensive Agents; Feasibility Studies; Female; Glaucoma, Open-Angle; Humans; Intraocula | 2018 |
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial.
Topics: Aged; Antifibrinolytic Agents; Antihypertensive Agents; Collagen; Combined Modality Therapy; Female; | 2016 |
Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G | 2017 |
Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Collagen; Female; Follow-Up Studies; Glaucoma, Open- | 2017 |
Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma.
Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocu | 2008 |
Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2008 |
Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
Topics: Administration, Topical; Alkylating Agents; Antihypertensive Agents; Antimetabolites; Combined Modal | 2009 |
Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Diplopia; Female; Follow-Up Studies; | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Effect of different application depths of mitomycin-C in deep sclerectomy with collagen implant: a randomized controlled trial.
Topics: Absorbable Implants; Aged; Aged, 80 and over; Cicatrix; Collagen; Female; Glaucoma, Open-Angle; Huma | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M | 2009 |
Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antihyper | 2010 |
A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma.
Topics: Amnion; Child; Child, Preschool; Conjunctiva; Freeze Drying; Glaucoma; Humans; Infant; Intraocular P | 2010 |
Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu | 2010 |
Anterior lens capsule versus mitomycin-C as an adjunct to trabeculectomy in combined phacotrabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Lens Capsule, Cry | 2011 |
A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma.
Topics: Absorbable Implants; Aged; Collagen; Cross-Linking Reagents; Female; Glaucoma Drainage Implants; Gla | 2010 |
Effect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit model.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blister; Cicatrix; Conjunctiva; Doxycyc | 2010 |
CO2 laser-assisted sclerectomy surgery, part II: multicenter clinical preliminary study.
Topics: Adult; Alkylating Agents; Exfoliation Syndrome; Female; Filtering Surgery; Glaucoma, Open-Angle; Hum | 2012 |
ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Conjunctiva; Drug Administration Schedule | 2011 |
Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2012 |
Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
Topics: Absorbable Implants; Aged; Collagen; Cross-Linking Reagents; Female; Glaucoma; Glycosaminoglycans; H | 2011 |
Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemothe | 2012 |
Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
Topics: Administration, Topical; Aged; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; | 2013 |
Comparison of the outcome of repeat trabeculectomy with adjunctive mitomycin C and initial trabeculectomy.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Int | 2011 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext | 2012 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Purified triamcinolone acetonide as antifibrotic adjunct in glaucoma filtering surgery.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Fibrosis; Glaucoma, Angle-Closure; Glaucoma, Open-Angl | 2013 |
Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
Topics: Adult; Alkylating Agents; Collagen; Female; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; | 2013 |
Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS).
Topics: Antimetabolites; Cataract Extraction; Endophthalmitis; Fluorouracil; Follow-Up Studies; Glaucoma, Op | 2013 |
Can early postoperative intraocular pressure predict success following mitomycin-C augmented trabeculectomy in primary angle-closure glaucoma.
Topics: Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Humans; Intraocu | 2013 |
Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female; Glaucoma, Open-An | 2002 |
Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctiva; Filtering Surgery; Follow-Up Stud | 2002 |
A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy.
Topics: Antimetabolites; Double-Blind Method; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Intraope | 2002 |
Two-site phacotrabeculectomy with intraoperative mitomycin-C: fornix- versus limbus-based conjunctival opening in fellow eyes.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2002 |
Five-year follow-up of LSL trabeculectomies with low dosage mitomycin-C in primary open-angle glaucoma.
Topics: Aged; Antimetabolites; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open-Angle; H | 2002 |
A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Humans; Hya | 2003 |
[Trabeculectomy combined with mitomycin C and removed suture in glaucoma].
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Postopera | 2003 |
[Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma].
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum | 2003 |
Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery.
Topics: Aged; Chemotherapy, Adjuvant; Connective Tissue; Female; Follow-Up Studies; Glaucoma; Glaucoma Drain | 2003 |
A comparative study of small incision trabeculectomy avoiding Tenon's capsule vis-à-vis trabeculectomy with Mitomycin-C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glaucoma, Open-Angle; H | 2004 |
Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up St | 2004 |
A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Blister; Cataract; Female; Filtering Surgery; Fluor | 2004 |
[Deep sclerectomy using a hyaluronate implant versus trabeculectomy. A comparison of two glaucoma operations using mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Descemet Membrane; Female; Filtering Surgery; Follow-Up Studies; Gla | 2004 |
[Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Endothelium, Corneal; F | 2004 |
Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Child, Preschool; Female; Glaucoma; Humans; Infan | 2001 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In | 2005 |
Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in west Africa.
Topics: Adult; Aged; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; | 2006 |
Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Fibrosis; Follow-Up Studies; Glaucoma; Hu | 2006 |
Prospective evaluation of preoperative factors associated with successful mitomycin C needling of failed filtration blebs.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Follow-Up Studies; Glaucoma; Humans; Inject | 2006 |
Comparison of 1-site versus 2-site phacotrabeculectomy.
Topics: Antihypertensive Agents; Case-Control Studies; Cataract; Fluorouracil; Follow-Up Studies; Glaucoma; | 2006 |
Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial.
Topics: Aged; Alkylating Agents; Collagen; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular | 2006 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female | 2007 |
A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs.
Topics: Aged; Alkylating Agents; Aqueous Humor; Blister; Conjunctiva; Diagnostic Techniques, Ophthalmologica | 2007 |
Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Catheterization; Chronic Disease; Female; Glau | 2007 |
A placebo controlled double blind clinical trial of mitomycin C in primary trabeculectomy in Ethiopian patients.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Case-Control Studies; Double-Blind Method; Ethiopia; | 2006 |
Laser suture lysis or releasable sutures after trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Exfoliation Syndrome; Female; Glau | 2007 |
The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.
Topics: Adult; Aged; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Gl | 2007 |
Randomized comparison of 1-Site and 2-Site phacotrabeculectomy with 3-year follow-up.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Ope | 2008 |
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
Topics: Aged; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intraocula | 2008 |
Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment.
Topics: Aged; Drug Implants; Female; Glaucoma; Humans; Hyaluronic Acid; Intraocular Pressure; Male; Middle A | 2008 |
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up.
Topics: Aged; Dose-Response Relationship, Drug; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, O | 2008 |
[Effect of mitomycin C on aqueous humor flow after trabeculectomy].
Topics: Adult; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Female; Follow-Up Stud | 1995 |
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
Topics: Adult; Aged; Case-Control Studies; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Intraocul | 1995 |
Adjunctive mitomycin C in Molteno implant surgery.
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Life Tables; Male; | 1995 |
Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma.
Topics: Administration, Topical; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma | 1993 |
Trabeculotomy ab externo: an alternative treatment in adult patients with primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open | 1993 |
Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fem | 1995 |
The effect of low-and high-dose adjunctive mitomycin C in trabeculectomy.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Dose-Response R | 1996 |
Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma.
Topics: Aged; Alkylating Agents; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intraocular Pre | 1996 |
Subconjunctival versus intrascleral mitomycin-C in trabeculectomy.
Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Conjunctiva; Drug Administration Routes; Female; Fo | 1996 |
Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; | 1996 |
A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures.
Topics: Aged; Aged, 80 and over; Cell Count; Chemotherapy, Adjuvant; Double-Blind Method; Endothelium, Corne | 1996 |
Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Female; Filter | 1995 |
Adjunctive subconjunctival mitomycin C in glaucoma triple procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Follow-Up | 1995 |
A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Double-Blind Method; Female; Glaucoma; Humans; Intraoc | 1997 |
A long-term dose-response study of mitomycin in glaucoma filtration surgery.
Topics: Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma | 1997 |
Comparative study of silicone versus acrylic foldable lens implantation in primary glaucoma triple procedure.
Topics: Acrylic Resins; Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lenses, Intraocula | 1997 |
Mitomycin-C in congenital glaucoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschoo | 1997 |
Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intraocul | 1998 |
The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Intrao | 1998 |
Risk of hypotony after primary trabeculectomy with antifibrotic agents in a black west African population.
Topics: Fluorouracil; Follow-Up Studies; Ghana; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Intraope | 1998 |
Delayed postoperative use of 5-fluorouracil in primary open angle glaucoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Fluorouracil; Follow-Up Studies; Glauc | 1997 |
The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotherapy, Adjuvant; Chr | 1998 |
The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Glaucoma; Humans; Incidence; Intraocula | 1998 |
Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C.
Topics: Aged; Aged, 80 and over; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 1998 |
Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma.
Topics: Aged; Aged, 80 and over; Antimetabolites; Chemotherapy, Adjuvant; Drug Administration Schedule; Fema | 1998 |
Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Ag | 1998 |
Oral prednisone in guarded filtration procedures supplemented with antimetabolites.
Topics: Administration, Oral; Aged; Chemotherapy, Adjuvant; Double-Blind Method; Female; Filtering Surgery; | 1999 |
Initial trabeculectomy with intraoperative mitomycin-C application in primary glaucomas.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, O | 1999 |
Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Corneal Diseases; Female; Glaucoma; Graft Survival; | 1999 |
Ab-interno goniotrabeculotomy versus mitomycin C trabeculectomy for adult open-angle glaucoma: a 2-year randomized clinical trial.
Topics: Anterior Chamber; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; | 1999 |
Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation.
Topics: Cataract; Ciliary Body; Endoscopy; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intrao | 1999 |
Simultaneous subconjunctival and subscleral mitomycin-C application in trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; | 2000 |
Posterior capsular opacification in phacotrabeculectomy : a long-term comparative study of silicone versus acrylic intraocular lens.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Female; Follow-Up | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial.
Topics: Female; Follow-Up Studies; Glaucoma Drainage Implants; Glaucoma, Angle-Closure; Glaucoma, Open-Angle | 2000 |
Postoperative application of mitomycin for trabeculectomies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Evaluation; Female; Follow-Up Studies; Glaucoma; Hu | 2000 |
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Evaluation; Female; Fluorouracil | 2000 |
Mini-trabeculectomy in eyes with high risk of scarring: midterm follow-up.
Topics: Aged; Aged, 80 and over; Cicatrix; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 2001 |
Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female; Follow-Up | 2002 |
Laser-assisted deep sclerectomy.
Topics: Adult; Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Male; Middle | 2002 |
Amniotic membrane graft for late-onset glaucoma filtering leaks.
Topics: Adult; Amnion; Biological Dressings; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Ag | 2002 |
A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Fo | 2002 |
Intraoperative episcleral versus postoperative topical application of mitomycin-C for trabeculectomies.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Ch | 2002 |
692 other studies available for mitomycin and Intraocular Pressure
| Article | Year |
|---|---|
Parallel Suture: A Simple Approach to Enable Early Laser Suture Lysis and Prevent Hypotony after Trabeculectomy.
Topics: Humans; Intraocular Pressure; Lasers; Mitomycin; Postoperative Complications; Suture Techniques; Sut | 2022 |
Comparison of bleb morphology by anterior segment optical coherence tomography and clinical outcome after phacotrabeculectomy with mitomycin C or Ologen implant.
Topics: Collagen; Follow-Up Studies; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin; Prospectiv | 2021 |
Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy.
Topics: Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Stud | 2022 |
Infective Necrotizing Scleritis After XEN Gel Stent With Mitomycin-C.
Topics: Aged; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomy | 2022 |
Longitudinal changes in complete avascular area assessed using anterior segmental optical coherence tomography angiography in filtering trabeculectomy bleb.
Topics: Adult; Aged; Computed Tomography Angiography; Female; Glaucoma; Humans; Intraocular Pressure; Longit | 2021 |
Acute iris toxicity following bilateral gel stent implantation with mitomycin-C and intracameral moxifloxacin January consultation #1.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Mitomycin; Moxifloxacin; Ref | 2022 |
Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery.
Topics: Animals; Collagen Type I, alpha 1 Chain; Glaucoma; Intraocular Pressure; Mitomycin; Rabbits; Valproi | 2022 |
Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study.
Topics: Adolescent; Child; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci | 2022 |
Surgical trends in glaucoma management: The current Indian scenario.
Topics: Cataract; Child; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Trab | 2022 |
Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma.
Topics: Adolescent; Child; Conjunctivitis, Allergic; Female; Glaucoma; Humans; Intraocular Pressure; Male; M | 2022 |
Does mitomycin-C concentration have any influence on XEN45 gel stent outcomes in a real-world setting?
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Sten | 2022 |
Survey of glaucoma surgical preferences among glaucoma specialists in Spain.
Topics: Collagen; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Spain | 2022 |
Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification.
Topics: Alkylating Agents; Collagen; Follow-Up Studies; Glaucoma, Open-Angle; Glycosaminoglycans; Humans; In | 2022 |
Efficacy of ab-interno gelatin microstent implantation in primary and refractory glaucoma.
Topics: Adult; Gelatin; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pres | 2023 |
One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis.
Topics: Cohort Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Trabeculec | 2023 |
Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy.
Topics: Bruch Membrane; Humans; Intraocular Pressure; Mitomycin; Nerve Fibers; Prospective Studies; Retinal | 2022 |
Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?
Topics: Choroidal Effusions; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Myopia | 2022 |
Current practice of trabeculectomy in a cohort of experienced glaucoma surgeons in Australia and New Zealand.
Topics: Australia; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; New Zealand; Retrospecti | 2023 |
Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival.
Topics: Cataract; Humans; Intraocular Pressure; Mitomycin; Phacoemulsification; Retrospective Studies; Trabe | 2022 |
The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy.
Topics: Cataract; Exfoliation Syndrome; Glaucoma; Humans; Intraocular Pressure; Lens Implantation, Intraocul | 2022 |
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Topics: Antihypertensive Agents; Cataract; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2022 |
The Norwich trabeculectomy study: risk factor analysis for the development of adverse, thin cystic blebs.
Topics: Antimetabolites; Conjunctiva; Factor Analysis, Statistical; Fluorouracil; Glaucoma; Humans; Intraocu | 2022 |
Glaucoma management in congenital ectropion uveae: Surgical outcomes from a large tertiary referral center in South India.
Topics: Ectropion; Follow-Up Studies; Glaucoma; Humans; Infant, Newborn; Intraocular Pressure; Mitomycin; Re | 2023 |
Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series.
Topics: Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Tonometry, Oc | 2022 |
Two Year Outcomes of Trabeculectomy in Cytomegalovirus Anterior Uveitis with Uncontrolled Intraocular Pressure.
Topics: Cytomegalovirus; Cytomegalovirus Infections; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retr | 2023 |
Effects of topical docosahexaenoic acid on postoperative fibrosis in an animal model of glaucoma filtration surgery.
Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Fibrosis; Filtering Surgery; Glaucoma; Intra | 2023 |
Same-site trabeculectomy with mitomycin and Ologen™ following failed non-penetrating deep sclerectomy.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Scleros | 2023 |
Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma.
Topics: Aged; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Mitomyc | 2022 |
Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome.
Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocorneal | 2023 |
Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes.
Topics: Animals; Antimetabolites; Conjunctiva; Dextrans; Fluorouracil; Glaucoma; Intraocular Pressure; Mice; | 2022 |
Trabeculectomy Tenon Advancement Technique May Reduce Bleb-Related Infections.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Postoperative Complications; | 2023 |
Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study.
Topics: Cross-Sectional Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Protein Kinase Inhibitor | 2022 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp | 2023 |
Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries.
Topics: Adolescent; Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Male; | 2023 |
Two routes of administration of mitomycin C in a trabeculectomy.
Topics: Humans; Intraocular Pressure; Mitomycin; Tonometry, Ocular; Trabeculectomy; Treatment Outcome | 2023 |
Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma.
Topics: Glaucoma; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ph | 2023 |
Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.
Topics: Cataract; Eye; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ret | 2023 |
One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Prospective Studies; Treatm | 2023 |
The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results.
Topics: Coronary Angiography; Coronary Artery Disease; Follow-Up Studies; Glaucoma Drainage Implants; Humans | 2023 |
The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits.
Topics: Animals; Cicatrix; Conjunctiva; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pressure; Matrix | 2023 |
Analysis of the Systemic Exposure of Mitomycin C Used in Glaucoma Filtering Surgery Among Women in the Reproductive Age Group.
Topics: Adolescent; Adult; Chromatography, Liquid; Female; Filtering Surgery; Glaucoma; Humans; Intraocular | 2023 |
Two-stage intra-tenon injection versus sponge-applied mitomycin C-augmented trabeculectomy: a one-year study.
Topics: Antiglaucoma Agents; Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Retrospective Studi | 2023 |
Impact of postoperative choroidal detachment on trabeculectomy outcomes: a four-year comparative study.
Topics: Aged; Eye; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retros | 2023 |
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 5 years of follow-up (Ophthalmology. 2022;129:1344-1356).
Topics: Eye; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomyci | 2023 |
Acute Necrotizing Retinopathy After Xen Gel Stent Implantation.
Topics: Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; | 2023 |
Clinical and Histopathological Effects of Intracameral Ranibizumab in Experimental Trabeculectomy.
Topics: Animals; Cicatrix; Intraocular Pressure; Mitomycin; Rabbits; Ranibizumab; Trabeculectomy | 2023 |
A retrospective study to assess visual field improvement following augmented trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; M | 2023 |
Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement.
Topics: Eye; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Treatment Outcome | 2023 |
Augmented trabeculectomy - The surgical journey and road trip forward.
Topics: Eye; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outcome | 2023 |
Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
Topics: Fibrosis; Glaucoma; Humans; Infant; Intraocular Pressure; Mitomycin; Retrospective Studies; Tonometr | 2023 |
Tube Versus Trabeculectomy IRIS Registry Study: 1-Year Secondary Treatment Outcomes.
Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies | 2023 |
Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand.
Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Female; Follow-Up Studies; Glaucoma; Glaucoma, O | 2023 |
Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma.
Topics: Exfoliation Syndrome; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospe | 2023 |
A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient.
Topics: Adult; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mal | 2023 |
Comparative study of surgical outcomes of twin-site phacotrabeculectomy with mitomycin C in primary open-angle glaucoma versus primary angle-closure glaucoma.
Topics: Antiglaucoma Agents; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mi | 2023 |
Surgical outcomes of trabeculectomy augmented with sub-Tenon injected mitomycin C.
Topics: Follow-Up Studies; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabecul | 2023 |
Childhood Glaucoma: Long-Term Outcomes of Glaucoma Drainage Device Implantation Within the First 2 Years of Life.
Topics: Alkylating Agents; Child, Preschool; Conjunctiva; Female; Glaucoma Drainage Implants; Humans; Hydrop | 2019 |
XEN Gel Stent to Treat ICE Syndrome: 4 Cases.
Topics: Adult; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma Drainage Implants; Glauco | 2019 |
Change in visual acuity 12 and 24 months after transscleral ab interno glaucoma gel stent implantation with adjunctive Mitomycin C.
Topics: Aged; Female; Follow-Up Studies; Gels; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pre | 2019 |
[Trabeculectomy with Ologen® implant and bevacizumab].
Topics: Bevacizumab; Collagen; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin; Retrospective St | 2020 |
Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
Topics: Adult; Aged; Alkylating Agents; Collagen; Female; Fibrosis; Follow-Up Studies; Glaucoma; Glaucoma Dr | 2019 |
Trabeculectomy followed by phacoemulsification versus trabeculectomy alone: The Collaborative Bleb-Related Infection Incidence and Treatment Study.
Topics: Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Ma | 2019 |
Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Dry Needling; Female; Glaucoma Drainage Implants; | 2020 |
XEN® stent complications: a case series.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Anterior Eye Segment; Aqueous Humor; Glaucoma Drainage I | 2019 |
Comments on: Mid-term outcome of mitomycin C-augmented trabeculectomy in open-angle glaucoma versus angle-closure glaucoma.
Topics: Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabeculecto | 2020 |
Response to comments on: Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle-closure glaucoma.
Topics: Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabeculecto | 2020 |
Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C.
Topics: Animals; Antimetabolites; Conjunctiva; Disease Models, Animal; Dogs; Filtering Surgery; Glaucoma; In | 2019 |
Hypotony Keratopathy Following Trabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Corneal Edema; Female; Glaucoma, Open-Angle; Humans; Int | 2020 |
Response to: Mitomycin C-augmented Phacotrabeculectomy Versus Phacoemulsification in Primary Angle-closure Glaucoma: A Randomized Controlled Study.
Topics: Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Mitomycin; Phacoemulsification; Trabeculectom | 2020 |
Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report.
Topics: Antibiotics, Antineoplastic; Choroidal Effusions; Chronic Disease; Glaucoma; Humans; Intraocular Pre | 2020 |
Mitomycin C-augmented Phacotrabeculectomy Versus Phacoemulsification in Primary Angle-closure Glaucoma: A Randomized Controlled Study.
Topics: Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Mitomycin; Phacoemulsification; Trabeculectom | 2020 |
A standardized protocol of laser suture lysis in postoperative management in trabeculectomy with mitomycin C: One-year study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Clinical Protocols; Device Removal; Female; Glaucoma, Op | 2021 |
Comparison of early versus late laser goniopuncture following deep sclerectomy for the management of open-angle glaucoma.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressu | 2020 |
The Tenons' Layer Reposition Approach of Trabeculectomy: A Longitudinal Case Series of a Mixed Group of Glaucoma Patients.
Topics: Adult; Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 2020 |
Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Endothelium, | 2020 |
Reoperations for Complications Within 90 Days After Glaucoma Surgery.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Ciliary Body; Female; Glaucoma; Glaucoma Drainage | 2020 |
A Comparison of Trabeculectomy Surgery Outcomes With Mitomycin-C Applied by Intra-Tenon Injection Versus Sponge.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma; Humans; Injections, Intraocula | 2020 |
Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C.
Topics: Aged; Alkylating Agents; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocul | 2020 |
Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study.
Topics: Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Prospective Studies; Trabeculectomy; Tre | 2020 |
Early Postoperative Intraocular Pressure is Associated With Better Pressure Control After XEN Implantation.
Topics: Adult; Aged; Exfoliation Syndrome; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; | 2020 |
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2020 |
Response to: Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2020 |
Bleb Plication for a Leaking Bleb After Trabeculectomy.
Topics: Adult; Aged, 80 and over; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; M | 2020 |
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2020 |
Response to letter to the Editor Regarding MMC and pH.
Topics: Blister; Filtering Surgery; Glaucoma; Humans; Hydrogen-Ion Concentration; Intraocular Pressure; Mito | 2020 |
Comparing Treatment Outcomes from the Tube Versus Trabeculectomy and Primary Tube Versus Trabeculectomy Studies.
Topics: Aged; Alkylating Agents; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocul | 2021 |
The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy.
Topics: Adult; Aged; Alkylating Agents; Cataract; Collagen; Drug Combinations; Female; Glaucoma, Open-Angle; | 2021 |
Scheimpflug Corneal Densitometry Changes After Trabeculectomy.
Topics: Aged; Alkylating Agents; Cell Count; Cornea; Densitometry; Female; Follow-Up Studies; Glaucoma, Open | 2021 |
Glaucoma Drainage Device Technique in a Cohort of Experienced Glaucoma Surgeons in Australia and New Zealand.
Topics: Adult; Aged; Alkylating Agents; Australia; Cohort Studies; Female; Glaucoma; Glaucoma Drainage Impla | 2020 |
Needling revision with marking maneuver to locate the scleral flap.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Pilot Projects; Prospective Studies; | 2021 |
Does bleb needling augmented by mitomycin C or 5-fluorouracil share similar efficacy with no antimetabolites?
Topics: Antimetabolites; Fluorouracil; Humans; Intraocular Pressure; Mitomycin; Nucleic Acid Synthesis Inhib | 2021 |
Comparison of Gonioscopy-assisted Transluminal Trabeculotomy Versus Trabeculectomy With Mitomycin C in Patients With Open-angle Glaucoma.
Topics: Cohort Studies; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; M | 2021 |
Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study.
Topics: Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Tonometry | 2021 |
Injected Versus Sponge-Applied Mitomycin C (MMC) During Modified Trabeculectomy in New Zealand White Rabbit Model.
Topics: Animals; Humans; Intraocular Pressure; Mitomycin; Rabbits; Sclera; Tonometry, Ocular; Trabeculectomy | 2020 |
Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study.
Topics: Follow-Up Studies; Gels; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Press | 2020 |
Outcome of Bleb Revision With Autologous Conjunctival Graft Alone or Combined With Donor Scleral Graft for Late-onset Bleb Leakage With Hypotony After Standard Trabeculectomy With Mitomycin C.
Topics: Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Postoperative Complications; Reoperatio | 2021 |
Outcomes and risk factors for failure after trabeculectomy in Taiwanese patients: medical chart reviews from 2006 to 2017.
Topics: Adult; Aged; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retr | 2022 |
[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C].
Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
Exact matching of trabectome-mediated ab interno trabeculectomy to conventional trabeculectomy with mitomycin C followed for 2 years.
Topics: Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Phacoemulsification; Retrospective Studi | 2021 |
A PVDF electrospun antifibrotic composite for use as a glaucoma drainage implant.
Topics: Aqueous Humor; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin | 2021 |
Outcome of repeat trabeculectomy with mitomycin C in isolation or combined with phacoemulsification.
Topics: Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Phacoemulsificatio | 2021 |
Comments on: Intraoperative injection versus sponge applied mitomycin C during trabeculectomy: One year study.
Topics: Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2021 |
Comments on: Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study.
Topics: Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2021 |
Reply to comments on: Intraoperative injection versus sponge-Applied mitomycin C during trabeculectomy: One - year study.
Topics: Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2021 |
Response to comments on: Intraoperative injection versus sponge-applied Mitomycin C during trabeculectomy: One-year study.
Topics: Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2021 |
Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort.
Topics: Child; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; | 2021 |
Letter to the Editor: Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-A Collagen Matrix Implant: A 3-Year Follow-up Study.
Topics: Collagen; Follow-Up Studies; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin | 2021 |
National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK.
Topics: Glaucoma; Humans; Intraocular Pressure; Ireland; Mitomycin; Trabeculectomy; United Kingdom | 2021 |
Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model.
Topics: Animals; Conjunctiva; Disease Models, Animal; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pre | 2021 |
Common and rare complications following filtering surgery for children with congenital glaucoma; a5 years study.
Topics: Child; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complicat | 2021 |
Prospective Evaluation of the First Mitomycin C Augmented Needle Revision in Patients With Failed Nonpenetrating Deep Sclerectomy.
Topics: Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Sclerostomy; Tonometry, Ocular; Trabecul | 2021 |
Evaluating CO
Topics: Adult; Carbon Dioxide; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lasers; Mitomyc | 2021 |
The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery.
Topics: Animals; Filtering Surgery; Glaucoma; Intraocular Pressure; Male; Mitomycin; Pyridones; Rabbits; Tra | 2021 |
Outcomes of primary trabeculectomy with mitomycin-C for primary angle closure glaucoma among supervised trainees in a tertiary eye center in Manila.
Topics: Follow-Up Studies; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Mitomycin; Philippines; Re | 2021 |
Long-term treatment outcomes for congenital ectropion uveae with ptosis and glaucoma.
Topics: Ectropion; Glaucoma; Humans; Intraocular Pressure; Iris Diseases; Mitomycin; Trabeculectomy; Treatme | 2020 |
Comparative outcome analysis of bleb needling of fibrotic blebs in the clinic versus the operating room: a retrospective case series.
Topics: Adult; Humans; Intraocular Pressure; Mitomycin; Operating Rooms; Reoperation; Retrospective Studies; | 2021 |
Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes.
Topics: COVID-19; Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; R | 2021 |
Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Trabecul | 2022 |
Augmented trabeculectomy-outcomes of first hundred versus second hundred surgeries of a fellowship-trained glaucoma surgeon.
Topics: Fellowships and Scholarships; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; | 2022 |
Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia.
Topics: Adolescent; Adult; Alkylating Agents; Aniridia; Cataract Extraction; Child; Child, Preschool; Combin | 2021 |
Trans-conjunctival Erosion of a Novel SIBS Microshunt After Revision Surgery Using Mitomycin C.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Reoperation; Tonometry, Ocular | 2021 |
Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction.
Topics: Aged; Anterior Eye Segment; Cross-Linking Reagents; Drug Implants; Female; Filtering Surgery; Follow | 2022 |
Cross-linked hyaluronic acid viscoelastic scleral implant in trabeculectomy.
Topics: Follow-Up Studies; Humans; Hyaluronic Acid; India; Intraocular Pressure; Mitomycin; Prospective Stud | 2021 |
Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15 mmHg.
Topics: Female; Humans; Intraocular Pressure; Japan; Low Tension Glaucoma; Male; Middle Aged; Mitomycin; Ret | 2021 |
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study.
Topics: Adolescent; Angiogenesis Inhibitors; Bevacizumab; Follow-Up Studies; Glaucoma, Open-Angle; Humans; I | 2022 |
Modifications to Combined Trabeculectomy and Manual Small Incision Cataract Surgery: Outcomes and Adaptability in Resource-constrained Areas.
Topics: Adult; Aged; Cataract; Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Ophthalmology; Re | 2021 |
Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma.
Topics: Child; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomy | 2021 |
Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients.
Topics: Cataract; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
Outcomes of Primary Trabeculectomy From Two Same-centre Cohorts 10 Years Apart.
Topics: Antimetabolites; Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; | 2021 |
Long-term outcomes of initial trabeculectomy in glaucoma associated with granulomatous and non-granulomatous uveitis.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; R | 2021 |
Changes in the morphology of the hyperemic blebs in eyes undergone trabeculectomy with mitomycin C after injection of triamcinolone acetonide during one-year follow-up.
Topics: Conjunctiva; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Mitom | 2021 |
Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention.
Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci | 2022 |
Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
Topics: Collagen; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin; | 2022 |
Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique.
Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2022 |
Response to Letter to the Editor: Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-A Collagen Matrix Implant: A 3-Year Follow-up Study.
Topics: Collagen; Follow-Up Studies; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin | 2021 |
Novel Bacterial Cellulose Membrane to Reduce Fibrosis Following Trabeculectomy.
Topics: Animals; Cellulose; Conjunctiva; Fibrosis; Intraocular Pressure; Mitomycin; Rabbits; Sclera; Trabecu | 2021 |
RETINAL TOXICITY FOLLOWING PRESUMED INADVERTENT INTRAOCULAR INJECTION OF MITOMYCIN C DURING TRABECULECTOMY.
Topics: Glaucoma; Humans; Injections, Intraocular; Intraocular Pressure; Mitomycin; Retina; Trabeculectomy | 2023 |
Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Trabecu | 2021 |
Letter to the Editor: Outcome of Bleb Revision With Autologous Conjunctival Graft Alone or Combined With Donor Scleral Graft for Late-onset Bleb Leakage With Hypotony After Standard Trabeculectomy With Mitomycin C.
Topics: Conjunctiva; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2021 |
Response to Letter to the Editor: Outcome of Bleb Revision With Autologous Conjunctival Graft Alone or Combined With Donor Scleral Graft for Late-onset Bleb Leakage With Hypotony After Standard Trabeculectomy With Mitomycin C.
Topics: Conjunctiva; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2021 |
Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
Topics: Adult; Alkylating Agents; Behcet Syndrome; Combined Modality Therapy; Conjunctiva; Female; Glaucoma; | 2017 |
[Early atrophy of the conjunctiva after trabeculectomy with mitomycin C and collagen matrix implant].
Topics: Aged; Atrophy; Collagen; Conjunctiva; Female; Humans; Intraocular Pressure; Mitomycin; Trabeculectom | 2018 |
Outcomes for Ab Interno Bleb Revision With a Novel Translimbal Sclerostomy Spatula.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; F | 2017 |
Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures.
Topics: Antibiotics, Antineoplastic; Blister; Conjunctiva; Female; Follow-Up Studies; Humans; Intraocular Pr | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag | 2017 |
Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma.
Topics: Administration, Topical; Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Eq | 2017 |
Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society.
Topics: Alkylating Agents; Cataract; Female; Filtering Surgery; Fluorouracil; Glaucoma Drainage Implants; Gl | 2017 |
Intermediate Term Outcomes of Early Posttrabeculectomy Bleb Leaks Managed by Large Diameter Soft Bandage Contact Lens.
Topics: Adult; Alkylating Agents; Bandages; Contact Lenses, Hydrophilic; Female; Glaucoma; Humans; Intraocul | 2017 |
Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Humans; Intraocular Pressure; Japan; Low Tensi | 2017 |
Posterior Surgical Revision of Failed Fornix-based Trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antihypertensive Agents; Conjunctiva; F | 2017 |
Primary Trabeculectomy Outcomes by Glaucoma Fellows in a Tertiary Hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Brazil; Education, Medical, Graduate; Fe | 2017 |
Same-site surgical revision of failed trabeculectomy blebs with mitomycin C augmentation: long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie | 2018 |
Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M | 2017 |
Two-year Results After Deep Sclerectomy With Nonabsorbable Uveoscleral Implant (Esnoper-Clip): Surgical Area Analysis Using Anterior Segment Optical Coherence Tomography.
Topics: Aged; Aged, 80 and over; Anterior Eye Segment; Antibiotics, Antineoplastic; Antihypertensive Agents; | 2017 |
The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma.
Topics: Adolescent; Adult; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Female; Glaucoma, Open-A | 2018 |
Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Collagen; Female; Follow-Up Studies; Glaucoma; Glycosami | 2018 |
Prospective evaluation of CO
Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidenc | 2018 |
Trabeculectomy Outcomes After Glaucoma Drainage Device Surgery.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma; Glaucoma Drainage Implants; Hum | 2018 |
Trabeculectomy With Mitomycin-C: Outcomes and Risk Factors for Failure in Primary Angle-closure Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Angle-Closur | 2018 |
Short-term change in higher-order aberrations after mitomycin-C-augmented trabeculectomy.
Topics: Antibiotics, Antineoplastic; Cornea; Corneal Topography; Corneal Wavefront Aberration; Female; Follo | 2019 |
Rescue of failing or failed trabeculectomy blebs with slit-lamp needling and adjunctive mitomycin C in Indian eyes.
Topics: Adult; Aged; Alkylating Agents; Female; Follow-Up Studies; Gonioscopy; Humans; Incidence; India; Int | 2018 |
Comparison of surgical outcomes between canaloplasty and trabeculectomy with mitomycin C at 2-year follow-up: A longitudinal cohort study.
Topics: Aged; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidence; Intraoc | 2018 |
Optical Coherence Tomography Angiography Description of Ocular Decompression Retinopathy After Deep Sclerectomy in Traumatic Glaucoma.
Topics: Alkylating Agents; Decompression, Surgical; Eye Injuries; Fluorescein Angiography; Glaucoma, Open-An | 2018 |
Trypan Blue for the Assessment of Filtering Bleb Function During Cataract Surgery.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Coloring Agents; Combined Modality Therapy; Conjunctiva; | 2018 |
Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations.
Topics: Aged; Alkylating Agents; Female; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Intraocular | 2018 |
Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery.
Topics: Adult; Combined Modality Therapy; Glaucoma; Humans; Hydrophthalmos; Intraocular Pressure; Male; Mito | 2018 |
Results of an Adaptive Surgical Approach for Managing Late Onset Hypotony After Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Blister; Combined Modality Therapy; Female; Glaucoma; Humans; Intrao | 2018 |
Ab Interno Gel Implant-associated Bleb-related Infection.
Topics: Aged; Alkylating Agents; Anti-Bacterial Agents; Endophthalmitis; Female; Follow-Up Studies; Gelatin; | 2018 |
Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children.
Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Equipment Design; Female; Follow-U | 2018 |
Glaucoma With Crouzon Syndrome.
Topics: Alkylating Agents; Anterior Eye Segment; Biometry; Child; Combined Modality Therapy; Corneal Pachyme | 2018 |
Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C.
Topics: Administration, Topical; Adolescent; Adult; Age Distribution; Age Factors; Aged; Alkylating Agents; | 2018 |
Comment on: Viscoelastic-augmented trabeculectomy - A newer concept.
Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Sclera; Trabeculecto | 2018 |
[Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant].
Topics: Collagen; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; Intrao | 2019 |
Trabeculectomy Following Failed Ab Interno Gelatin Microstent: Case Series.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; | 2018 |
Observational Outcomes of Initial Trabeculectomy With Mitomycin C in Patients of African Descent vs Patients of European Descent: Five-Year Results.
Topics: Aged; Alkylating Agents; Black or African American; Combined Modality Therapy; Female; Follow-Up Stu | 2018 |
Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study.
Topics: Animals; Anti-Inflammatory Agents; Blister; Conjunctiva; Disease Models, Animal; Drug Therapy, Combi | 2018 |
Trabeculectomy With Mitomycin-C: Outcomes and Risk Factors for Failure in Primary Angle-closure Glaucoma.
Topics: Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Mitomycin; Risk Factors; Trabeculectomy | 2018 |
One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Exfoliation Syndro | 2019 |
Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure.
Topics: Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Male | 2018 |
XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases.
Topics: Aged; Alkylating Agents; Dexamethasone; Drug Implants; Female; Glaucoma Drainage Implants; Glucocort | 2019 |
Trabeculectomy with subconjunctival collagen implant in Indian eyes: Long-term results.
Topics: Adult; Alkylating Agents; Collagen; Conjunctiva; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gl | 2018 |
Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report.
Topics: Alkylating Agents; Anterior Chamber; Chronic Disease; Filtering Surgery; Glaucoma; Humans; Intraocul | 2019 |
Outcomes of Laser Goniopuncture Following Nonpenetrating Deep Sclerectomy With Mitomycin C: A Large Retrospective Cohort Study.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Glaucoma | 2019 |
Determinants of Corneal Endothelial Cell Loss After Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Combined Modality Therapy; Corneal En | 2019 |
Cataract extraction after deep sclerectomy and its effect on intraocular pressure control.
Topics: Age Factors; Aged; Analysis of Variance; Cataract; Cataract Extraction; Female; Humans; Intraocular | 2019 |
Smaller-incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucom | 2019 |
The treatment of ocular hypotony after trabeculectomy with a scleral lens: A case series.
Topics: Adolescent; Aged; Alkylating Agents; Child; Contact Lenses; Female; Humans; Intraocular Pressure; Ma | 2019 |
1-year outcomes of the Xen45 glaucoma implant.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma Drainage Implants; Glaucom | 2019 |
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Child; Child, Preschool; Do | 2019 |
Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Collagen; Exfoliation Syndrome; Female; Glauco | 2019 |
The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series.
Topics: Adult; Alkylating Agents; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomyc | 2019 |
One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma.
Topics: Adult; Aged; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Male; Middle Aged; Mitom | 2019 |
[Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety].
Topics: Aged; Bevacizumab; Collagen; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Trabecu | 2020 |
Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma.
Topics: Aged; Aged, 80 and over; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pre | 2020 |
Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model.
Topics: Absorbable Implants; Animals; Drug Delivery Systems; Drug Implants; Drug Liberation; Endophthalmitis | 2019 |
Bilateral decompression retinopathy after deep sclerectomy with mitomycin C in a child with tubulointerstitial nephritis and uveitis syndrome.
Topics: Alkylating Agents; Child; Combined Modality Therapy; Female; Humans; Intraocular Pressure; Mitomycin | 2020 |
Response: Smaller Incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Topics: Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2019 |
Smaller-incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Topics: Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy | 2019 |
pH of Mitomycin-C Formulations for Filtration Surgery.
Topics: Chemistry, Pharmaceutical; Combined Modality Therapy; Drug Compounding; Filtering Surgery; Humans; H | 2019 |
A complex case of haemodialysis induced increased intraocular pressure.
Topics: Acetazolamide; Antihypertensive Agents; Diabetes Mellitus, Type 1; Glaucoma, Neovascular; Humans; In | 2019 |
Bleb Needling with Mitomycin C as Adjunctive Therapy in Failing Blebs: A Retrospective Study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctival Diseases; Female; Glaucoma, Open-Angle; Hum | 2019 |
Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study.
Topics: Adult; Aged; Case-Control Studies; Combined Modality Therapy; Female; Glaucoma; Glaucoma, Open-Angle | 2019 |
Comparison of 2-year-results of mitomycin C-augmented trabeculectomy with or without cataract extraction in glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 2019 |
Long-term Results of Trabeculectomy With Mitomycin-C in Patients With Bilateral Acute Iris Transillumination.
Topics: Acute Disease; Adult; Aged; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Female; Follow- | 2019 |
Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma.
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intra | 2019 |
Remodeling an Avascular Bleb.
Topics: Adult; Alkylating Agents; Amnion; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomyci | 2019 |
[Ocular decompression retinopathy with pre-retinal hemorrhage after trabeculectomy: A case report].
Topics: Child; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Mitomycin; Postoperative Hemorr | 2019 |
Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops.
Topics: Female; Follow-Up Studies; Glaucoma; Humans; Incidence; Intraocular Pressure; Japan; Male; Middle Ag | 2020 |
Can intraoperative intraocular pressure during primary trabeculectomy predict early postoperative pressure?
Topics: Adult; Aged; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; In | 2014 |
Deep sclerectomy with bevacizumab and mitomycin C: a comparative study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2015 |
Using the early postoperative intraocular pressure to predict pressure control after a trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2014 |
Surgical management of secondary glaucoma in Fuchs' heterochromic iridocyclitis.
Topics: Adult; Aged; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; | 2013 |
Can augmented trabeculectomies cause iatrogenic melanoma?
Topics: Alkylating Agents; Chemotherapy, Adjuvant; Conjunctival Neoplasms; Eye Enucleation; Female; Glaucoma | 2014 |
Polypropylene vs silicone Ahmed valve with adjunctive mitomycin C in paediatric age group: a prospective controlled study.
Topics: Alkylating Agents; Analysis of Variance; Child; Child, Preschool; Female; Glaucoma; Glaucoma Drainag | 2013 |
Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Endotamponade; Female; Follow-Up Studies; Glaucom | 2014 |
A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C.
Topics: Aged; Alkylating Agents; Cataract; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intra | 2013 |
Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Catheterization; Exfolia | 2013 |
Intracameral ranibizumab and subsequent mitomycin C augmented trabeculectomy in neovascular glaucoma.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Combined Modality The | 2014 |
Comparison of trabeculectomy with mitomycin-C versus medical treatment in moderate stage of steroid induced glaucoma.
Topics: Administration, Topical; Adolescent; Adult; Alkylating Agents; Child; Combined Modality Therapy; Fem | 2013 |
Secondary subconjunctival implantation of a biodegradable collagen-glycosaminoglycan matrix to treat ocular hypotony following trabeculectomy with mitomycin C.
Topics: Absorbable Implants; Aged; Aged, 80 and over; Alkylating Agents; Collagen; Combined Modality Therapy | 2013 |
Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery.
Topics: Administration, Topical; Analysis of Variance; Animals; Anti-Infective Agents, Local; Antibiotics, A | 2013 |
Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Child, Preschool; Female; Glau | 2013 |
Outcomes of same-site re-operation with minimal use of mitomycin in failed trabeculectomy.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Female; Glaucom | 2014 |
Epiconjunctival mitomycin-C application for early failing filtering blebs.
Topics: Alkylating Agents; Conjunctiva; Female; Fibrosis; Glaucoma; Humans; Intraocular Pressure; Male; Midd | 2014 |
Postoperative flat anterior chamber: incidence, risk factors, and effect on the long-term success of trabeculectomy.
Topics: Alkylating Agents; Anterior Chamber; Female; Glaucoma; Humans; Incidence; Intraocular Pressure; Male | 2013 |
Secondary glaucoma due to chronic scleritis: trabeculectomy in scleromalacia: a case report.
Topics: Aged; Alkylating Agents; Chronic Disease; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; I | 2014 |
Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cohort Studies; Female; Glaucom | 2014 |
Comparison of Surgical Outcomes Between Phacocanaloplasty and Phacotrabeculectomy at 12 Months' Follow-up: A Longitudinal Cohort Study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; | 2015 |
Fornix-based Trabeculectomy With Mitomycin C Using the Horizontal Conjunctival Suture Technique.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma; Humans; Intraocula | 2015 |
Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Collagen; Combined Modality Therapy; Female; Glaucoma; G | 2014 |
Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Anterior Eye Segment; Combined Modality Therapy; Cross-S | 2014 |
Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C.
Topics: Aged; Alkylating Agents; Female; Fluorouracil; Glaucoma; Gonioscopy; Humans; Intraocular Pressure; L | 2014 |
Challenging cases of ocular injection and increased intraocular pressure.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Dilatation, Pathologic; Female; Gonioscopy; Hum | 2014 |
Reply to Kivelä et al.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2014 |
Interval censoring and competing risks when reporting results of glaucoma surgery.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2014 |
Long-term outcomes of resident- versus attending-performed primary trabeculectomy with mitomycin C in a United States residency program.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Clinical Competence; Cohort Studies; Combined Mod | 2014 |
Iridocorneal endothelial syndrome in a Chinese child.
Topics: Child; Combined Modality Therapy; Filtering Surgery; Humans; Intraocular Pressure; Iridocorneal Endo | 2013 |
Traumatic aniridia after trabeculectomy.
Topics: Aniridia; Eye Injuries; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Middle Aged; Mitomycin; | 2014 |
Corneal decompensation following bleb needling with 0.01% mitomycin C: a case study.
Topics: Aged; Alkylating Agents; Cataract; Combined Modality Therapy; Conjunctiva; Corneal Edema; Female; Gl | 2014 |
Efficacy and safety of mitomycin C--augmented revisions of non-functioning filtering blebs after trabeculectomy--7 year results.
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; Male; M | 2013 |
Qualitative and quantitative analysis of filtering blebs with optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma; Humans; Intraocula | 2014 |
CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Topics: Alkylating Agents; Animals; Chitosan; Conjunctiva; Disease Models, Animal; Drug Carriers; Fibrosis; | 2014 |
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Topics: Adult; Aged; Blister; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Male; M | 2014 |
Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.
Topics: Aged; Alkylating Agents; Anthracenes; Antihypertensive Agents; Collagen; Combined Modality Therapy; | 2015 |
Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique.
Topics: Administration, Topical; Adult; Cysts; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implan | 2014 |
Conjunctival Advancement With Subconjunctival Amniotic Membrane Draping Technique for Leaking Cystic Blebs.
Topics: Adult; Aged; Alkylating Agents; Amnion; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; | 2016 |
Safety And Efficacy Of Achieving Single-Digit Intraocular Pressure Targets With Filtration Surgery In Eyes With Progressive Normal-Tension Glaucoma.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Humans; Intraocular Pressure; Low Tension Glauco | 2016 |
Long-term outcomes of needle revision of failing deep sclerectomy blebs.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans | 2015 |
Incidence of Postoperative Ptosis Following Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Alkylating Agents; Blepharoptosis; Female; Glaucoma; Humans; Incidence; Intraocular Pre | 2015 |
The Long-term Outcomes of Glaucoma Drainage Device in Pediatric Glaucoma.
Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma; Glaucom | 2016 |
Combined deep sclerectomy and descemet stripping automated endothelial keratoplasty.
Topics: Aged; Aged, 80 and over; Cell Count; Cornea; Corneal Edema; Descemet Stripping Endothelial Keratopla | 2014 |
Risk Factors for a Severe Bleb Leak Following Trabeculectomy: A Retrospective Case-Control Study.
Topics: Age Factors; Aged; Alkylating Agents; Case-Control Studies; Female; Glaucoma; Humans; Intraocular Pr | 2015 |
Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography.
Topics: Aged; Alkylating Agents; Aqueous Humor; Conjunctiva; Cross-Sectional Studies; Female; Fistula; Glauc | 2015 |
Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery.
Topics: Adult; Aged; Alkylating Agents; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Biomarkers; | 2016 |
Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction.
Topics: Alkylating Agents; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-An | 2015 |
Outcomes of chronic hypotony following trabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Chronic Disease; Female; Glaucoma; Humans; Intraocular P | 2015 |
Visual improvement following glaucoma surgery: a case report.
Topics: Alkylating Agents; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Male; Middle Aged | 2014 |
Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.
Topics: Adult; Aged; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Female; Follow-Up Studies; Gla | 2016 |
Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2015 |
Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon.
Topics: Adult; Aged; Alkylating Agents; Conjunctiva; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Hum | 2015 |
Nonpenetrating deep sclerectomy for glaucoma after descemet stripping automated endothelial keratoplasty: three consecutive case reports.
Topics: Administration, Topical; Aged; Descemet Stripping Endothelial Keratoplasty; Female; Glaucoma; Humans | 2015 |
Histopathological findings of a 1-month-old Ologen implant.
Topics: Absorbable Implants; Alkylating Agents; Collagen; Combined Modality Therapy; Device Removal; Glaucom | 2015 |
Monitoring corneal densities following primary pterygium excision with adjuvant topical mitomycin-C application--an observational study of corneal scar changes.
Topics: Adult; Aged; Alkylating Agents; Cell Count; Combined Modality Therapy; Cornea; Female; Humans; Intra | 2015 |
Comparison of Superior Rectus and Peripheral Lamellar Corneal Traction Suture during Trabeculectomy.
Topics: Adult; Antihypertensive Agents; Cornea; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Human | 2016 |
Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients.
Topics: Child, Preschool; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; I | 2015 |
Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome.
Topics: Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Period; Iridocorne | 2016 |
Effect of a Fenestration Between an Intrascleral Lake and Supraciliary Space on Deep Sclerectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Ciliary Body; Combined Modality Th | 2016 |
Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Bevacizumab; Chemotherapy, Adjuvant; Disease Mo | 2015 |
The effect of adjustable suture (Khaw) trabeculectomy on intraocular pressure: a retrospective case series.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mi | 2016 |
The Degradation of Mitomycin C Under Various Storage Methods.
Topics: Alkylating Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; | 2016 |
Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Bacteria; Combined Modality Therapy; Conjunctiva; | 2016 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endop | 2016 |
Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-U | 2015 |
Outcomes of Bleb Revision With Mitomycin C After Ex-PRESS Shunt Surgery.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma Drainage Implants; Glaucoma, Op | 2016 |
Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure | 2015 |
[One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Filtering Surgery; Glaucoma; Humans; Intr | 2015 |
Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results.
Topics: Alkylating Agents; Combined Modality Therapy; Drug Implants; Female; Glaucoma, Open-Angle; Humans; H | 2016 |
A Novel Method for the Delivery of Antimetabolites During Glaucoma Surgery.
Topics: Antimetabolites; Drug Delivery Systems; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postopera | 2016 |
Outcomes of Trabeculectomy With Transconjunctival Application Versus Subconjunctival Application of Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Cohort Studies; Combined Modality Therapy; Conjun | 2016 |
Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; | 2015 |
A rare case of primary congenital glaucoma in combination with neurofibromatosis 1: a case report.
Topics: Alkylating Agents; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Hydrophthalmos; Infan | 2015 |
Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens.
Topics: Adolescent; Adult; Aged; Child; Female; Glaucoma; Humans; Intraocular Pressure; Lens Subluxation; Le | 2016 |
Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Conjunctiva; Exfoliation Sy | 2017 |
A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Syndrome; F | 2016 |
Three-Year Follow-up of a Novel Aqueous Humor MicroShunt.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Anterior Chamber; Aqueous Humor; Female; Follow-U | 2016 |
Intraoperative transconjunctival mitomycin-C application for needle revision of trabeculectomy.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Glaucoma | 2016 |
Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease.
Topics: Adult; Alkylating Agents; Cohort Studies; Combined Modality Therapy; Conjunctiva; Female; Glaucoma; | 2016 |
Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Cataract Extraction; Female; Glaucoma; Humans; Intraocular Pressure; | 2014 |
Transconjunctival Revision With Mitomycin-C Following Failed Trabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Fluorour | 2016 |
Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Human | 2016 |
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliatio | 2016 |
Evaluation of Corneal Biomechanics After Excimer Laser Corneal Refractive Surgery in High Myopic Patients Using Dynamic Scheimpflug Technology.
Topics: Adult; Biomechanical Phenomena; Cornea; Female; Humans; Intraocular Pressure; Keratomileusis, Laser | 2017 |
Trabeculectomy with ologen in secondary glaucomas following failed trabeculectomy with MMC: comparative study.
Topics: Alkylating Agents; Collagen; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Glycosaminoglyca | 2016 |
Tube Fenestration in the Tube Versus Trabeculectomy Study.
Topics: Aged; Alkylating Agents; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; | 2016 |
Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study.
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Predictiv | 2016 |
Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Drug T | 2017 |
Same-site Trabeculectomy Revision for Failed Trabeculectomy: Outcomes and Risk Factors for Failure.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 2016 |
Trabeculectomy and Combined Phacoemulsification-Trabeculectomy: Outcomes and Risk Factors for Failure in Primary Angle Closure Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma, Angle-Closure; Hum | 2016 |
Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma.
Topics: Aged; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Ag | 2016 |
The Combination of PlGF Inhibition and MMC as a Novel Anti-Scarring Strategy for Glaucoma Filtration Surgery.
Topics: Animals; Anterior Chamber; Blood Proteins; Cicatrix; Disease Models, Animal; Filtering Surgery; Glau | 2016 |
α5β1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model.
Topics: Administration, Topical; Alkylating Agents; Aminoquinolines; Animals; Collagen; Conjunctiva; Disease | 2017 |
Re: Panarelli et al.: A retrospective comparison of primary Baerveldt implantation versus trabeculectomy with mitomycin C (Ophthalmology 2016;123:789-95).
Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Postoperative Complic | 2016 |
Revision of trabeculectomy filtering blebs with mitomycin C: Long term results.
Topics: Aged; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Nucleic Ac | 2016 |
Bleb Morphology After Needling With Viscoelastic of an Ab Interno Microstent Assessed by Optical Coherence Tomography.
Topics: Alkylating Agents; Conjunctiva; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; In | 2017 |
Outcome of repeat trabeculectomies: long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud | 2017 |
Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma.
Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Glaucoma; | 2017 |
Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Choroid Diseases; Glaucoma, Open-Angle; Humans; Intraocu | 2017 |
Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.
Topics: Aged; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; In | 2017 |
The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma.
Topics: Adult; Alkylating Agents; Antihypertensive Agents; Case-Control Studies; Cataract; Female; Glaucoma, | 2017 |
Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma.
Topics: Adult; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studies; Glaucoma; Humans; Intr | 2017 |
Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; | 2008 |
Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Cataract Extraction; Combined Modalit | 2008 |
Efficacy and safety of deep sclerectomy in uveitic glaucoma.
Topics: Adolescent; Adult; Child; Drug Delivery Systems; Female; Glaucoma; Glaucoma Drainage Implants; Human | 2009 |
Effects of topical mitomycin C on the ciliary body and intraocular pressure after PRK: an experimental study.
Topics: Administration, Topical; Alkylating Agents; Animals; Ciliary Body; Intraocular Pressure; Lasers, Exc | 2008 |
Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application.
Topics: Aged; Blister; Glaucoma; Humans; Incidence; Intraocular Pressure; Intraoperative Care; Middle Aged; | 2008 |
Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.
Topics: Adolescent; Age Distribution; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modalit | 2008 |
Trabeculectomy with mitomycin-C in neovascular galucoma patients.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma, Neovascular; Humans; Intraocul | 2008 |
Postvitrectomy posturing resulting in contralateral ocular hypotony.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Pos | 2008 |
Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Intraocular Pressure; Intraoperative Care; Male; Mid | 2008 |
Decompression retinopathy and possible risk factors.
Topics: Child; Decompression, Surgical; Eye Diseases; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci | 2009 |
Superior versus inferior Ahmed glaucoma valve implantation.
Topics: Adult; Antihypertensive Agents; Equipment Safety; Female; Follow-Up Studies; Glaucoma; Glaucoma Drai | 2009 |
Block suture for trabeculectomy using only 2 anchors.
Topics: Alkylating Agents; Conjunctiva; Glaucoma; Humans; Intraocular Pressure; Intraoperative Complications | 2008 |
Surgical reduction of dysesthetic blebs.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Glaucoma | 2008 |
Trabeculectomy surgery augmented with intra-Tenon injection of mitomycin C.
Topics: Aged; Blister; Choroid Diseases; Cysts; Eye Diseases; Glaucoma; Humans; Hyphema; Injections; Intraoc | 2008 |
Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Cell Count; Cell Size; Cell Survival; Combined Moda | 2008 |
Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; F | 2009 |
Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb.
Topics: Aged; Alkylating Agents; Blister; Combined Modality Therapy; Conjunctival Diseases; Diagnostic Techn | 2010 |
Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Fluorouracil; F | 2009 |
Modified deep sclerectomy (D-lectomy MMC) for primary open-angle glaucoma: preliminary results.
Topics: Aged; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Int | 2009 |
A thin honeycomb-patterned film as an adhesion barrier in an animal model of glaucoma filtration surgery.
Topics: Absorbable Implants; Animals; Blister; Conjunctival Diseases; Disease Models, Animal; Filtering Surg | 2009 |
Late-onset bleb leakage.
Topics: Aged; Blister; Fluorescein; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Ocular Hypotens | 2009 |
Adenovirus-mediated delivery of p27(KIP1) to prevent wound healing after experimental glaucoma filtration surgery.
Topics: Adenoviridae; Animals; Blotting, Western; Cell Line; Cell Proliferation; Cyclin-Dependent Kinase Inh | 2009 |
The increasingly iatrogenic indications for mitomycin C trabeculectomy over 10 years.
Topics: Alkylating Agents; Combined Modality Therapy; Corneal Transplantation; Female; Glaucoma; Humans; Iat | 2009 |
Correlation between optical coherence tomography scan and histological specimen of a filtering bleb.
Topics: Animals; Aqueous Humor; Blister; Conjunctiva; Disease Models, Animal; Female; Filtering Surgery; His | 2010 |
Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Education, Medical, Co | 2009 |
Conjunctival characteristics in primary open-angle glaucoma and modifications induced by trabeculectomy with mitomycin C: an in vivo confocal microscopy study.
Topics: Aged; Case-Control Studies; Conjunctiva; Conjunctival Diseases; Female; Glaucoma, Open-Angle; Humans | 2009 |
Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C.
Topics: Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage | 2009 |
Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bev | 2010 |
Noncontact in vivo scanning laser microscopy of filtering blebs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Blister; Combined Modality Therapy; Conju | 2009 |
Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.
Topics: Aged; Anterior Chamber; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chor | 2010 |
The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results.
Topics: Absorbable Implants; Aged; Anterior Chamber; Collagen; Conjunctival Diseases; Female; Follow-Up Stud | 2010 |
Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model.
Topics: Animals; Cell Adhesion; Chymases; Cicatrix; Conjunctiva; Fibrillar Collagens; Gene Expression Regula | 2009 |
Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy after glaucoma filtration surgery.
Topics: Aged; Alkylating Agents; Female; Glaucoma; Humans; Imaging, Three-Dimensional; Intraocular Pressure; | 2010 |
Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; Female; Follow-Up Studies; | 2011 |
Angle closure glaucoma.
Topics: Antihypertensive Agents; Cataract; Chronic Disease; Glaucoma, Angle-Closure; Humans; Intraocular Pre | 2009 |
Phacoemulsification and glaucoma.
Topics: Antihypertensive Agents; Cataract; Chronic Disease; Glaucoma, Angle-Closure; Humans; Intraocular Pre | 2009 |
Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma.
Topics: Cornea; Female; Glaucoma; Graft Survival; Humans; Intraocular Pressure; Keratoplasty, Penetrating; M | 2010 |
Recurrent anterior uveitis after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Female; Humans; Intraocular Pressure; Mal | 2009 |
Central retinal vein occlusion after nonperforating sclerectomy without mitomycin.
Topics: Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retinal Vein Occ | 2009 |
Phacotrabeculectomy without mitomycin C in primary angle-closure and open-angle glaucoma.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Clo | 2011 |
Application of handheld cautery for reduction of symptomatic circumferential trabeculectomy blebs.
Topics: Aged; Ambulatory Surgical Procedures; Blister; Conjunctival Diseases; Electrocoagulation; Female; Gl | 2010 |
Glaucoma surgery decreases the rates of localized and global visual field progression.
Topics: Algorithms; Disease Progression; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular P | 2010 |
Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2011 |
Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Topics: Adult; Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2010 |
Early trabeculectomy bleb walls on anterior-segment optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Conjunctiva; Cross-Sectional Studies; Fe | 2010 |
Three-year follow-up of the tube versus trabeculectomy study.
Topics: Antihypertensive Agents; Cataract Extraction; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implant | 2010 |
Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma.
Topics: Adult; Aged; Alkylating Agents; Disease Progression; Female; Follow-Up Studies; Humans; Intraocular | 2010 |
Postoperative IOP is related to intrascleral bleb height in eyes with clinically flat blebs following deep sclerectomy with collagen implant and mitomycin.
Topics: Aged; Aged, 80 and over; Blister; Collagen; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressu | 2010 |
Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal; | 2011 |
Pediatric Ahmed valves.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; | 2010 |
Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Equipment Design; Female; Follow-Up Studies; Glaucoma; Hu | 2010 |
Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mi | 2010 |
Mitomycin-C and pediatric Ahmed valves.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; | 2010 |
Imaging of blebs after phacotrabeculectomy with Ologen collagen matrix implants.
Topics: Aged; Blister; Case-Control Studies; Collagen; Female; Humans; Intraocular Pressure; Male; Mitomycin | 2011 |
The prognostic value of the wuerzburg bleb classification score for the outcome of trabeculectomy.
Topics: Antimetabolites; Blister; Combined Modality Therapy; Conjunctiva; Female; Fluorouracil; Follow-Up St | 2011 |
Posterior revision for failed blebs: long-term outcomes.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud | 2011 |
Chiasm-compressing rhabdomyosarcoma in a patient presumed to have juvenile-onset open-angle glaucoma.
Topics: Adult; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Magnetic Resonance Imaging; Male; Mitomyc | 2011 |
Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Combined Modality Therapy; Eye In | 2011 |
Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Cell Count; Child; Chi | 2011 |
[Corneal epitheliopathy following trabeculectomy with postoperative adjunctive 5-fluorouracil].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Combined Modality Therapy; Corne | 2010 |
Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cross-Linking Reagents; Femal | 2011 |
Trabeculectomy with mitomycin for open-angle glaucoma in phakic vs pseudophakic eyes after phacoemulsification.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Fema | 2011 |
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
Topics: Actins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Ce | 2011 |
Success rates of trabeculotomy for steroid-induced glaucoma: a comparative, multicenter, retrospective cohort study.
Topics: Adult; Alkylating Agents; Cohort Studies; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Int | 2011 |
Different modes of intraocular pressure reduction after three different nonfiltering surgeries and trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pres | 2011 |
Postoperative complications after glaucoma surgery for primary angle-closure glaucoma vs primary open-angle glaucoma.
Topics: Aged; Female; Fluorouracil; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Gonioscopy; Humans; Incid | 2011 |
Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Cornea; Female; Glaucoma; Humans; Intraocular Pr | 2013 |
A comparative study of trabeculectomy and the new clear-cornea filtering procedure, intrastromal diathermal keratostomy (IDK).
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cornea; Female; Filterin | 2012 |
Effect of trabeculectomy on ocular and corneal higher order aberrations.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Topography; Corneal Wavef | 2011 |
Vision loss and recovery after trabeculectomy: risk and associated risk factors.
Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Postoperative Complications; | 2011 |
Success rates of trabeculotomy for steroid-induced glaucoma: a comparative, multicenter, retrospective cohort study.
Topics: Cohort Studies; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Mitomycin; Mult | 2011 |
Success rates of trabeculotomy for steroid-induced glaucoma: a comparative, multicenter, retrospective cohort study.
Topics: Cohort Studies; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Mitomycin; Mult | 2011 |
Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months' follow-up.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Filtering Surg | 2011 |
Needling augmented with topical application of mitomycin C for management of bleb failure.
Topics: Administration, Topical; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Fibrosis | 2011 |
Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia.
Topics: Aged; Analysis of Variance; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Mal | 2012 |
Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma.
Topics: Adult; Antihypertensive Agents; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular | 2012 |
Progression of normal tension glaucoma in Kearns-Sayre syndrome over 10 years.
Topics: Adult; Alkylating Agents; Corneal Endothelial Cell Loss; Disease Progression; Female; Follow-Up Stud | 2012 |
Dramatic dysesthetic overhanging bleb.
Topics: Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Female; Glaucoma, Open-Angle; Human | 2011 |
Canaloplasty with intraoperative low dosage mitomycin C: a retrospective case series.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Fema | 2013 |
Impact of phacoemulsification on failure of trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Synd | 2012 |
Effects of trabeculectomy on posture-induced intraocular pressure changes over time.
Topics: Adult; Aged; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mi | 2012 |
Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty.
Topics: Alkylating Agents; Case-Control Studies; Descemet Stripping Endothelial Keratoplasty; Female; Glauco | 2012 |
Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C.
Topics: Animals; Anterior Chamber; Collagen; Conjunctiva; Delayed-Action Preparations; Dexamethasone; Filter | 2012 |
Effect of photorefractive keratectomy with mitomycin-C on corneal biomechanical features.
Topics: Adult; Alkylating Agents; Biomechanical Phenomena; Combined Modality Therapy; Cornea; Elasticity; Fe | 2012 |
Suppression of avascular bleb formation by a thin biodegradable film in a rabbit filtration surgery with mitomycin C.
Topics: Absorbable Implants; Alkylating Agents; Animals; Biocompatible Materials; Conjunctival Diseases; Dis | 2012 |
Prognostic risk factors for failure of trabeculectomy with mitomycin C after vitrectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma; Huma | 2012 |
Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study.
Topics: Alkylating Agents; Cataract Extraction; Combined Modality Therapy; Female; Follow-Up Studies; Glauco | 2014 |
Mitomycin-augmented non-penetrating deep sclerectomy: preoperative gonioscopy and postoperative perimetric, tonometric and medication trends.
Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma; Gonioscopy; Humans; Intraocu | 2013 |
Interval censoring for survival curves when reporting the results of glaucoma surgery.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2013 |
Response to Dulku and de Klerk and Moriarty.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2013 |
Comment on 'deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia'.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy | 2013 |
Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia.
Topics: Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Open-Angle; Human | 2014 |
Surgical outcome of mitomycin C-soaked collagen matrix implant in trabeculectomy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Collagen; Cross-Linking Reagents; Female; Follow-U | 2013 |
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
Topics: Absorbable Implants; Aged; Alkylating Agents; Cataract; Collagen; Female; Glaucoma; Glycosaminoglyca | 2013 |
Long-term outcomes of primary trabeculectomy in diabetic patients with primary open angle glaucoma.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Blood Glucose; Case-Control Studies; Diabetes Mell | 2013 |
Trabeculectomy with antiproliferative agents in uveitic glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineopla | 2002 |
Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant.
Topics: Adult; Aged; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Life Tables; Middle | 2002 |
Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans | 2002 |
Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glau | 2002 |
Modifying subsceral fluid pressure in an experimental model of mitomycin-C diffusion.
Topics: Diffusion; Humans; In Vitro Techniques; Intraocular Pressure; Intraoperative Care; Mitomycin; Models | 2002 |
Clinical experience of e-PTFE membrane implant surgery for refractory glaucoma.
Topics: Adult; Aged; Equipment Design; Female; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Huma | 2003 |
Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Glaucoma, Neovascular; Humans; | 2002 |
Subconjunctival injection of autologous platelet concentrate in the treatment of overfiltrating bleb.
Topics: Blood Platelets; Combined Modality Therapy; Conjunctiva; Female; Filtering Surgery; Glaucoma, Open-A | 2003 |
[The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract].
Topics: Animals; Antimetabolites, Antineoplastic; Cataract; Epithelial Cells; Female; Follow-Up Studies; Int | 2001 |
Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Aqueous Humor; Combined Mod | 2003 |
Five-year results of trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocular Pre | 2003 |
Fornix-based trabeculectomy using the 'anchoring' corneal suture technique.
Topics: Adult; Antibiotics, Antineoplastic; Asian People; Combined Modality Therapy; Conjunctiva; Cornea; Fe | 2003 |
[Non-penetrating trabecular surgery with application of mitomycin C].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Press | 2002 |
Transconjunctival mitomycin-C in needle revisions of failing filtering blebs.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Conjunctiva; Fe | 2003 |
The Armenian Eye Care Project: surgical outcomes of complicated paediatric glaucoma.
Topics: Adolescent; Anti-Bacterial Agents; Armenia; Child; Cohort Studies; Glaucoma; Humans; Intraocular Pre | 2003 |
Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Connective Tissue; Female; Glaucom | 2003 |
Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up.
Topics: Adult; Aged; Female; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Intrao | 2003 |
Suramin modulates wound healing of rabbit conjunctiva after trabeculectomy: comparison with mitomycin C.
Topics: Animals; Antimetabolites; Conjunctiva; Growth Substances; Intraocular Pressure; Intraoperative Care; | 2003 |
Optical coherence tomography assessment of retinal nerve fiber layer thickness changes after glaucoma surgery.
Topics: Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Interferometry; Intraocu | 2003 |
Mitomycin C Molteno tube implantation.
Topics: Humans; Intraocular Pressure; Intraoperative Care; Mitomycin; Molteno Implants; Ocular Hypertension | 2003 |
Correlation between the early morphological appearance of filtering blebs and outcome of trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Exfoliation Syndrome; Fem | 2003 |
[Clinical experiences and results of application of mitomycin C in trabeculectomy].
Topics: Aged; Choroid Diseases; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Intr | 2003 |
Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C.
Topics: Adult; Antibiotics, Antineoplastic; Child; Combined Modality Therapy; Conjunctival Diseases; Cysts; | 2003 |
Needling revision of failed filtering blebs after trabeculectomy: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Child, Preschool; Conjunctiva; Female; Fluorouracil; Follow-Up Studi | 2003 |
Amnion-shielded trabeculectomy.
Topics: Amnion; Aqueous Humor; Biological Dressings; Chronic Disease; Glaucoma; Humans; Intraocular Pressure | 2003 |
Mitomycin C trabeculectomy in an eye with cicatricial conjunctiva following amniotic membrane transplantation.
Topics: Adult; Amnion; Antibiotics, Antineoplastic; Biological Dressings; Cicatrix; Conjunctival Diseases; G | 2003 |
Aqueous shunt devices compared with trabeculectomy with Mitomycin-C for children in the first two years of life.
Topics: Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Glaucoma; Glaucoma Drainage I | 2003 |
Outcome of consecutive trabeculectomy.
Topics: Adolescent; Adult; Aged; Antimetabolites; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Intrao | 2004 |
Hypotonus maculopathy: magnetic resonance appearance.
Topics: Choroid Diseases; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Macula Lutea; Magnetic Resonan | 2004 |
[Postoperative results of non-penetrating trabeculectomy for primary open-angle glaucoma].
Topics: Adult; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Pos | 2004 |
Consultation section. Refractive surgical problem.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antihypertensive Agents; Astigmatism; Corneal | 2004 |
Combined trabeculectomy and vitrectomy for pseudophakic malignant glaucoma and extensive peripheral anterior synechia-induced secondary glaucoma.
Topics: Aged; Antibiotics, Antineoplastic; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Ir | 2004 |
Effect of temporal corneal phacoemulsification on intraocular pressure in eyes with prior trabeculectomy with an antimetabolite.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Case-Control Studies; Cornea; Female; Fluorouracil; | 2004 |
Upper eyelid retraction after glaucoma filtering surgery and topical application of mitomycin C.
Topics: Administration, Topical; Adolescent; Adult; Antibiotics, Antineoplastic; Conjunctiva; Eyelid Disease | 2004 |
Recurrent retinal haemorrhages after glaucoma surgery.
Topics: Adolescent; Antibiotics, Antineoplastic; Combined Modality Therapy; Fluorescein Angiography; Glaucom | 2004 |
Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C.
Topics: Antibiotics, Antineoplastic; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; | 2004 |
Bleb revision for hypotony maculopathy after trabeculectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blister; Combined Modality Therapy; Female; Humans; Intr | 2004 |
Clinical and anatomical reversal of long-term hypotony maculopathy.
Topics: Antibiotics, Antineoplastic; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; Middle Age | 2004 |
Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life.
Topics: Antibiotics, Antineoplastic; Aqueous Humor; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; In | 2004 |
Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2004 |
Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Cataract Extraction | 2004 |
Fornix vs limbal-based trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chi-Square Distribution; Cornea; Female | 2005 |
[Non-penetrating deep sclerectomy in the treatment of advanced cases of open angle glaucoma].
Topics: Anti-Bacterial Agents; Female; Glaucoma, Open-Angle; Humans; Hyaluronic Acid; Intraocular Pressure; | 2004 |
[Implication of non-perforating deep sclerectomy with amniotic membrane implantation for primary open-angle glaucoma].
Topics: Adolescent; Adult; Aged; Amnion; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocula | 2002 |
Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocu | 2004 |
Foldable acrylic versus rigid polymethylmethacrylate intraocular lens in combined phacoemulsification and trabeculectomy.
Topics: Aged; Antibiotics, Antineoplastic; Biocompatible Materials; Cataract; Glaucoma; Hospitals, Universit | 2004 |
Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Conjunct | 2005 |
Augmented trabeculectomy in paediatric glaucoma.
Topics: Antimetabolites; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorouracil; Glaucoma; | 2005 |
Deep sclerectomy augmented with mitomycin C.
Topics: Aged; Antihypertensive Agents; Blister; Cicatrix; Conjunctiva; Epidemiologic Methods; Exudates and T | 2005 |
[Clinical results of fornix-based trabeculectomy with a scleral tunnel].
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M | 2005 |
Correlation between surgical success rate and severity of congenital glaucoma.
Topics: Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Press | 2005 |
Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C.
Topics: Child; Combined Modality Therapy; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Retinal H | 2005 |
Protocol for mitomycin C use in glaucoma surgery.
Topics: Aged; Antibiotics, Antineoplastic; Clinical Protocols; Conjunctiva; Female; Glaucoma; Humans; Intrao | 2005 |
Effect of mitomycin C on ciliary body and intraocular pressure with various application depths: an experimental study.
Topics: Animals; Antibiotics, Antineoplastic; Ciliary Body; Conjunctiva; Intraocular Pressure; Mitomycin; Ra | 2005 |
Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy.
Topics: Aged; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Intraoper | 2005 |
[Characteristics of filtering blebs after fornix-based trabeculectomy with a scleral tunnel].
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 2005 |
Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma; | 2005 |
Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.
Topics: Aged; Cataract; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions.
Topics: Aged; Aged, 80 and over; Biometry; Cataract; Cornea; Eye; Female; Glaucoma; Humans; Intraocular Pres | 2005 |
Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Follow-Up Studies; Glauco | 2005 |
Filtering blebs imaging by optical coherence tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Blister; Child; Combined Modality Thera | 2005 |
Trabeculectomy with mitomycin C in glaucoma associated with uveitis.
Topics: Adult; Antimetabolites; Croatia; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care | 2005 |
Risk of sudden visual loss following filtration surgery in end-stage glaucoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Blindness; Female; Follow-Up Studies; Glaucoma, Angle-Clos | 2005 |
Wipe-out: a complication of glaucoma surgery or just a blast from the past?
Topics: Antibiotics, Antineoplastic; Blindness; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Intermediate-term comparison of trabeculectomy with intraoperative mitomycin-C between Asian American and Caucasian glaucoma patients: a case-controlled comparison.
Topics: Adult; Aged; Asian; Combined Modality Therapy; Epidemiologic Methods; Female; Glaucoma; Humans; Intr | 2007 |
Cyclosporin as an adjunct to glaucoma filtration surgery.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiv | 2005 |
Is intraocular pressure in the early postoperative period predictive of antimetabolite-augmented filtration surgery success?
Topics: Aged; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Glaucoma; Humans; Intraocula | 2005 |
Failed trabeculectomy.
Topics: Antimetabolites; Conjunctiva; Fistula; Fluorouracil; Glaucoma Drainage Implants; Glaucoma, Open-Angl | 2005 |
Deep sclerectomy with mitomycin C in failed trabeculectomy.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Drug Administration Schedu | 2007 |
Outcomes of laser suture lysis after initial trabeculectomy with adjunctive mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Int | 2006 |
Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.
Topics: Aged; Blister; Conjunctiva; Conjunctival Diseases; Female; Fluorouracil; Glaucoma; Humans; Intraocul | 2006 |
Short and long term effect of combined cataract and glaucoma surgery with MMC on ocular dimensions.
Topics: Antihypertensive Agents; Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Mitomycin | 2006 |
Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
Topics: Antihypertensive Agents; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy | 2006 |
Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes.
Topics: Adult; Antibiotics, Antineoplastic; Cataract; Follow-Up Studies; Glaucoma; Humans; Intraocular Press | 2006 |
Long-term results of early trabeculectomy with mitomycin-C and subsequent posterior segment intervention in the treatment of neovascular glaucoma with hazy ocular media.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Glaucoma, Neovascular; Humans; | 2005 |
Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glaucoma, O | 2006 |
Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C.
Topics: Adolescent; Adult; Aged; Antimetabolites; Blister; Child; Combined Modality Therapy; Conjunctiva; Co | 2006 |
Incidence of disc hemorrhages in open-angle glaucoma before and after trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Glaucoma, Open-Angle; Humans; Incidence; In | 2006 |
Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Diabetic Retinopathy; Glaucoma, Neovascul | 2006 |
Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Cohort Studies; Combined Modality Therapy; Female; | 2006 |
Risk of sudden visual loss after filtration surgery in end-stage glaucoma.
Topics: Blindness; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; P | 2006 |
Protection of the conjunctival flap from contact with mitomycin C during tunnel-trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Blister; Conjunctiva; Female; Follow-Up Studies; Humans; Intraocular | 2007 |
Surgical reduction of symptomatic, circumferential, filtering blebs.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Conjunctiv | 2006 |
Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud | 2006 |
Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.
Topics: Aged; Aged, 80 and over; Antimetabolites; Cataract; Female; Fluorouracil; Glaucoma; Humans; Intraocu | 2006 |
Long-term results of surgery in childhood glaucoma.
Topics: Alkylating Agents; Child, Preschool; Combined Modality Therapy; Cornea; Female; Follow-Up Studies; H | 2007 |
Intrastromal diathermal keratostomy: a new micropenetrating clear-cornea glaucoma procedure.
Topics: Adult; Aged, 80 and over; Corneal Stroma; Electrocoagulation; Filtering Surgery; Glaucoma, Open-Angl | 2006 |
Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cautery; Combined Modality Therapy; Female; Glaucoma, Neov | 2006 |
[Glaucoma with unilateral reddening of the eye].
Topics: Antihypertensive Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Glaucoma, Ope | 2007 |
Phacotrabeculectomy with mitomycin C in patients with uveitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract; Co | 2006 |
Refractory glaucoma--here there be dragons.
Topics: Ciliary Body; Combined Modality Therapy; Glaucoma; Humans; Intraocular Pressure; Laser Coagulation; | 2006 |
Trabeculectomy with brief exposure to mitomycin C.
Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Glaucoma; Humans; Int | 2006 |
Immediate postoperative intraocular pressure measurements after trabeculectomy with releasable sutures.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; False Negative Reactions; Female; Fluorou | 2006 |
Use of amniotic membrane as an adjuvant in refractory glaucoma.
Topics: Amnion; Antibiotics, Antineoplastic; Cryopreservation; Glaucoma, Open-Angle; Humans; Intraocular Pre | 2006 |
Mitomycin C "straight scleral tunnel incision"--trabeculectomy with a releasable suture.
Topics: Aged; Astigmatism; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; | 2006 |
Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cryotherapy; Diabetic Retinopathy; Female | 2006 |
Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient.
Topics: Adolescent; Alkylating Agents; Combined Modality Therapy; Corneal Diseases; Dilatation, Pathologic; | 2006 |
[An experimental trial of glaucoma filtering surgery with amniotic membrane].
Topics: Amnion; Animals; Antimetabolites; Fibroblasts; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ra | 2005 |
Glaucoma tube or trabeculectomy? That is the question.
Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Glaucoma; Glaucoma Drainage Implants; Humans; | 2007 |
Intraocular lens opacification after nonpenetrating glaucoma surgery with mitomycin-C.
Topics: Antibiotics, Antineoplastic; Calcinosis; Calcium Carbonate; Combined Modality Therapy; Device Remova | 2007 |
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antihypertensive Agents; Behcet Syndrome; Combined M | 2007 |
Phacotrabeculectomy study.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Fluorouracil; Glaucoma; Humans; Intraocular Pr | 2007 |
Management of glaucoma in patients with nanophthalmos.
Topics: Adolescent; Adult; Aged; Cataract Extraction; Eye Abnormalities; Female; Glaucoma, Open-Angle; Human | 2008 |
Mietz H, Krieglstein GK: Postoperative application of mitomycin C improves the complete success rate of primary trabeculectomy: a prospective, randomized trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1429-1436.
Topics: Alkylating Agents; Fibrosis; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; P | 2007 |
Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Mod | 2007 |
The use of a "cheese-wire" suture in trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; | 2007 |
Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
Topics: Aged; Aged, 80 and over; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular | 2008 |
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
Topics: Alkylating Agents; Animals; Antimetabolites; Blister; Conjunctiva; Connective Tissue; Connective Tis | 2006 |
Trabeculectomy with mitomycin C.
Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Le | 2007 |
Long-term results of trabeculectomy with mitomycin C applied under the scleral flap.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Combined Modality Therapy; Female; Follow-Up Stud | 2007 |
Retinal detachment and congenital glaucoma.
Topics: Combined Modality Therapy; Female; Humans; Hydrophthalmos; Intraocular Pressure; Male; Mitomycin; Po | 2007 |
Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Disease Progression; Female; Follow-Up Studies; G | 2007 |
Surgical revision of failed filtration surgery with mitomycin C augmentation.
Topics: Aged; Antihypertensive Agents; Antimetabolites, Antineoplastic; Combined Modality Therapy; Female; F | 2007 |
Iris prolapse after non-penetrating trabeculectomy with sinusotomy and mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Humans; Intraocular Pressure; Iris; Iris Diseases; Male; Mitomyci | 2007 |
Management of suprachoroidal hemorrhage.
Topics: Aged, 80 and over; Choroid Hemorrhage; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocu | 2007 |
Simultaneous bilateral ocular decompression retinopathy after trabeculectomy with mitomycin C for uveitic glaucoma.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glaucoma, Open | 2008 |
Focal corneal decompensation after filtering surgery with mitomycin C.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Edema; Glaucoma; Humans; Intraocular Pr | 2007 |
Long-term results of amniotic membrane transplantation-assisted bleb revision for leaking blebs.
Topics: Adult; Aged; Alkylating Agents; Amnion; Blister; Combined Modality Therapy; Female; Humans; Intraocu | 2008 |
[Midterm patient satisfaction following mitomycin C-assisted trabeculectomy].
Topics: Aged; Female; Follow-Up Studies; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Ophthal | 2008 |
Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Diagnostic Techniques, | 2008 |
Self-drainage of a posttrabeculectomy choroidal effusion: loss of protective effect.
Topics: Alkylating Agents; Choroid Diseases; Combined Modality Therapy; Exudates and Transudates; Glaucoma, | 2008 |
Co-treatment of suberoylanilide hydroxamic acid and mitomycin-C induces the apoptosis of rabbit tenon's capsule fibroblast and improves the outcome of glaucoma filtration surgery.
Topics: Alkylating Agents; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Caspase 3; C | 2008 |
Flap suture--a simple technique for the revision of hypotony maculopathy following trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma, Open | 2008 |
[Progress in laser sclerotomy ab externo] Enlarging the sclerostomy channel and local mitomycin administration].
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Follow-Up Studies; Glaucoma, Open-Angle; Hum | 1995 |
Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs.
Topics: Animals; Collagen; Conjunctiva; Connective Tissue; Dogs; Drug Implants; Fibroblasts; Fibrosis; Filte | 1995 |
[Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 minute). Independent evaluation of a retrospective nonrandomized study].
Topics: Aged; Aged, 80 and over; Cataract Extraction; Dose-Response Relationship, Drug; Female; Follow-Up St | 1995 |
[Comparative study of administration time of mitomycin C in trabeculectomy: 2.5 or 5 minutes?].
Topics: Adult; Aged; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intraocular Pressure; | 1995 |
[Hypotonous maculopathy following trabeculectomy with mitomycin C].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Incidence; Intraocular Pressure; Macula | 1995 |
The effect of brief intrascleral or episcleral application of mitomycin C on the ciliary epithelium and pressure in the rabbit eye.
Topics: Animals; Aqueous Humor; Ciliary Body; Intraocular Pressure; Mitomycin; Ocular Hypotension; Pigment E | 1994 |
Treatment of postfiltration bleb leaks with autologous blood.
Topics: Aged; Anterior Chamber; Blood; Female; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Ma | 1995 |
Removable sutures in glaucoma surgery.
Topics: Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Suture Techniques; Time Factors; Tr | 1994 |
Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 1995 |
Adjunctive mitomycin C in primary trabeculectomy in phakic eyes.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Incide | 1995 |
One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction.
Topics: Adult; Aged; Astigmatism; Cataract; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Gl | 1995 |
Mitomycin C as adjunctive therapy with glaucoma implant surgery.
Topics: Adult; Aged; Biocompatible Materials; Chemotherapy, Adjuvant; Female; Fibrosis; Follow-Up Studies; G | 1994 |
Successful surgical treatment of hypotony maculopathy following trabeculectomy with topical mitomycin C.
Topics: Administration, Topical; Adult; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Mitomyci | 1994 |
Profound long-term hypotony without maculopathy after trabeculectomy with antimetabolite.
Topics: Aged; Female; Fluorescein Angiography; Fluorouracil; Fundus Oculi; Glaucoma, Open-Angle; Humans; Int | 1994 |
[Trabeculectomy for normal-tension glaucoma].
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M | 1994 |
Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Int | 1994 |
[Experiences with mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Huma | 1994 |
Filtering surgery with mitomycin-C in uncomplicated (primary open angle) glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mi | 1994 |
Treatment of hypotonous maculopathy after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Blood Transfusion, Autologous; Contact Lenses; Female; Humans; Intraocular Pressure; Ma | 1994 |
Adjunctive use of transconjunctival mitomycin-C in ab externo diode laser sclerostomy surgery in rabbits.
Topics: Animals; Chemotherapy, Adjuvant; Conjunctiva; Glaucoma; Intraocular Pressure; Laser Therapy; Mitomyc | 1994 |
Mitomycin C in anterior chamber tube shunt to a surgical membrane.
Topics: Animals; Anterior Chamber; Glaucoma; Intraocular Pressure; Mitomycin; Polytetrafluoroethylene; Prost | 1993 |
Low-energy argon laser suture lysis after trabeculectomy.
Topics: Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Mitomycin; Surgical Flap | 1994 |
Effects of topical mitomycin C on glaucoma filtration surgery.
Topics: Administration, Topical; Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studi | 1993 |
Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Child; Combined Modality Therap | 1993 |
Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Conjunctiva; Female; Fibrosis | 1993 |
Effects of topical mitomycin C on primary trabeculectomies and combined procedures.
Topics: Administration, Topical; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Post | 1993 |
Trabeculectomy with mitomycin C for refractory glaucoma in blacks.
Topics: Adult; Aged; Black People; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; I | 1993 |
Late argon laser suture lysis after mitomycin C trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; | 1993 |
Anterior chamber reaction after mitomycin and 5-fluorouracil trabeculectomy: a comparative study.
Topics: Anterior Chamber; Aqueous Humor; Biological Transport, Active; Blood; Chemotherapy, Adjuvant; Eye Pr | 1993 |
Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit.
Topics: Animals; Double-Blind Method; Drug Evaluation, Preclinical; Fluorouracil; Glaucoma; Intraocular Pres | 1993 |
Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomycin C.
Topics: Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Mitomycin; Ocular Hypotension; Postoperative | 1993 |
Intracameral tissue plasminogen activator in neovascular glaucoma.
Topics: Adult; Female; Glaucoma, Neovascular; Humans; Intraocular Pressure; Mitomycin; Thrombosis; Tissue Pl | 1993 |
Surgical management of post-traumatic angle recession glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Child; Combined Modality Therapy; Drai | 1993 |
Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery.
Topics: Adolescent; Adult; Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Conjunctiva; | 1995 |
Laser suture lysis after mitomycin C trabeculectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chi | 1996 |
Trabeculectomy at the inferior limbus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Chemotherapy, Adjuvant; Child; Chi | 1996 |
Needle elevation of the scleral flap for failing filtration blebs after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Chemotherapy, Adju | 1996 |
Endophthalmitis after filtering surgery with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bact | 1996 |
Use of oversized bandage soft contact lenses in the management of early hypotony following filtration surgery.
Topics: Aged; Aged, 80 and over; Antimetabolites; Contact Lenses, Hydrophilic; Female; Fluorouracil; Follow- | 1996 |
Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Drainage; Filtering Surgery; Glaucoma; Intraocular | 1996 |
Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Conjunctiva; Cornea; Epinephrine; Epithelium; Female; Fluorescein | 1996 |
Experimentally designed glaucoma implant surgery with mitomycin C in rabbit.
Topics: Animals; Anterior Eye Segment; Antibiotics, Antineoplastic; Aqueous Humor; Chemotherapy, Adjuvant; G | 1995 |
Regression of rubeosis iridis after trabeculectomy combined with mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; H | 1996 |
Decrease of intraocular pressure after subconjunctival injection of mitomycin in human glaucoma.
Topics: Anti-Bacterial Agents; Blindness; Conjunctiva; Glaucoma; Humans; Injections; Intraocular Pressure; M | 1996 |
Retinal vein occlusion after trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Postop | 1996 |
Combined phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative mitomycin-C: comparison between 3.2- and 6.0-mm incisions.
Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Lenses, Intraocular; Male | 1996 |
Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Intraocular | 1996 |
Combined phacoemulsification and trabeculectomy with mitomycin-C.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Follow-Up Studies; Glaucoma, Open-Angle; Hum | 1996 |
Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Child; Corneal Diseases; Female; Follow-Up Studies; | 1996 |
Slit-lamp needle revision of failed filtering blebs using mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Filtering Surgery; Follow-Up Studies | 1996 |
Use of a scleral shield for the application of mitomycin-C during trabeculectomy: preliminary clinical results.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cell Division; Drug Delivery Systems; Female; Glaucoma; Hu | 1996 |
Surgery for refractory glaucoma.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intrao | 1996 |
Intermediate-term outcome of variable dose mitomycin C filtering surgery.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocular Pressu | 1997 |
Mitomycin-C in laser sclerostomy: benefit and complications.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Follow-Up Studies; Glaucoma, Open-Angle; Human | 1997 |
Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery.
Topics: Aged; Cataract; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Lens | 1997 |
Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment.
Topics: Adult; Aged; Cataract Extraction; Chemotherapy, Adjuvant; Cornea; Female; Filtering Surgery; Follow- | 1997 |
Severe visual loss after autologous blood injection for mitomycin-C-associated hypotonous maculopathy.
Topics: Adult; Blood; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macula Lutea; Male; Mi | 1997 |
Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma.
Topics: Animals; Autoradiography; Conjunctiva; Eye; Glaucoma; Intraocular Pressure; Intraoperative Period; M | 1997 |
[Effect of local administration of mitomycin C on intraocular pressure].
Topics: Adult; Aged; Female; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Ophthalmic Solution | 1996 |
An ultrasound biomicroscopic study of filtering blebs after mitomycin C trabeculectomy.
Topics: Adolescent; Adult; Aged; Anterior Eye Segment; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; | 1995 |
Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 1997 |
Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites; Chemotherapy, Adjuvant | 1997 |
Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biological Transport; Cell Membrane Permeability; Chemothe | 1997 |
Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fem | 1996 |
Intraoperative mitomycin-C for glaucoma associated with ocular inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chi | 1997 |
Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fo | 1997 |
[Surgical revision of failed filtering bleb with mitomycin C].
Topics: Adult; Aged; Aged, 80 and over; Female; Filtering Surgery; Fluorouracil; Follow-Up Studies; Glaucoma | 1997 |
Mitomycin-C supplemented trabeculectomy, phacoemulsification, and foldable lens implantation.
Topics: Aged; Cataract; Cataract Extraction; Equipment Design; Female; Humans; Intraocular Pressure; Lenses, | 1997 |
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Follow-Up | 1997 |
Echographic diagnosis of scleral fold in hypotony.
Topics: Cataract; Diagnosis, Differential; Eye Foreign Bodies; Female; Humans; Intraocular Pressure; Middle | 1997 |
Management of chronic hypotony following trabeculectomy with mitomycin C.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Blood; Chronic Disease; Follow-Up Studies; Gla | 1997 |
Combined phacoemulsification and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Female; Foll | 1997 |
[Surgical revision for hypotonia after glaucoma operation with mitomycin C].
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intraocular P | 1997 |
Encapsulated filtering blebs after trabeculectomy with mitomycin-C.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-U | 1997 |
Fornix-based trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow- | 1997 |
Corneal blood staining following autologous blood injection for hypotony maculopathy.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Blood; Cornea; Follow-Up Studies; Glauc | 1997 |
Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Follow-Up Studies; Glaucoma; Huma | 1997 |
The effect of adjunctive mitomycin C in Molteno implant surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucom | 1997 |
Bleb-related ocular infection in children after trabeculectomy with mitomycin C.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; | 1997 |
Midterm reversible failure in trabeculectomies with adjunctive mitomycin-C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucom | 1997 |
Simultaneous use of mitomycin-C with Baerveldt implantation.
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Filtering Surgery; Follow-Up Studies; G | 1997 |
Combined trabeculectomy and extracapsular cataract extraction with mitomycin C.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Female; Humans; Intraocular Pressure; Male; Middle Age | 1997 |
Corneal safety-valve incision in mitomycin filtering surgery.
Topics: Antibiotics, Antineoplastic; Cornea; Fibrosis; Filtering Surgery; Humans; Intraocular Pressure; Intr | 1998 |
Surgical results of secondary glaucomas in childhood.
Topics: Adolescent; Child; Child, Preschool; Ciliary Body; Cryotherapy; Eye Abnormalities; Follow-Up Studies | 1998 |
Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glau | 1998 |
[The cytotoxic effect of topical mitomycin C on the ciliary body in rabbits].
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Aqueous Humor; Blood-Aqueous Barrier; | 1998 |
Outcomes of primary trabeculectomy with the use of adjunctive mitomycin.
Topics: Administration, Topical; Aged; Chemotherapy, Adjuvant; Cohort Studies; Female; Glaucoma; Humans; Int | 1998 |
Late removal of releasable sutures after trabeculectomy or combined trabeculectomy with cataract extraction supplemented with antifibrotics.
Topics: Aged; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intraocular Pr | 1998 |
Molteno implant with mitomycin C: intermediate-term results.
Topics: Adult; Chemotherapy, Adjuvant; Cohort Studies; Female; Filtering Surgery; Follow-Up Studies; Glaucom | 1998 |
Penetrating keratoplasty with a valved glaucoma drainage implant for congenital glaucoma and corneal scarring secondary to hydrops.
Topics: Administration, Topical; Anterior Chamber; Antibiotics, Antineoplastic; Corneal Edema; Corneal Opaci | 1998 |
Antimetabolites in glaucoma surgery: our experiences and results.
Topics: Antimetabolites; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraopera | 1997 |
Permanent glaucomatous visual loss after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cornea; Dexamethasone; Filtering Surgery; | 1998 |
The effect of paclitaxel powder on glaucoma filtration surgery in rabbits.
Topics: Animals; Antineoplastic Agents, Phytogenic; Conjunctiva; Filtering Surgery; Glaucoma; Intraocular Pr | 1998 |
Trabeculectomy augmented with mitomycin C application under the scleral flap.
Topics: Adult; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Life Ta | 1998 |
Conditions for balance between lower normal pressure control and hypotony in mitomycin trabeculectomy.
Topics: Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mi | 1998 |
Needling revision of glaucoma drainage device filtering blebs.
Topics: Chemotherapy, Adjuvant; Drainage; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pre | 1998 |
An image analysis study of cataract development after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 1998 |
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ciliary Body; Drainage; Female; Follow-Up Studies; Glauc | 1998 |
Trabeculectomy with mitomycin C: intermediate-term results.
Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Postopera | 1998 |
Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glauc | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma.
Topics: Cataract; Cataract Extraction; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation | 1998 |
Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoper | 1998 |
Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients.
Topics: Adolescent; Adult; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular | 1998 |
Trabeculectomy with long-term-stored mitomycin C in West Indian population.
Topics: Adult; Aged; Animals; Drug Storage; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Age | 1998 |
The results of trabeculectomy with and without mitomycin C in young patients.
Topics: Adolescent; Adult; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Nucleic Acid Synthesis Inhibit | 1998 |
Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy.
Topics: Adolescent; Adult; Aged; Antimetabolites; Aqueous Humor; Female; Glaucoma; Humans; Intraocular Press | 1998 |
Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma; Hu | 1998 |
Rapid preparation of small-volume autologous fibrinogen concentrate and its same day use in bleb leaks after glaucoma filtration surgery.
Topics: Administration, Topical; Adult; Aged; Female; Fibrin Tissue Adhesive; Follow-Up Studies; Glaucoma; H | 1998 |
Occlusive ligature and standardized fenestration of a Baerveldt tube with and without antimetabolites for early postoperative intraocular pressure control.
Topics: Aged; Antimetabolites; Aqueous Humor; Female; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Hu | 1998 |
Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Cicatrix; Conjunctival Diseases; Follow-Up S | 1998 |
Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciliary Body; Cryotherapy; Female; Follow-Up Stud | 1999 |
Mitotic effect of autologous blood injection and diode laser bleb revision on rabbit filtration blebs.
Topics: Animals; Blood Transfusion, Autologous; Bromodeoxyuridine; Cell Count; Cell Division; Conjunctival D | 1999 |
Combined penetrating keratoplasty and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Corneal Diseases; Female; Glaucoma; Graft Survival; Humans; Intraocu | 1999 |
Management of congenital glaucoma.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Ciliary Body; Cryosurgery; Decision Making; Filtering | 1999 |
Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated congenital glaucoma.
Topics: Chemotherapy, Adjuvant; Child, Preschool; Corneal Opacity; Female; Glaucoma; Humans; Infant; Infant, | 1999 |
Results of medical management and mitomycin C-augmented excisional bleb revision for encapsulated filtering blebs.
Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ophthalmic Solutions; Postoper | 1999 |
Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fluorouracil; Follow-Up Studies | 1999 |
Clinical and histopathologic findings of iris nevus (Cogan-Reese) syndrome.
Topics: Adult; Corneal Edema; Glaucoma; Humans; Intraocular Pressure; Iris Neoplasms; Male; Mitomycin; Nevus | 1999 |
Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraocular Pressu | 1999 |
The comparative benefits of glaucoma filtering surgery with an electric-pulse targeted drug delivery system demonstrated in an animal model.
Topics: Animals; Bleomycin; Chemotherapy, Adjuvant; Conjunctiva; Cornea; Drug Delivery Systems; Electroporat | 1999 |
Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intra | 1999 |
Effects of subconjunctival injection of mitomycin-C on iridial circulation in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Blood Flow Velocity; Conjunctiva; Injections; Intraocular Pres | 1999 |
Combination of autologous blood injection and bleb compression sutures to treat hypotony maculopathy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Blood; Combined Modality Therapy; Female; Glaucoma; Huma | 1999 |
Effect of mitomycin C for combined trabeculectomy and phacoemulsification.
Topics: Aged; Aged, 80 and over; Female; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Phacoem | 2000 |
Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Corneal Diseases; Endothelium, | 2000 |
Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas.
Topics: Adolescent; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fo | 2000 |
[Sinusotomy with intraoperative mitomycin C administration in selected eyes with advanced glaucomatous damage].
Topics: Adult; Aged; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle | 2000 |
Antimetabolite use in revising failing filtering blebs.
Topics: Anterior Eye Segment; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Fibrosis; Glaucoma, O | 1999 |
The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Disease Progression; Female; Glaucoma, Open-Angle; Humans; Intr | 2000 |
Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications.
Topics: Aged; Antimetabolites; Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; I | 2000 |
Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery.
Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Chronic Disease; Female; Glaucoma; Humans | 2000 |
Trabeculectomy with mitomycin C for post-keratoplasty glaucoma.
Topics: Adult; Aged; Female; Glaucoma; Graft Rejection; Humans; Intraocular Pressure; Keratoplasty, Penetrat | 2000 |
Long term results of glaucoma surgery among participants in an east African population survey.
Topics: Africa, Eastern; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Midd | 2000 |
Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma.
Topics: Aged; Antimetabolites; Glaucoma, Neovascular; Humans; Intraocular Pressure; Male; Mitomycin; Retinal | 2000 |
Conjunctival dysfunction and mitomycin C-induced hypotony.
Topics: Adolescent; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Conjunctival Dise | 2000 |
Fornix-based trabeculectomy with Wise's suture technique in Chinese patients.
Topics: Antimetabolites, Antineoplastic; Asian People; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gl | 2000 |
Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Cataract; Cataract Extraction; Female; | 2000 |
Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits.
Topics: Animals; Antimetabolites; Biocompatible Materials; Conjunctiva; Dose-Response Relationship, Drug; Dr | 2000 |
Success criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Fluorouracil; Glaucoma; Humans; Intraocular | 2000 |
Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma.
Topics: Adolescent; Adult; Aged; Eye Injuries; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pres | 2001 |
Central retinal vein occlusion after trabeculectomy with mitomycin C.
Topics: Fluorescein Angiography; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Ophthalmoscopy; | 2001 |
Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism.
Topics: Adolescent; Adult; Aged; Anthropometry; Astigmatism; Chemotherapy, Adjuvant; Cornea; Eye; Female; Gl | 2001 |
Management of the failing filter.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Ocular Hypertensio | 2001 |
Should antiproliferatives be used in filtering surgery of normal tension glaucoma?
Topics: Antineoplastic Agents; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mito | 2001 |
Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure.
Topics: Aged; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Middle Aged; Mit | 2001 |
Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression.
Topics: Aged; Antimetabolites; Chemotherapy, Adjuvant; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; I | 2001 |
Intraoperative mitomycin-C without conjunctival and Tenon's capsule touch in primary trabeculectomy.
Topics: Conjunctiva; Connective Tissue; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intra | 2001 |
Autologous blood injection for marked overfiltration early after trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Blood; Female; Glaucoma, Open-Angle; Humans; Injections; Int | 2001 |
Bilateral chronic hypotony following trabeculectomy with mitomycin-C.
Topics: Adult; Age Factors; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2001 |
Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.
Topics: Adult; Antihypertensive Agents; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Follow-Up Stud | 2001 |
Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report.
Topics: Antihypertensive Agents; Diagnosis, Differential; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2001 |
Comparison of long-term incidence of posterior capsular opacification between phacoemulsification and phacotrabeculectomy.
Topics: Aged; Antimetabolites; Case-Control Studies; Cataract; Female; Glaucoma, Open-Angle; Humans; Inciden | 2002 |
[Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Conjunctiva; Dry Eye Synd | 2001 |
[Cytotoxic effect of mitomycin C on the nonpigmented epithelium of ciliary body in rabbit eyes].
Topics: Animals; Ciliary Body; Epithelium; Female; Intraocular Pressure; Male; Mitomycin; Rabbits | 1998 |
[Results and complications after deep sclerectomy].
Topics: Cataract Extraction; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Compl | 2002 |
Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb after trabeculectomy.
Topics: Antimetabolites; Aqueous Humor; Chemotherapy, Adjuvant; Conjunctiva; Cross-Sectional Studies; Female | 2002 |
Phacotrabeculectomy: peripheral iridectomy or no peripheral iridectomy?
Topics: Aged; Aged, 80 and over; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Lens Implan | 2002 |
[Antimetabolites in glaucoma surgery--long-term results].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Glaucoma; Humans; Intraocular Pressur | 2002 |
Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma, Angle-C | 2002 |
Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomycin C.
Topics: Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Mitomycin; Postoperative Complicatio | 1992 |
Hypotony maculopathy following trabeculectomy with mitomycin C.
Topics: Adult; Fundus Oculi; Humans; Intraocular Pressure; Macula Lutea; Male; Mitomycin; Postoperative Comp | 1992 |
Effect of topical mitomycin C on glaucoma filtration surgery in monkeys.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Disease Models, Animal; Glaucoma; Intraocula | 1992 |
The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits.
Topics: Administration, Topical; Animals; Cicatrix; Combined Modality Therapy; Glaucoma; Intraocular Pressur | 1991 |
Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Follow-Up | 1990 |